<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD>
<!-- Created by: EDGAR Online, Inc. EDGAR Filing HTML Converter, Version: 4.63, http://www.edgar-online.com -->
<TITLE> Biostar Pharmaceuticals, Inc. (Form: 10-K, Received: 04/14/2016 16:06:03) </TITLE>
<META NAME="TABLES" CONTENT="FIS_FORM **FIS_PART_I **FIS_BUSINESS **FIS_RISK_FACTORS **FIS_UNRESOLVED_STAFF_COMMENTS **FIS_PROPERTIES **FIS_LEGAL_PROCEEDINGS **FIS_MINE_SAFETY_DISCLOSURE **FIS_PART_II **FIS_MARKET **FIS_FINANCIAL_DATA **FIS_MANAGEMENTS_DISCUSSION **FIS_RESULTS_OF_OPERATIONS **FIS_LIQUIDITY_CAPITAL **FIS_MARKET_RISK **FIS_FINANCIAL_STATEMENTS **FIS_AUDITORS_OPINION **FIS_BALANCE_SHEET **FIS_INCOME_STATEMENT **FIS_STOCKHOLDERS_EQUITY **FIS_CASH_FLOW **FIS_NOTES_TO_FINANCIAL_STATEMENT **FIS_SUBSEQUENT_EVENTS **FIS_ACCOUNTING_CHANGES **FIS_CONTROL_AND_PROCEDURES **FIS_OTHER_INFORMATION **FIS_PART_III **FIS_DIRECTORS_AND_OFFICERS **FIS_NAME_AND_TITLE **FIS_COMPENSATION **FIS_SECURITY_OWNERS **FIS_BENEFICIAL_OWNERS **FIS_BENEFICIAL_OWNERS_2 **FIS_OFFICER_TRANSACTIONS **FIS_ACCOUNTANT_FEES **FIS_PART_IV **FIS_EXHIBITS **FIS_SIGNATURES FIS_EXHIBIT_21 **FIS_SUBSIDIARIES FIS_EXHIBIT_23 **FIS_EXPERTS_CONSENT FIS_EXHIBIT_23_2 **FIS_EXPERTS_CONSENT_2 FIS_EXHIBIT_23_3 **FIS_EXPERTS_CONSENT_3 FIS_EXHIBIT_31 **FIS_CERTIFICATION FIS_EXHIBIT_31_2 **FIS_CERTIFICATION_2 FIS_EXHIBIT_32 **FIS_CERTIFICATION_3 FIS_EXHIBIT_32_2 **FIS_CERTIFICATION_4 ">
<META NAME="DETECTED PAGES" CONTENT="93">
<STYLE TYPE="text/css">
<!--
	body          { background-color: white; color: black }
	.eolNewPage   { page-break-after: always; line-height: 0; height: 0; margin: 0; padding: 0 }
	.eolLeftAlign { text-align: left; margin-left: auto; margin-right: auto }
	.eolCenter    { text-align: center }
	a:link        { color: blue }
	a:active      { color: red }
	a:visited     { color: purple }
	
	@media print
	{
		@page           { margin: 0.25in }
		body            { font-size: 10pt }
		a               { text-decoration: none }
		thead           { display: table-header-group }
		tfoot           { display: table-footer-group }
		hr.eolPageBreak { display: none }
		.eolPrint50pt   { font-size: 5pt }
		.eolPrint55pt   { font-size: 5.5pt }
		.eolPrint60pt   { font-size: 6pt }
		.eolPrint65pt   { font-size: 6.5pt }
		.eolPrint70pt   { font-size: 7pt }
		.eolPrint75pt   { font-size: 7.5pt }
		.eolPrint80pt   { font-size: 8pt }
		.eolPrint85pt   { font-size: 8.5pt }
		.eolPrint90pt   { font-size: 9pt }
		.eolPrint95pt   { font-size: 9.5pt }
	}
-->
</STYLE>
</HEAD>
<BODY>
<A NAME="eolPage1"></A>
<A NAME="FIS_TOP_OF_DOCUMENT"></A>

<A NAME="BIOSTARPHARMA10K123115_HTM"></A>
<EFX_FORM>
<A NAME="FIS_FORM"></A>
<DIV>
<HR STYLE="COLOR: #000000; MARGIN-TOP: -5PX" NOSHADE SIZE="4">
<HR STYLE="COLOR: #000000; MARGIN-TOP: -10PX" NOSHADE SIZE="1">
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 16PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	UNITED STATES
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 16PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	SECURITIES AND EXCHANGE COMMISSION
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Washington, D.C. 20549
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<HR STYLE="COLOR: BLACK" ALIGN="CENTER" NOSHADE SIZE="2" WIDTH="12%">
</DIV>
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 16PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	FORM 10-K
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
<DIV>
<HR STYLE="COLOR: BLACK" ALIGN="CENTER" NOSHADE SIZE="2" WIDTH="12%">
	&#160;
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(Mark One)
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: WINGDINGS; DISPLAY: INLINE">
	x
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="84%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For the fiscal year ended:
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;December 31, 2015
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Or
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: WINGDINGS; DISPLAY: INLINE">
	&#168;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="84%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For the transition period from ______________ to _______________
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Commission File Number:&#160;
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	001-34708
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 18PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	BIOSTAR PHARMACEUTICALS, INC.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(Exact name of registrant as specified in its charter)
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="45%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE">
	Maryland
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="45%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE">
	20-8747899
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="45%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(State or other jurisdiction of incorporation of origination)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="45%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(I.R.S. Employer Identification Number)
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="45%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	No. 588 Shiji Xi Avenue
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Xianyang, Shaanxi Province
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE">
	People&#8217;s Republic of China
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="45%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE">
	712046
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="45%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(Address of principal executive offices)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="45%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(Zip code)
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	86-29-33686638
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(Registrant&#8217;s telephone number, including area code)
</FONT>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(Former name, former address and former fiscal year, if changed since last report)
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_2"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Securities Registered pursuant to Section 12(b) of the Act:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="43%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE">
	Title of each class
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="43%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE">
	Name of each exchange on which registered
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="43%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Common Stock, par value $0.001 per share
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="43%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	NASDAQ Stock Market LLC
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(NASDAQ&#160;Capital Market)
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Securities Registered pursuant to Section 12(g) of the Act: Common stock, par value $0.001 per share
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160; Yes&#160;
<FONT STYLE="DISPLAY: INLINE" FACE="WINGDINGS">
	&#168;
</FONT>
	&#160;&#160; No&#160;
<FONT STYLE="DISPLAY: INLINE" FACE="WINGDINGS">
	x
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.&#160;&#160; Yes&#160;
<FONT STYLE="DISPLAY: INLINE" FACE="WINGDINGS">
	&#168;
</FONT>
	&#160;&#160; No&#160;
<FONT STYLE="DISPLAY: INLINE" FACE="WINGDINGS">
	x
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160; &#160;Yes&#160;
<FONT STYLE="DISPLAY: INLINE" FACE="WINGDINGS">
	x
</FONT>
	&#160;&#160; No&#160;
<FONT STYLE="DISPLAY: INLINE" FACE="WINGDINGS">
	&#168;
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160; Yes&#160;
<FONT STYLE="DISPLAY: INLINE" FACE="WINGDINGS">
	x
</FONT>
	&#160;&#160; No&#160;
<FONT STYLE="DISPLAY: INLINE" FACE="WINGDINGS">
	&#168;
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (&#167; 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant&#8217;s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
<FONT STYLE="DISPLAY: INLINE" FACE="WINGDINGS">
	&#168;
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="28%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Large accelerated filer&#160;&#160;
<FONT STYLE="FONT-FAMILY: WINGDINGS; DISPLAY: INLINE">
	&#168;
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="20%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="29%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Accelerated filer&#160;
<FONT STYLE="FONT-FAMILY: WINGDINGS; DISPLAY: INLINE">
	&#168;
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="28%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="20%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="29%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="28%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Non-accelerated filer&#160;
<FONT STYLE="FONT-FAMILY: WINGDINGS; DISPLAY: INLINE">
	&#168;
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="20%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="29%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Smaller reporting company&#160;
<FONT STYLE="FONT-FAMILY: WINGDINGS; DISPLAY: INLINE">
	x
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160; Yes&#160;
<FONT STYLE="DISPLAY: INLINE" FACE="WINGDINGS">
	&#168;
</FONT>
	&#160;&#160; No&#160;
<FONT STYLE="DISPLAY: INLINE" FACE="WINGDINGS">
	x
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As of the close of business on December 31, 2015, the aggregate market value of the voting stock (common stock) held by non-affiliates of the registrant was approximately $4,992,047&#160;based on the closing sale price of $2.8 per share post one-for-seven reverse stock split ($0.40 per pre-reverse share pre-split) of our common stock on NASDAQ Stock Market LLC on the same date.
</FONT>
</FONT>
</DIV>
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As of March 28, 2016, the Company had 2,210,913&#160;shares of common stock issued and outstanding.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage2"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_TOC">
	T
</A>
	ABLE OF CONTENTS
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	TO ANNUAL REPORT ON FORM 10-K
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	FOR YEAR ENDED DECEMBER 31, 2015
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="5%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Page
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	PART I
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 1.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_1">
	Business
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 1A.&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_1A">
	Risk Factors
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160; 19
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 1B.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_1B">
	Unresolved Staff Comments
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	33
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 2.&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_2">
	Properties
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	34
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 3.&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_3">
	Legal Proceedings
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	34
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 4.&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_4">
	Mine Safety Disclosures
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	34
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	PART II
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 5.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_5">
	Market for Registrant&#8217;s Common Equity, Related Stock Holder Matters, Issuer Purchases of Equity Securities
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	35
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 6.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_6">
	Selected Financial Data
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	35
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 7.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_7">
	Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	36
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 7A.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_7A">
	Quantitative and Qualitative Disclosures About Market Risk
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	43
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 8.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_8">
	Financial Statements
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-1
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 9.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_9">
	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	44
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 9A.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_9A">
	Controls and Procedures
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	44
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 9B.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_9B">
	Other Information
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	44
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	PART III
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 10.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_10">
	Directors, Executive Officers, and Corporate Governance
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	45
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 11.&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_11">
	Executive Compensation
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
	48
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 12.&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_12">
	Securities Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	50
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 13.&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_13">
	Certain Relationships and Related Transactions, and Director Independence
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	52
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 14.&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_14">
	Principal Accounting Fees and Services
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	53
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	PART IV
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Item 15.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_15">
	Exhibits
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	54
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="74%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP" WIDTH="82%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<!--EFPLACEHOLDER-->
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_SIG">
	Signatures
</A>
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	55
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage3"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	All statements contained in this Annual Report on Form 10-K (&#8220;Form 10-K&#8221;) for Biostar Pharmaceuticals, Inc., other than statements of historical facts, that address future activities, events or developments are forward-looking statements, including, but not limited to, statements containing the words &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;expect&#8221; and words of similar import.&#160;&#160;These statements are based on certain assumptions and analyses made by us in light of our experience and our assessment of historical trends, current conditions and expected future developments as well as other factors we believe are appropriate under the circumstances.&#160;&#160;However, whether actual results will conform to the expectations and predictions of management is subject to a number of risks and uncertainties that may cause actual results to differ materially.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Such risks include, among others, the following: national and local general economic and market conditions; our ability to sustain, manage or forecast our growth; raw material costs and availability; new product development and introduction; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; the ability to protect technology; and other factors referenced in this and previous filings.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Consequently, all of the forward-looking statements made in this Form 10-K are qualified by these cautionary statements and there can be no assurance that the actual results anticipated by management will be realized or, even if substantially realized, that they will have the expected consequences to or effects on our business operations.&#160;&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	These statements reflect our current view of future events and are subject to certain risks and uncertainties as noted below. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, our actual results could differ materially from those anticipated in these forward-looking statements. Actual events, transactions and results may materially differ from the anticipated events, transactions or results described in such statements. Although we believe that our expectations are based on reasonable assumptions, we can give no assurance that our expectations will materialize. Many factors could cause actual results to differ materially from our forward looking statements including those set forth in Item 1A of this report. Other unknown, unidentified or unpredictable factors could materially and adversely impact our future results. We undertake no obligation and do not intend to update, revise or otherwise publicly release any revisions to our forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of any unanticipated events.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We file reports with the Securities and Exchange Commission (&#8220;SEC&#8221; or &#8220;Commission&#8221;). We make available on our website (http://www.andatee.com) free of charge our public reports filed pursuant to the Exchange Act and amendments to those reports as soon as reasonably practicable after we electronically file such materials with or furnish them to the SEC. Information appearing at our website is not a part of this Annual Report on Form 10-K. You can also read and copy any materials we file with the Commission at its Public Reference Room at 100 F Street, NE, Washington, DC 20549. You can obtain additional information about the operation of the Public Reference Room by calling the Commission at 1-800-SEC-0330. In addition, the Commission maintains an Internet site (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the Commission, including our reports.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our fiscal year begins on January 1, and ends on December 31, and any references herein to &#8220;Fiscal 2015&#8221; mean the year ended December 31, 2015, and references to other &#8220;Fiscal&#8221; years mean the year ending December 31, of the year indicated.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We obtained statistical data, market data and other industry data and forecasts used in this Form 10-K from publicly available information. While we believe that the statistical data, industry data, forecasts and market research are reliable, we have not independently verified the data, and we do not make any representation as to the accuracy of that information.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage4"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_PART_I>
<A NAME="FIS_PART_I"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	PART I
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_BUSINESS>
<A NAME="FIS_BUSINESS"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_1">
	ITEM
</A>
	1.&#160; BUSINESS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Overview
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Biostar Pharmaceuticals, Inc. (&#8220;Biostar&#8221;)&#160;is a holding company that, through our wholly-owned subsidiary Shaanxi Biostar Biotech, Ltd. (&#8220;Shaanxi Biostar&#8221;) and our variable interest entities ("VIEs") Shaanxi Aoxing Pharmaceutical Co., Ltd. (&#8220;Aoxing Pharmaceutical&#8221;), and Shaanxi Weinan Huaren Pharmaceuticals Ltd.&#160;(&#8220;Shaanxi Weinan&#8221;) develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions in the People&#8217;s Republic of China (the &#8220;PRC&#8221; or &#8220;China&#8221;).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Corporate Organization and History
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Biostar was incorporated in the State of Maryland on March 27, 2007. Through the steps described immediately below, we became the indirect holding company for Aoxing Pharmaceutical, a medical and pharmaceutical developer, manufacturer and marketer in the PRC on November 1, 2007.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 9PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On June 15, 2007, we formed Shaanxi Biostar in the PRC as our wholly-owned subsidiary.&#160;&#160;Because Shaanxi Biostar is wholly-owned by Biostar, a U.S. company, it is a wholly foreign-owned enterprise, or WFOE, under PRC laws.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Aoxing Pharmaceutical was formed on May 8, 1997, as a limited liability company under the laws of the PRC. Its current registered address is No. 588 Shiji Xi Road, Xianyang, Shaanxi Province, PRC, and its registered capital is Renminbi (&#8220;RMB&#8221;) 61,800,000.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On November 1, 2007, Shaanxi Biostar and Aoxing Pharmaceutical entered into a series of agreements (collectively the &#8220;Contractual Arrangements&#8221;) pursuant to which we have acquired control over Aoxing Pharmaceutical and which requires us to consolidate the profits and losses of Aoxing Pharmaceutical under U.S. Generally Accepted Accounting Principles (&#8220;GAAP&#8221;):
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Management Entrustment Agreement.
</FONT>
	Pursuant to the management entrustment agreement, Aoxing Pharmaceutical and its shareholders agreed to transfer control, or entrust, the operations and management of Aoxing Pharmaceutical&#8217;s business to Shaanxi Biostar. Shaanxi Biostar manages the operations and assets of Aoxing Pharmaceutical, controls all of the cash flow of Aoxing Pharmaceutical through a bank account controlled by Shaanxi Biostar, is entitled to all of the net profits of Aoxing Pharmaceutical as a management fee, and is obligated to pay all payables and loan payments of Aoxing Pharmaceutical. In addition, Shaanxi Biostar has been granted certain rights which include, in part, the right to appoint and terminate members of Aoxing Pharmaceutical&#8217;s board of directors, hire management and administrative personnel and control decisions relating to entering and performing customer contracts and other instruments. We anticipate that Aoxing Pharmaceutical will continue to be the contracting party under its customer contracts, bank loans and certain other instruments unless Shaanxi Biostar exercises its option. Global Law Office, our PRC counsel, has advised us that in their opinion the management entrustment agreement is legal and enforceable under PRC law.&#160;In exchange for causing Aoxing Pharmaceutical to enter into the management entrustment agreement, we issued an aggregate of 944,396 shares after one-for-seven reverse stock split (6,610,771 shares pre-reverse split) our common stock to the shareholders of Aoxing Pharmaceutical, which was allocated based on their respective pro rata ownership of Aoxing Pharmaceutical.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On May 6, 2008, Shaanxi Biostar entered into an amended and restated management entrustment agreement with Aoxing Pharmaceutical and its shareholders in order to remove a provision that allows the management entrustment agreement to be terminated at a mutually agreed date. As amended and restated, the management entrustment agreement, and all of the attendant rights of Shaanxi Biostar, remains in effect until such time that Shaanxi Biostar acquires all of the assets or equity of Aoxing Pharmaceutical under the terms of the exclusive option agreement as more fully described below, or until Aoxing Pharmaceutical ceases its business operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Voting Proxy Agreement.
</FONT>
	&#160;&#160;In order to give us further&#160;control over Aoxing Pharmaceutical, Aoxing Pharmaceutical&#8217;s shareholders entered into a voting proxy agreement with Shaanxi Biostar, whereby these shareholders irrevocably and exclusively appointed the members of Shaanxi Biostar's board of directors as their proxies to vote on all Aoxing Pharmaceutical matters that require shareholder approval, including, without limitation, the right to appoint members of Aoxing Pharmaceutical&#8217;s board of directors. The voting proxy agreement further provides that Shaanxi Biostar will appoint all members of Biostar&#8217;s board of directors to Aoxing Pharmaceutical&#8217;s board of directors. As the composition of Biostar&#8217;s board of director changes, Shaanxi Biostar must accordingly remove and appoint new members to Aoxing Pharmaceutical&#8217;s board of directors. The voting proxy agreement terminates upon the exercise of the option by Shaanxi Biostar to purchase the shares of Aoxing Pharmaceutical as described below, and is governed by the laws of the PRC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage5"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Exclusive Option
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	&#160;
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Agreement.
</FONT>
	In order to permit Aoxing Pharmaceutical to become an&#160;&#160;indirectly wholly-owned subsidiary of Biostar when permitted under PRC law, Aoxing Pharmaceutical and its shareholders entered into an exclusive option agreement with Shaanxi Biostar, whereby Aoxing Pharmaceutical&#8217;s shareholders granted Shaanxi Biostar an irrevocable and exclusive purchase option (the &#8220;Option&#8221;) to acquire Aoxing Pharmaceutical's equity and/or remaining assets, but only to the extent that the acquisition does not violate limitations imposed by PRC law on such transactions. Current PRC law does not specifically provide for the equity of a non-PRC entity to be used as consideration for the purchase of a PRC entity's assets or equity unless the value of the shares are equal to or greater than the value of the enterprise acquired. In addition, there is a lengthy appraisal process which must be approved by the provincial PRC government entities. The consideration for the exercise of the Option is to be determined by the parties and memorialized in future definitive agreements setting forth the kind and value of such consideration.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We will consider exercising the Option under such circumstances we believe will be in the best interests of the Company and our shareholders, and the exclusive option agreement has been drafted to give us such flexibility. In considering whether or not we will exercise the Option, we may consider such factors as: (1) if the exercise price can be lower than the appraised value under current PRC law, (2) availability of funds, (3) any relevant tax considerations at the time, (4) any other relevant PRC laws that may exist at the time, (5) the value of our shares that were previously paid to Aoxing Pharmaceutical&#8217;s shareholders, and (6) whether or not the exercise of the Option will provide any other additional benefits to us or our shareholders.&#160;Upon exercise of the Option, the parties will prepare transfer documents to be submitted for governmental approval and work together to obtain all approvals and permits. The exclusive option agreement may be terminated by the agreement of all parties or by Shaanxi Biostar with 30 days&#8217; notice, and is governed by the laws of the PRC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Share Pledge Agreement.
</FONT>
	In order to further solidify our control over Aoxing Pharmaceutical, Shaanxi Biostar and Aoxing Pharmaceutical&#8217;s shareholders entered into a share pledge agreement, whereby Aoxing Pharmaceutical&#8217;s shareholders pledged all of their equity interests in Aoxing Pharmaceutical, including the proceeds thereof, to guarantee the performance by the shareholders of all of the agreements they entered into with Shaanxi Biostar. Upon breach by any shareholder of any of the Contractual Arrangements, Shaanxi Biostar is entitled by operation of law to become the beneficial owner of the shareholders&#8217; equity interests of Aoxing Pharmaceutical. Prior to termination of the share pledge agreement, the pledged equity interests of Aoxing Pharmaceutical cannot be transferred without Shaanxi Biostar's prior written consent. The share pledge agreement will not terminate until agreed to by all of the parties in writing, and is governed by the laws of the PRC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Contractual Arrangements described above were utilized instead of a direct acquisition of the assets, common stock or a share exchange because we could not pay cash to directly or indirectly acquire Aoxing Pharmaceutical or its assets. PRC law permits the purchase of equity interests, or assets of a PRC entity by a non-PRC entity for cash. The purchase price must be based on the appraised value of the equity or assets. Because we did not have sufficient cash to pay the estimated full value of all of the assets of Aoxing Pharmaceutical, we, through Shaanxi Biostar, entered into the Contractual Arrangements in exchange for the right to exercise functional control over Aoxing Pharmaceutical, and we obtained substantially the same result as a direct share exchange with Aoxing Pharmaceutical.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On May 11, 2015, following to the change in registered owners of Aoxing Pharmaceutical, a set of new agreements had been entered into with all the existing registered owners of Aoxing Pharmaceutical on the same date.&#160;&#160;
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On October 29, 2014,&#160;a set of new Contractual Agreements had been entered into with all the existing registered owners of Aoxing Pharmaceutical. The agreements are merely replacement of the agreements dated October 29, 2014 and May 24, 2013, and therefore, there is no significant change in the contractual terms between the agreements dated May 11, 2015, October 29, 2014, May 24, 2013, July 9, 2010 and November 1, 2007. The existing registered owners of Aoxing Pharmaceutical, Shaanxi Biostar and Biostar had mutually agreed that no consideration would be paid upon the execution of the agreements on May 11, 2015. The interest of Biostar in Aoxing Pharmaceutical was not affected by the replacement for the Agreements.
</FONT>
</FONT>
</DIV>
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shaanxi Biostar&#8217;s control over Aoxing Pharmaceutical under the Contractual Arrangements requires us to consolidate its financial statements pursuant to the Accounting Standards Codification ("ASC") 810, Consolidation because Aoxing Pharmaceutical is considered a VIE of Shaanxi Biostar.&#160;ASC 810, Consolidation&#160;requires a VIE to be consolidated by any company that is subject to a majority of the risk of loss for the variable interest entity or is entitled to receive a majority of the variable interest entity&#8217;s residual returns. Since Shaanxi Biostar is the primary and only beneficiary of Aoxing Pharmaceutical (the VIE),&#160;ASC 810 Consolidation&#160;requires the consolidation of its financial statements with Shaanxi Biostar and ultimately consolidated with Shaanxi Biostar&#8217;s parent company, Biostar.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In October 2011, Aoxing Pharmaceutical entered into a Share Transfer Agreement to acquire Shaanxi Weinan Huaren Pharmaceuticals, Ltd. (&#8220;Shaanxi Weinan&#8221;) from the holders of 100% of equity interests in Shaanxi Weinan.&#160;&#160;The aggregate purchase price is RMB 61 million (approximately $9.55 million), in cash and payable in several tranches. Shaanxi Weinan owns drug approvals and permits for a portfolio of 86 drugs and one health product, all of which were added to the Company&#8217;s current drug portfolio following the completion of this acquisition. The Company completed this acquisition on October 25, 2011.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage6"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following diagram illustrates our current corporate structure:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/04/14/0001185185-16-004237_DIAGRAM1.JPG" ALT="GRAPHIC">
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On March 11, 2013, Aoxing Pharmaceutical entered into a supplemental agreement to the Share Transfer Agreement with all the former equity holders of Shaanxi Weinan to acquire 13 drug approval numbers which were excluded from the Share Transfer Agreement due to incomplete reregistration.&#160;&#160;Following the execution of the supplemental agreement, the Company will acquire the ownership of the 13 drug approval numbers for which reregistration has been completed. The aggregate purchase price is RMB 66 million (approximately $10.6 million) for the 13 drug approval numbers, of which RMB 30 million (approximately $4.8 million) was paid on November 26, 2012, RMB 25 million (approximately $4.0 million) was paid on December 31, 2012 and the balance of RMB 11 million (approximately $1.8 million) shall be paid in the Company&#8217;s common stock. Based on an agreed issuance price of $7.70 per share, RMB 11 million is equivalent to 228,938 shares of common stock of the Company. The Company completed this acquisition in April 2013.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On March 10, 2014, Biostar and certain institutional investors entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) in connection with an offering (&#8220;Offering&#8221;) pursuant to which the Company agreed to sell, and the investors agreed to purchase 235,714 shares after one-for-seven reverse stock split (1,650,000 shares pre-reverse split) of the Company&#8217;s common stock and warrants to purchase up to 94,286 shares after split (660,000 shares pre-reverse split) of the Company&#8217;s common stock, for aggregate gross proceeds, before deducting fees to the placement agents and other estimated offering expenses payable by the Company, of approximately $4.1 million.&#160;&#160;The warrants will be immediately exercisable upon issuance and will remain exercisable for three years thereafter at an exercise price of $3.23 per share.&#160;&#160;The exercise price and number of shares underlying the warrants are subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions. The net proceeds from the offering will be used for working capital and other general corporate purposes. Moody Capital Solutions, Inc. and Axiom Capital Management, Inc. served as the placement agents for the offering. The Offering was effected as a takedown off the Company&#8217;s shelf registration statement on Form S-3 (File No. 333-192963), which became effective on January 3, 2014, pursuant to a prospectus supplement filed with the Securities and Exchange Commission.
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	When we sell our equity or borrow funds, we expect the proceeds will be forwarded to Aoxing Pharmaceutical and accounted for as a loan to Aoxing Pharmaceutical and eliminated during consolidation. We may also use the proceeds to repurchase our capital stock or for our corporate overhead expenses. If we borrow funds we expect to be the primary obligor on any debt.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Neither Biostar nor Shaanxi Biostar has any operations or plans to have any operations in the future other than acting as a holding company and management company for Aoxing Pharmaceutical and raising capital for its operations. However, we reserve the right to change our operating plans regarding Biostar and Shaanxi Biostar.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage7"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Our Business
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company has experienced a substantial decrease in sales volume of all Aoxing Pharmaceutical Products in the year ended December 31, 2015. The foregoing decrease was due to Aoxing Pharmaceutical&#8217;s temporarily suspension of production to conduct maintenance of its production lines to renew its GMP certificates by the second quarter in 2016. While our production levels of Shaanxi Weinan products helped to offset the substantial decrease in our sales volume in the most recent fiscal quarter, our sales volume continue to remain at the present decreased levels. We currently anticipate that the production will resume in the second quarter in 2016. There is no assurance that the production lines will resume and the renewal of GMP certificates will occur when anticipated or, even if they do, we will be able to return to the production levels as anticipated.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We develop, manufacture and market pharmaceutical products in the PRC for a variety of diseases and conditions. Our most popular product is the Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter (&#8220;OTC&#8221;) medicine for chronic hepatitis B and a disease affecting approximately 10% of the Chinese population. Our current product line also includes twelve other&#160;OTC products, seventeen prescription-based pharmaceuticals.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our products are derived from medicinal herbs that are either grown at our own facility or purchased from our suppliers. We rely on approximately four suppliers for our raw materials.&#160;For Fiscal 2015, we purchased most our raw materials from suppliers because most of the herbs planted at our facility were not yet ready for harvest or use.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We devote substantial resources to the research and development of new products that must be approved by the regulatory agencies. We currently have eight products under development to complement our existing product line, one of which is currently awaiting approval from the China Military Food and Drug Administration of the PRC. We have adopted international manufacturing standards and currently hold one patent, with two additional patents pending approval. We are subject to extensive government regulation which is discussed in detail in the section below called &#8220;Government Regulation.&#8221; In the event that a new product is not approved or it is found in violation of these laws and regulations, it could have a materially adverse effect on the prospects of our business operations.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our products are currently being sold in over 28 provinces in the PRC through 63 distributors and an established network of more than 226 dedicated sales people. In addition, we have been enhancing our marketing efforts with the launch of our internet-based China Hepatitis Internet Hospital since June 2009. The multi-function website is designed to be a one-stop portal for HBV patients, providing current and relevant information on HBV and treatment options as well as a convenient method to purchase our HBV medicine. Registered users can secure a membership card for a fee of RMB 200 (approximately $25). Members are entitled to a 20% discount on diagnosis and medical services provided on CHIH, free expert diagnosis and free medicine delivery, and a wide range of inquiry, instruction and other complementary services. Registered users can also seek medical advice from a pool of HBV health professionals without having to go to the hospital.&#160;CHIH will facilitate our ability to provide customer service and add purchasing convenience for our consumers.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Since 2013, we have improved our customer portfolio and provided subcontracting services to hospital which provides the prescription. For the year ended December 31, 2015 and 2014, the subcontracting services income to hospital contributed $12.4 million and $18.1 million, respectively.
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage8"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_3"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Our Products
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The table below summarizes the pharmaceutical products that are currently manufactured and sold by us in the PRC:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="13%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Name
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="16%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Treatments
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="56%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Benefits and Side Effects
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	SFDA Classification
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	XinAoxing Oleanolic Acid Capsule
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Hepatitis B
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Relieves hepatic injury, reduce glutamic-pyruvic transaminase activity, reduce r-GLO. Believed to promote hepatic cell regeneration, to be effective in hepatic coma treatment, to inhibit fibrous hyperplasia and prevent hepatocirrhosis. Used to reduce hepatic damage caused by HBV regeneration.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	OTC
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Ganwang Compound Paracetamol Capsule
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Colds, runny nose, sore throat, headache and fever
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Relieves the symptoms of the common cold, including runny nose, sniffles and sneezing. Some patients experience symptoms of anorexia, queasiness and upset stomach after use.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	OTC
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Tianqi Dysmenorrhea Capsule
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Dysmenorrhea
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Used as Chinese traditional medicine for treatment of pain and other symptoms associated with menstruation. There are no known side effects.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	OTC
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Hernia Belt
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Hernia
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Relieves hernia, no side effects.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Medical Device
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Tangning Capsule
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Diabetes
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Believed to treat type II diabetes
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Nutrient, OTC
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Yizi Capsule
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Fertility
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Believed to aid fertility and helps in fetal development during pregnancy.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Nutrient, OTC
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shengjing Capsule
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Kidney
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Believed to replenish kidney function.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Nutrient, OTC
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Aoxing Ointment
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Psoriasis, vitiligo and various dermatitis
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Used to treat psoriasis, vitiligo and various dermatitis.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Nutrient, OTC
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Jingang Tablets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For waist and knees, impotence, nocturnal emission, premature ejaculation, frequent urination
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Used to protect the kidneys and increase blood flow in sexual organs by triggering production of natural hormones in the body.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Prescription
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="MIDDLE" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Compound Paracetamol and Amantadine Hydrochloride Tablets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Colds, influenza
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Used to alleviate the symptoms of fever, headache, aching limbs, sneezing, runny nose, stuffy nose, sore throat caused by common cold and influenza.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	OTC
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Danxiang Rhinitis Tablets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For chronic simple rhinitis, allergic rhinitis, acute and chronic sinusitis.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Used as anti-inflammatory drug, alleviating cold symptoms, analgesic Tongqiao.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Prescription
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Deafness Tongqiao pills
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For hepatobiliary Huosheng, head swelling, deafness and tinnitus, pus in ears, dry stool, urine-yellow.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Used to circulate blood flow, unblock orifice, and relieve chest oppressing symptoms.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	OTC
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage9"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_4"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Yanlixiao Capsules
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For heat syndrome bacillary dysentery, acute tonsillitis, acute and chronic bronchitis, acute gastroenteritis, acute mastitis and other infectious diseases.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Used for clearing and detoxifying, anti-inflammatory.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Prescription
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Piracetam Tablets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Adapts to acute and chronic cerebrovascular disease, traumatic brain injury, memory loss, mild and moderate brain dysfunction caused by multiple reasons of a variety of toxic encephalopathy. And also for children retarded mental development.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Prescription
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Huangyangning Tablets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For the patients with the symptoms of chest stuffiness and pains, Knotted and intermittent pulse; coronary heart disease, arrhythmias
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Helps Qi and blood circulation; relieve pain.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Prescription
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Hyperthyroidism Capsules
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For the patients of hyperthyroidism with the symptoms of palpitations, sweating, irritability, dry throat, rapid pulse, and other symptoms of hyperthyroidism.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Used to improve blood circulation and suppress clustering of red blood cells and platelets.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Prescription
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="MIDDLE" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Zhitongtougu Ointment
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Joint pain, swelling, tenderness or dysfunction.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Used for alleviating cold symptoms, blood stagnation line, tongluo and relieving pain. Also used for patients with knee, lumbar blood stasis.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	OTC
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Fosfomycin Calcium Capsules
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Prescribes orally for the following infections caused by pathogen that is sensitive to fosfomycin&#160;&#160;pathogens: 1. Intestinal infections: bacterial enteritis, dysentery. 2. Urinary tract infections: cystitis, pyelonephritis,urethritis. 3. Dermatology and soft tissue infections: furunculosis, hidradenitis, lymphadenitis, folliculitis. 4. Respiratory tract infection: Nasopharyngitis, tonsillitis, bronchitis. 5. Ophthalmology: hordeolum, dacryocystitis. 6. GynaeVaginitis, cervicitis.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Prescription
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="MIDDLE" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Wenweishu&#160;&#160;Capsules
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Used to help with chronic gastritis, pain of epigastric cold.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	OTC
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Yituo Erythromycin particles
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1. The alternative medicine for the patients who is sensitive to penicillin: 2. Legionella 3. Mycoplasma pneumoniae pneumonia 4. genitourinary infection caused by other chlamydia, mycoplasma. 6. Chlamydia trachomatis conjunctivitis. 7. Oral infections caused by anaerobic bacteria. 8. Campylobacter jejuni enteritis. 9. Pertussis. 10. Rheumatic fever recurrence, infective endocarditis.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Prescription
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="MIDDLE" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Chuzhang Zehaifu Tablets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For cataract.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Clears the abnormalities in the body, such as black bile and kidney deficiencies. Also helps with eye problems, such as redness, dry eyes,&#160;&#160;and blurred vision.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	OTC
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Muxiang Shunqi Pills
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Abdominal pain, bloating.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Believes to promote Qi circulation and resolve dampness inside the body. Protects and strengthen the spleen and stomach. For distension, abdominal distention, nausea and vomiting, loss of appetite caused by the dampness obstructing spleen and stomach, chest and diaphragm.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Sifangwei Capsules
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Stomach pain, Hyperacidity
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Smoothing the liver stomach pain, Acid to relieve pain. For stomach pain, too much gastric acidity, indigestion, stomach and duodenum ulcer with the above symptoms caused by liver stomach discord.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Prescription
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="MIDDLE" WIDTH="13%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Aspirin Enteric-coated Tablets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Antithrombotic
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="56%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Prevention of transient ischemic attack, myocardial infarction, atrial fibrillation, unstable angina.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Prescription
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage10"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Xin Ao Xing Oleanolic Acid Capsule, also known as Ao Xing Liver Cure, is the only non-prescription drug currently being sold on the market for the sub-category of Oleanolic Acid that has been approved by the SFDA for the treatment of chronic hepatitis B virus (&#8220;HBV&#8221;), which is prevalent in the PRC. It is estimated that more than 130 million people are infected with HBV, or 10% of the population (some estimates are as high as 15% of the population) in the PRC. According to the World Health Organization, approximately about 1 million people die from hepatic failure, hepatocirrhosis and primary hepatoma caused by HBV infection per year; however, it was not until December 2, 2005, that the Chinese government first issued an HBV prevention manual for the general public.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	There are two kinds of medications typically used for antivirotic treatment: interferon and ribonucleotide analog, both of which do not kill the HBV directly, but inhibit the metabolizing of HBV replication.&#160;&#160;Their side effects, however, include damage to normal healthy cells, and they require prolonged treatment periods of more than one year and high costs. (Source: Pharmacopoeia of the People's Republic of China).
</FONT>
</FONT>
</DIV>
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our Xin Ao Xing Oleanolic Acid Capsule is a pentacyclic triterpenoid which contains extracts from natural plants, Fructus Ligustri Lucidi and Hemsleya, and is the only SFDA-approved product to be manufactured as an OTC hepatitis B medicine in the PRC. It is also certified by the Chinese Medical Association as a specific product for hepatitis B treatment. Its pharmacological actions include the relief of hepatic injury, reduction of glutamic-pyruvic transaminase activity, promotion of hepatic cell regeneration, the inhibition of fibrous hyperplasia and prevention of hepatocirrhosis.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We estimate the demand for medicines treating hepatitis B amount to approximately $8 billion annually.&#160;&#160;We believe that we are positioned to become a leader in the sale of OTC medicines for the treatment of hepatitis B as our Xin Ao Xing Oleanolic Acid Capsule is the only oral OTC drug approved by the SFDA for such treatment.&#160;We continue to aggressively advertise this product and have started various promotion programs since 2011.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In addition, following our acquisition of Shaanxi Weinan, we added 86 additional drugs and one health product to our current line. The 86 drugs include 60 prescription and 26 OTC drugs. We continued manufacturing and marketing Shaanxi Weinan&#8217;s existing products: Fosfomycin Calcium (prescription drug used to fight urinary tract infections), Huangyangning Tablets (prescription drug used for the treatment of cardiovascular disease), Zhitong Tougu Plaster Cream (OTC cream used as a pain reliever), Jiakangling Capsule (prescription drug used for the treatment of hyperthyroidism), Qianlietong Capsule (prescription drug used to diagnose benign prostatic hypertrophy), and Wenweishu Capsules (prescription drug used to treat chronic gastritis). We also started to manufacture and market a number of new products including: Compound Paracetamol and Amantadine Hydrochloride (OTC drug used to fight the common cold), Danshen Tablets (prescription drug used for the&#160;treatment of coronary heart disease), Piracetam Tablets (prescription drug used for the treatment of cerebrovascular disease), Erythromycin Estolate Coated Particles (prescription drug used as anti-bacterial anti-inflammatory).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Upon completion of the supplemental agreement with former equity holders of Shanxi Weinan, we acquired additional drug approval numbers, which cover 13 drugs including Jing Kong Tablet, Vitiligo Capsule, Danxiangrhinitis Tablets, Azithromycin Dispersible Tablet, Gynecological Leucorrhea Tablet, Chu Zhang Ze Haipu Tablets, Antideaf Otic Pill, Deafness Tongqiao Pills, Warm Palace Pregnant Son Pill, Peikun Pill, Four Square Stomach Capsule, Quick-Acting Anti-Inflammation Capsule, and Legalon Capsule.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Most of these drugs target widespread diseases and conditions affecting all ages, are sold in local pharmacies and hospitals in China, are included in the National Essential Medicines List and in most cases, are covered by personal health insurance.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Due to change of the PRC government regulations and policies, we stopped manufacturing 5 products including Hernia Belt, Tangning Capsule, Yizi Capsule, Shengjing Capsule and Aoxing Ointment.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Market for Our Products
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Based on data that we have compiled from the business intelligence service DataMonitor, over the past decade, the Chinese medicine and pharmaceutical industry has developed at an annual growth rate of over 16%, making it one of the fastest growing industries in the Chinese economy. The PRC is among the ten largest medicine manufacturing countries and medical raw materials exporting countries in the world.&#160;With approximately one-fifth of the world's population and a fast-growing gross domestic product, the PRC presents significant potential for the pharmaceutical industry. We believe that the burgeoning market provides business opportunities for us. We are pursuing opportunities in several sectors that we believe will experience growth and that we can address with&#160;our manufacturing and distribution expertise. The following is a brief overview of these potential sectors:
</FONT>
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	10
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage11"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV>
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Hepatitis
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We estimate that there are approximately 120 million hepatitis patients in the PRC. Currently, the most common way to establish an effective treatment protocol is through a doctor or hospital. As many patients have chronic HBV, ailments are prevalent and typically become more severe if not properly treated. However, HBV patients in the PRC also bear substantial psychological pressure, since it is very contagious. Infected patients are often fearful that their relatives, friends and coworkers will become aware of their circumstances and wind up soliciting treatment in secret, if at all. In addition to producing a medicine to treat HBV,&#160;we have launched CHIH, an internet portal designed to promote our product while providing HBV patients with current and relevant treatment information at the same time.&#160;
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Coronary Disease
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	According to the World Heart Federation, cardiovascular disease is the leading cause of death in the developing world (with the exception of sub-Saharan Africa). Its rise is linked to the increase in prevalence of risk factors such as tobacco use and relative lack of access to interventions to managing the ensuing disease. In the PRC, annual direct costs are estimated at (euro) 30.76 billion or 4% percent of gross national income. The PRC is facing an increase in cardiac disease on two fronts. We believe that in urban and upscale areas, heart disease is on the rise as the prevailing lifestyles have appeared to result in higher incidents of stress, poorer nutrition, decreased physical activity and increase in tobacco use. Within the rural provinces, we believe that impoverishment is also contributing to the rise in coronary disease as most villages have no or limited access to medical help. Our Danshen Granule has been accepted as a product for the treatment of coronary heart disease, myocarditis and angina pectoris and&#160;we are marketing the product within the rural and urban markets.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Dysmenorrhe
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As the PRC continues to develop, the demand by women for products to treat their health concerns will continue to rise.&#160; We believe that&#160;our Tianqi Dysmenorrhea Capsule is positioned to take a leading role in this sector.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Influenza
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Influenza is one of the most common recurring diseases in the PRC. It has been estimated that there is an annual market of $6.25 billion for flu-related healthcare in the PRC, 85% of which is in the form of OTC consumption.&#160;&#160;Some of&#160;our pharmaceutical and nutrient products are designed to relieve symptoms associated with the flu.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Pediatric Medicine
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Increased access to information through education programs and the general promotion of good health within the PRC are helping to generate demand for products designed specifically for children. Furthermore, as the PRC continues to advocate the one child per family policy, parents' demands for quality children's medicines are increasing, as is the interest in brand differentiation. However, at present, few manufacturing plants specialize in pediatric medicine and there is no leading national brand. Approximately 90% of general pharmaceuticals and medicines utilized in the PRC have no corresponding pediatric formula for their drugs, leaving substantial opportunity for growth.&#160; We plan to introduce new products to address these issues.&#160;&#160;In particular, we plan to enhance production of our pediatric medicines and market our pediatric cough medication.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Respiratory Disease
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	With the aggravation of air pollution and worsening environmental conditions, the incidence of respiratory diseases remains high in the PRC. Influenza is one of the most common diseases in the PRC, and according to the Ministry of Health of the PRC, an estimated 75% of the population suffers from influenza every year and 5.5% suffer from tracheitis caused by influenza. This rate is more than 15% for senior citizens, who often suffer from influenza more than 3 times per year.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As is shown in the related statistics in the National Health Care Department in the PRC, the percentage of the population suffering from some form of respiratory diseases in the PRC is approximately 6.94%, or approximately 80 million&#160;people suffering from respiratory diseases every year.&#160;&#160;The four common respiratory diseases - acute nasopharyngitis, influenza, tonsillar tracheitis, and chronic bronchitis - account for 80% of the respiratory diseases in the PRC.&#160;&#160;Our Taohuasan Pediatrics Medicine is used to treat respiratory disease in children.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	11
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage12"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Industry Consolidation
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In 2003, the Chinese government issued &#8220;The Medicine Management Law&#8221;, &#8220;Pharmaceutical Manufacturing Quality Management Specifications&#8221; and implemented the Good Manufacturing Practices (&#8220;GMP&#8221;). This action has, and will continue to result in, industry consolidation as those companies without GMP certificates and without qualified facilities, capital or management expertise necessary to secure approval are forced to find strategic alternatives or cease operations. Since 2003, the number of pharmaceutical companies in the PRC has decreased rather significantly, from 6,700 to approximately 3,600. This trend has also resulted in significant opportunity for us, as&#160;we plan to identify companies that have similar products or other assets, but an inability to bring them to market.
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Our Customers
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our top ten customers accounted for 80% and 63% of our total sales in fiscal 2015 and 2014, respectively.&#160;Two of&#160;our top customers individually accounted for 46% and 19% respectively, and totally accounted for 65% of our net sales in fiscal 2015. Two of our top ten customers accounted for 49% of our total net sales in fiscal 2014. Please refer to our financial statements relating to Risks Concentration.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Competition
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The pharmaceutical industry both within the PRC and globally is intensely competitive and is characterized by rapid and significant technological progress.&#160;&#160;Our competitors, both domestic and international, include large pharmaceutical companies, universities, and public and private research institutions that currently engage in or may engage in efforts related to the discovery and development of new pharmaceuticals. Many of these entities have substantially greater research and development capabilities and financial, scientific, manufacturing, marketing and sales resources than us, as well as more experience in research and development, clinical trials, regulatory matters, manufacturing, marketing and sales.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following table lists the primary competitors for each of our current product offerings as well as the nutrient products that we are licensed to produce:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_5"></A>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="95%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="35%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Products
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="60%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Competitors
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Xin Ao Xing Oleanlic Acid Capsule
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Wulanhaote Zhong Meng pharmaceutical Co., Ltd., Yang Ling Mai Di Sen Pharmaceutical Co., Ltd. and other suppliers of prescription medicines that are used for hepatitis treatment
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Ganwang Compound Paracetamol &amp; Amantadine Hydrochloride Capsule
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Jiang Xi Ren He Pharmaceuticals, Inc. and Hainan Asia Pharmaceuticals, Inc.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Danshen Granule
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Yun Nan Yong An Pharmaceuticals, Inc. and Hai Nan Min Hai Pharmaceuticals, Ltd.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Taohuasan Pediatric Medicine
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shandong Bai Cao Pharmaceuticals, Ltd., and Chang Chun Ren Min Pharmaceuticals, Ltd.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Tianqi Dysmenorrhea Capsule
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Yun Nan Yu Xi City Wei He Pharmaceutical, Ltd., and Shandong Phoenix Pharmaceuticals, Ltd.
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Nutrient Products
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Wulanhaote Zhong Meng Pharmaceutical Co., Ltd., Yang Ling Mai Di Sen Pharmaceutical Co., Ltd. and other traditional Chinese medicine suppliers
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Of these companies, our three major competitors are Wulanhaote Zhong Meng Pharmaceutical Co., Ltd., Yang Ling Mai Di Sen Pharmaceutical Co., Ltd., and Inner Mongolia Ku Lun Pharmaceutical, Co., Ltd. because some of their products are sold in the same markets as ours.&#160;&#160;Additionally, only Shan Dong Phoenix Pharmaceutical Inc., Yun Nan Yu Xi Wei He Pharmaceutical, Ltd., Yang Ling Mai Di Sen Pharmaceutical Co., Ltd., and Yun Nan Yong An Pharmaceuticals, Co., Ltd. hold GMP certificates.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Sources and Availability of Raw Materials and Principal Suppliers
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our principal raw materials are the active ingredients for each of our products. We currently have the ability to source part of the Danshen raw materials internally, while the remaining part of the Danshan raw materials and other raw materials, as well as packaging materials, are sourced from various independent suppliers in the PRC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Third party vendors are selected based on a number of factors, including quality, timely delivery, cost and technical capability. Management also conducts periodic onsite reviews of our suppliers&#8217; facilities. The vast majority of our raw material needs are readily available.&#160;&#160;We try to maintain relationships with at least two vendors for each major raw material in order to ensure a reliable supply at reasonable prices.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We rely on a number of suppliers for&#160;our raw materials and packaging materials.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
	&#160;
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	12
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage13"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In Fiscal 2015, Xi&#8217;an Chinese Medicine and Herbs Factory (&#8220;Xi&#8217;an Chinese Medicine&#8221;), Shaanxi Haoyuan Chinese Medicine and Herbs Factory (&#8220;Haoyuan&#8221;) and&#160;Xianyang Wenlin Color Printing Co., Ltd. (&#8220;Wenlin&#8221;) accounted for approximately 26%, 27% and 7% of our total raw material purchase, respectively. In Fiscal 2014, Xi&#8217;an Chinese Medicine and Herbs Factory (&#8220;Xi&#8217;an Chinese Medicine&#8221;), Shaanxi Haoyuan Chinese Medicine and Herbs Factory (&#8220;Haoyuan&#8221;) and&#160;Xianyang Wenlin Color Printing Co., Ltd. (&#8220;Wenlin&#8221;) accounted for approximately 29%, 22% and 10% of our total raw material purchase, respectively.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We have also been cultivating herbs since October 2008, including salvia miltiorrhiza, priclklyash peel, eucommia bark, gingko, honeysuckle, shizandra berry, scutellaeria baicalensis georgi, milk veteh and radix codonopsitis. Once completed, we will be able to process these herbs into raw materials for our products. We estimate there is an annual increase of 10% to 20% in production of Danshen in the coming years. Other herbs will be ready for harvest in three years. We will also be able to sell excesses on the market as raw materials.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Intellectual Property
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We rely on a combination of trademark, patent and trade secret protection laws in the PRC, as well as confidentiality procedures and contractual provisions to protect our intellectual property. We also require our employees to execute confidentiality and trade secret agreements.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We currently hold one patent for the production method of our Aoxing Ganbao product, with two additional patents pending approval, and 9&#160;registered trademarks in the PRC, and own the rights to the internet domain names
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	www.biostarpharmaceuticals.com
</FONT>
	and
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	www.aoxing-group.com
</FONT>
	. Our patent, patent number ZL2007100180930, was approved on September 16, 2009, and&#160;is valid for twenty years.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Below is a list of our trademarks, all registered with Trademark Bureau of SAIC (State Administration of Industry and Commerce) by Aoxing Pharmaceutical.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="95%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<EFX_UNIDENTIFIED_TABLE>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="35%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<A NAME="FIS_UNIDENTIFIED_TABLE_6"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Trade Mark
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="60%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Term
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;Yi Wen Ling&#8221; &amp; device (Certificate: No. 1008816)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	May 21, 2007 to May 20, 2017
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;Zhong Ao&#8221; &amp; device. (Certificate: No. 1728599)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	March 14, 2012 to March 13, 2022
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;Xin Tai Ke&#8221; &amp; device (Certificate No. 1908333)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	September 28, 2012 to September 27, 2022
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;Gan Wang&#8221; &amp; device, (Certificate No. 3001006)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	November 14, 2012 to November 13, 2022
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;Hei Gen&#8221; (Certificate: No. 3168882)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	July 7, 2003 to July 6, 2013
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="35%">
<A NAME="FIS_UNIDENTIFIED_TABLE_7"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;Shi Li Ming&#8221; (Certificate: No. 3180355)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	August 7, 2013 to August 6, 2023
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;Aoxing No.1&#8221; (Certificate: No. 3168883)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	February 21, 2004 to February 20, 2024
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;Cha Ge De &#8221; &amp; device (Certificate: No. 4770095)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	December 21, 2008 to December 20, 2018
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;Cha Ge De Ri&#8221; &amp; device (Certificate: No. 1624463)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	August 28, 2011 to August 27, 2021
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;Ao Xing Xin Le&#8221; &amp; device (Certificate: No. 4319027)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	November 28, 2007 to November 27, 2017
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;Yin Shi&#8221; &amp; device (Certificate: No. 3650168)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	November 21, 2015 to November 20, 2025
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;KangbinDu&#8221; &amp; device (Certificate: No. 3832841)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	April 14, 2006 to April 13, 2016
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;Shabinjun &amp; device (Certificate: No. 3832844)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	April 14, 2006 to April 13, 2016
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;KangbinDu&#8221; &amp; device (Certificate: No. 7858678)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	January 14, 2011 to January 13, 2021
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;XinNao No.1&#8221; (Certificate: No. 3619525)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	October 14, 2015 to October 13, 2025
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="TOP" WIDTH="35%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8220;Baoertong&#8221; &amp; device (Certificate: No. 3829856)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="60%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	June 14, 2006 to June 13, 2016
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Bio-pharmaceutical companies are at times involved in litigation based on allegations of infringement or other violations of intellectual property rights. Furthermore, the application of laws governing intellectual property rights in China and abroad is uncertain and evolving and could involve substantial risks to us.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Government Regulation
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The testing, approval, manufacturing, labeling, advertising and marketing, post-approval safety reporting, and export of our products are extensively regulated by governmental authorities in the PRC.&#160;&#160;We are also subject to the Drug Administration Law of the PRC, which governs the licensing, manufacturing, marketing and distribution of pharmaceutical products in the PRC and sets penalties for violations of the law. We are also subject to various other regulations and permit systems by the Chinese government. These regulations and their impact on our business are set forth in more detail below.
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	13
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage14"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="84%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Drug Administration Law of the PRC
</FONT>
	was promulgated by the Standing Committee of National People&#8217;s Congress on February 28, 2001 and effective as of December 1, 2001, and its implementing guidelines were promulgated by the State Council on August 4, 2004 and effective as of September 15, 2002. According to Drug Administration Law of the PRC and its implementing guidelines, a pharmaceutical manufacturer is required to obtain a Pharmaceutical Manufacturing Permit and Drug Approval Number for each manufactured drug from the relevant SFDA&#8217;s provincial branch, which will be valid for five years and is renewable upon application before expiration. Accordingly, we are required to apply for these approvals and any extensions thereof for each of our products.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="84%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Administration Regulations for Drug Registration
</FONT>
	was promulgated by the SFDA on July 10, 2007, and was effective as of October 1, 2007.&#160;&#160;The Administration Regulations for Drug Registration specifies the requirements and procedure for obtaining a Drug Approval Number for a new drug.&#160;&#160;It includes the requirements for clinical trial of new drugs, procedure for registering imported medicine and reporting and approval procedure for generic medicine
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	.
</FONT>
	The Drug Approval Number is valid for five years and can be re-registered upon expiration. We are required to obtain a Drug Approval Number for each of our new drugs and reapply for an extension prior to the expiration date the drugs.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="84%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Good Manufacturing Practices (GMP) for Pharmaceutical Products
</FONT>
	, as revised in 1998 was promulgated by the SFDA on June 18, 1999 and became effective as of August 1, 1999, and the
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	&#160;Authentication Regulations for Drug GMP
</FONT>
	was promulgated by the SFDA on September 7, 2005 and became effective on October 1, 2005.
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	&#160;
</FONT>
	A pharmaceutical manufacturer must meet the GMP standards and obtain the GMP Certificate with a five-year validity period from SFDA. Before the GMP Certification expires, the pharmaceutical manufacturer must apply again and complete the relevant procedures, which may take about 120 working days, to obtain a new GMP Certificate. On October 24, 2007, the SFDA issued new guidelines for authentication standards of GMP, effective as of January 1, 2008. The new guideline may result in a rise of cost for a pharmaceutical manufacturer to meet the new standards in order to maintain the GMP qualification. If a pharmaceutical manufacturer fails to obtain or maintain GMP Certification and still carries on production of its drugs, it will be fined and its Pharmaceutical Manufacturing Permit may be revoked under serious circumstances. We are required to apply for a GMP certificate for each of our products and reapply prior to the expiration date and maintain our Pharmaceutical Manufacturing Permit.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="84%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Administration Regulations for Drug Call-back
</FONT>
	was&#160;promulgated by the SFDA on December 10, 2007 and effective on the same day. According to the Administration Regulations for Drug Call-back, the pharmaceutical manufacturer should establish a drug call-back system and collect information regarding the drug safety. If a manufacturer discovers any unreasonable danger of drug that threatens people&#8217;s safety and health, it should immediately stop the manufacturing and sale of such drug, notify the distributors and report to the branch of the SFDA. This regulation also stipulates the procedures of drug call-back and danger valuation standards established and maintain a drug call back system in conformance the regulations.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="84%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Administration Regulations for Drug Instructions and Labels
</FONT>
	was promulgated by the SFDA on March 15, 2006 and was effective as of June 1, 2006. According to Administration Regulations for Drug Instructions and Labels, the contents of instructions and labels of each drug must be approved by the SFDA, and the smallest packing unit of drug shall be attached with instruction.&#160;&#160;We have developed, received approval and maintain drug labeling in conformance with the regulations for&#160;our existing products and must do so for new products.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="84%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Supervision Administration Regulations for Drug Distribution
</FONT>
	was promulgated by the SFDA on January 31, 2007 and effective as of May 1, 2007. According to Supervision Administration Regulations for Drug Distribution, a pharmaceutical manufacturer can only sell drugs produced by itself, and it shall not sell drugs produced by other manufacturers or produced by itself but for commissioning manufacturing purposes. We do not resell drugs from any other pharmaceutical manufacturers.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="84%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Regulations for Drug Advertisement Censoring
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
	was promulgated by the SFDA and State Administration for Industry and Commerce (the &#8220;SAIC&#8221;) on March 13, 2007 and effective as of May 1, 2007.
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	&#160;
</FONT>
	The
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Standards for Drug Advertisement Censoring and Publication
</FONT>
	was promulgated by the SFDA and the SAIC
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
	on March 3, 2007 and made effective as of May 1, 2007. According to Regulations for Drug Advertisement Censoring, a pharmaceutical manufacturer must obtain a Drug Advertisement Approval Number from the provincial branch of the SFDA which is valid period of one year if the drug advertisement describes the functions or benefits of a drug. However, if an over the counter drug advertisement in any media, or a prescription drug advertisement in professional medical magazine, only refers to the name of the drug, including the general name and commercial name, without any other addition promotional information, the advertisement does not need to be censored or approved.&#160;&#160;We have obtained a Drug Advertisement Approval Number for all our drugs and review all of our OTC drug advertisements so that they are in conformance with the regulations relating to advertising these products.
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="84%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="84%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Food Hygiene Law and Rules on Food Hygiene Certification
</FONT>
	mandates that a distributor of nutritional supplements and other food products must obtain a food hygiene certificate from relevant provincial or local health regulatory authorities. The grant of such certificate is subject to an inspection of the distributor&#8217;s facilities, warehouses, hygienic environment, quality control systems, personnel and equipment. The food hygiene certificate is valid for four years, and the holder must apply for renewal of the certificate within six months prior to its expiration.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We have enjoyed a sound, cooperative working relationship with the Shaanxi People's Government and related government departments since our founding. Adjustments to our operating strategies and long-term business plans have been unanimously approved by relevant departments and by provincial-level government entities.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	14
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage15"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	The SFDA
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The application and approval procedure in the PRC for a newly developed drug has numerous steps. For each new product, we prepare documentation covering pharmacological, toxicity, pharmacokinetics and drug metabolism studies in addition to providing samples of the drug. The documentation and samples are then submitted to the provincial SFDA. This process typically takes approximately three months. After the documentation and samples have been approved by the provincial SFDA, the provincial administration submits the approved documentation and samples to the SFDA. The SFDA examines the documentation and tests the samples and presents the findings to the New Drug Examination Committee for approval. If the application is approved by the SFDA, the SFDA will issue a clinical trial license to the applicant for clinical trials. This clinical trial license approval typically takes one year, followed by approximately two years of trials, depending on the category and class of the new drug. The SFDA then examines the documentation from the trial and, if approved, issues the new drug license to the applicant. This process usually takes eight months. The entire process takes anywhere from three to four years.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The SFDA and the China Traditional Medicine Administration Bureau regulate the process for new drug approval and licensing in the PRC, which can involve many levels of authority, lacking in transparency, and presents one of the greatest obstacles for companies to introduce new drugs into the market. One of the preliminary aspects of the application process involves a review of the Chinese market's need for a particular drug. If the SFDA determines that the market niche for a particular drug is saturated, the drug will not receive further consideration and the licensing application will be denied. According to industry analysts, eighty-five percent of applications for new drugs licensing is determined by SFDA to be in saturated markets and thus are not considered for approval. Only fifteen percent of new-to-market drug applications are considered for approval by the SFDA.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Furthermore, only companies that meet the GMP standard may apply for new drug approvals with the SFDA. The SFDA estimates that less than 20% out of the 6,000 pharmaceutical companies in the PRC currently meet the GMP standard.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We estimate that the cost to receive approval from the SFDA for a new product will range from RMB 1.1 million (approximately $174,000) to RMB 4.15 million (approximately $659,000).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our receipt of a GMP certificate and approval by the SFDA of&#160;our prescription and OTC drugs represent a significant competitive advantage as these approvals present a significant barrier to entry by new companies hoping to enter the pharmaceutical drug industry.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 9PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Nevertheless, the new drugs we seek to bring to market are regulated by the SFDA and the China Traditional Medicine Administration Bureau and are estimated to now cost between RMB 1.1 million (approximately $174,000) to RMB 4.15 million (approximately $659,000) per product which must be provided through our cash flow or from financing activities as new products are introduced. In addition, our new products may not pass the clinical review and testing process which can negatively affect our cash flow and income.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We are subject to possible administrative and legal proceedings and actions by these various regulatory bodies. Such actions may include product recalls, seizures and other civil and criminal sanctions which could have a materially adverse effect on our prospects.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Environmental Regulation
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our operations and facilities are subject to environmental laws and regulations stipulated by the national and the local environment protection bureaus in the PRC. Relevant laws and regulations include provisions governing air emissions, water discharge and the management and disposal of hazardous substances and wastes. The PRC regulatory authorities require pharmaceutical companies to carry out environmental impact studies before engaging in new construction projects to ensure that their production processes meet the required environmental standards.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We maintain controls at our production facilities to facilitate compliance with environmental rules and regulations. We are not aware of any investigations, prosecutions, disputes, claims or other proceedings in respect of environmental protection, nor have we been subject to any action by any environmental administration authorities of the PRC. To our knowledge, our operations meet or exceed the existing requirements of the PRC.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Advertising Laws
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Advertisement Law of the People&#8217;s Republic of China and Rules of Medicine Advertisements Management from State Admission for Industry and Commerce, Regulations on Control of Advertisements (tentative) from State Council provide guidelines for advertising prescription and OTC drugs and nutrients. The rules limit where advertisements may be placed and govern the claims that may be made by the manufacturer.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	15
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage16"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Product Liability and Consumers Protection
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Product liability claims may arise if the products sold have any harmful effect on the consumers. The injured party may make a claim for damages or compensation. The General Principles of the Civil Law of the PRC, which became effective in January&#160;1987, state that manufacturers and sellers of defective products causing property damage or injury shall incur civil liabilities for such damage or injuries.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Product Quality Law of the PRC was enacted in 1993 and amended in 2000 to strengthen the quality control of products and protect consumers&#8217; rights and interests. Under this law, manufacturers and distributors who produce or sell defective products may be subject to confiscation of earnings from such sales, revocation of business licenses and imposition of fines, and in severe circumstances, may be subject to criminal liability.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Law of the PRC on the Protection of the Rights and Interests of Consumers was promulgated on October&#160;31, 1993 and became effective on January&#160;1, 1994 to protect consumers&#8217; rights when they purchase or use goods or services. All business operators must comply with this law when they manufacture or sell goods and/or provide services to customers. In extreme situations, pharmaceutical product manufacturers and distributors may be subject to criminal liability if their goods or services lead to the death or injuries of customers or other third parties.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Circular 106
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On May 31, 2007, China&#8217;s State Administration of Foreign Exchange (&#8220;SAFE&#8221;) issued an official notice known as &#8220;Circular 106&#8221;, which requires the owners of any Chinese companies to obtain SAFE&#8217;s approval before establishing any offshore holding company structure in so-called &#8220;round-trip&#8221; investment transactions for foreign financing as well as subsequent acquisition matters in China. Likewise, the &#8220;Provisions on Acquisition of Domestic Enterprises by Foreign Investors&#8221;, issued jointly by Ministry of Commerce (&#8220;MOFCOM&#8221;), State-owned Assets Supervision and Administration Commission, State Taxation Bureau, State Administration for Industry and Commerce, China Securities Regulatory Commission and SAFE in September 2006, impose approval requirements from MOFCOM for &#8220;round-trip&#8221; investment transactions, including acquisitions in which equity was used as consideration.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	&#160;Dividend Distribution
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The principal laws, rules and regulations governing dividends paid by our PRC affiliated entities include the Company Law of the PRC (1993), as amended in 2006, Wholly Foreign Owned Enterprise Law (1986), as amended in 2000, and Wholly Foreign Owned Enterprise Law Implementation Rules (1990), as amended in 2001. Under these laws and regulations, each of our consolidated PRC entities, including wholly foreign owned enterprises, or WFOEs, and domestic companies in China may pay dividends only out of their accumulated profits, if any, determined in accordance with PRC accounting standards and regulations. In addition, each of our consolidated PRC entities, including WFOEs and domestic companies, is required to set aside at least 10% of its after-tax profit based on PRC accounting standards each year to its statutory surplus reserve fund until the accumulative amount of such reserve reaches 50% of its respective registered capital. These reserves are not distributable as cash dividends. As of December 31, 2015, the accumulated balance of our statutory reserve funds reserves amounted to RMB 55&#160;million (approximately $7.4&#160;million) and the accumulated profits of our consolidated PRC entities that were available for dividend distribution amounted to RMB 130.3 million (approximately $15.9 million).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Foreign Exchange Regulation
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The ability of our PRC affiliated entities to make dividends and other payments to the Company may also be restricted by changes in applicable foreign exchange and other laws and regulations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Foreign currency exchange regulation in the PRC is primarily governed by the following rules:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE" FACE="SYMBOL, SERIF">
	&#183;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Foreign Exchange Administration Rules (1996), as amended in August 2008, or the Exchange Rules;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE" FACE="SYMBOL, SERIF">
	&#183;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Administration Rules of the Settlement, Sale and Payment of Foreign Exchange (1996), or the Administration Rules.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Currently, under the Administration Rules, Renminbi is freely convertible for current account items, including the distribution of dividends, interest payments, trade and service related foreign exchange transactions, but not for capital account items, such as direct investments, loans, repatriation of investments and investments in securities outside of the PRC, unless the prior approval of the State Administration of Foreign Exchange (the &#8220;SAFE&#8221;) is obtained and prior registration with the SAFE is made. Foreign-invested enterprises like Shaanxi Biostar&#160;that need foreign exchange for the distribution of profits to its shareholders may effect payment from their foreign exchange accounts or purchase and pay foreign exchange rates at the designated foreign exchange banks to their foreign shareholders by producing board resolutions for such profit distribution. Based on their needs, foreign-invested enterprises are permitted to open foreign exchange settlement accounts for current account receipts and payments of foreign exchange along with specialized accounts for capital account receipts and payments of foreign exchange at certain designated foreign exchange banks.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	16
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage17"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Although the current Exchange Rules allow the convertibility of Chinese Renminbi into foreign currency for current account items, conversion of Chinese Renminbi into foreign exchange for capital items, such as foreign direct investment, loans or securities, requires the approval of SAFE, which is under the authority of the People&#8217;s Bank of China. These approvals, however, do not guarantee the availability of foreign currency conversion. The Company cannot be sure that it will be able to obtain all required conversion approvals for its operations or the Chinese regulatory authorities will not impose greater restrictions on the convertibility of Chinese Renminbi in the future. Currently, most of the Company&#8217;s retained earnings are generated in Renminbi. Any future restrictions on currency exchanges may limit the Company&#8217;s ability to use its retained earnings generated in Renminbi to make dividends or other payments in U.S. dollars or fund possible business activities outside China.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Taxation
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The PRC Enterprise Income Tax Law, or the EIT Law provides that enterprises established outside of China whose &#8220;de facto management bodies&#8221; are located in China are considered &#8220;resident enterprises&#8221; and are generally subject to the uniform 25% enterprise income tax rate as to their worldwide income. Under the implementation regulations for the EIT Law, &#8220;de facto management body&#8221; is defined as a body that has material and overall management and control over the manufacturing and business operations, personnel and human resources, finances and treasury, and acquisition and disposition of properties and other assets of an enterprise. Although substantially all of our operational management is currently based in the PRC, it is unclear whether PRC tax authorities would treat us as a PRC resident enterprise.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Under the EIT Law and implementation regulations, PRC income tax at the rate of 10% is applicable to dividends payable to investors that are &#8220;non-resident enterprises,&#8221; which do not have an establishment or place of business in the PRC, or which have such establishment or place of business but the relevant income is not effectively connected with the establishment or place of business, to the extent such dividends are derived from sources within the PRC. Similarly, any gain realized on the transfer of shares by such investors is also subject to 10% PRC income tax if such gain is regarded as income derived from sources within the PRC. If we are considered a PRC &#8220;resident enterprise,&#8221; it is unclear whether dividends we pay with respect to our common shares, or the gain you may realize from the transfer of our common shares, would be treated as income derived from sources within the PRC and be subject to PRC income tax. It is also unclear whether, if we are considered a PRC &#8220;resident enterprise,&#8221; holders of our common shares might be able to claim the benefit of income tax treaties entered into between China and other countries.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Price Controls
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The retail prices of some pharmaceutical products sold in China, primarily those included in the national and provincial medical insurance catalogs and those pharmaceutical products whose production or distribution are deemed to constitute monopolies, are subject to price controls in the form of fixed prices (for non-profit medical institutions) or price ceilings. Manufacturers or distributors cannot freely set or change the retail price for any price-controlled product above the applicable price ceiling or deviate from the applicable fixed price imposed by the PRC government. The prices of medicines that are not subject to price controls are determined freely at the discretion of the respective pharmaceutical companies, subject to notification to the provincial pricing authorities.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 9PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The retail prices of medicines that are subject to price controls are administered by the Price Control Office of the National Development and Reform Commission (&#8220;NDRC&#8221;), and provincial and regional price control authorities. The retail price, once set, also effectively determines the wholesale price of that medicine. From time to time, the NDRC publishes and updates a list of medicines that are subject to price control. Fixed prices and price ceilings on medicine are determined based on profit margins that the relevant government authorities deem reasonable, the type and quality of the medicine, its production costs, the prices of substitute medicine and the extent of the manufacturer&#8217;s compliance with the applicable Good Manufacturing Practice (&#8220;GMP&#8221;) standards. The NDRC directly regulates the pricing of a portion of the medicine on the list, and delegates to provincial and regional price control authorities the authority to regulate the pricing of the rest of the medicine on the list. Provincial and regional price control authorities have discretion to authorize price adjustments based on the local conditions and the level of local economic development. Currently, approximately 2,014 pharmaceutical products are subject to price controls. The price controls of all of those pharmaceutical products are administered by the NDRC.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Only the manufacturer of a medicine may apply for an increase in the retail price of the medicine, and it must either apply to the provincial price control authorities in the province where it is incorporated, if the medicine is provincially regulated, or to the NDRC, if the medicine is NDRC regulated. For a provincially regulated medicine, in cases where provincial price control authorities approve an application, manufacturers must file the newly approved price with the NDRC for record and thereafter the newly approved price will become binding and enforceable across China.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Since May&#160;1998, the PRC government has been ordering reductions in the retail prices of various pharmaceutical products. The latest price reduction occurred in October 2008. As of December&#160;31, 2011, only one of our pharmaceutical products was subject to price controls. Price controls, however, have had no significant impact on our operations as our price points have historically been substantially below such government-imposed ceilings.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	17
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage18"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The NDRC may grant premium pricing status to certain pharmaceutical products that are under price control. The NDRC may set the retail prices of pharmaceutical products that have obtained premium pricing status at a level that is significantly higher than comparable products.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Research and Development
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We currently have three potential products in the research and development pipeline. Identified compounds are currently being tested for indications related to neoplastic disease, central nervous system disease, an anti-infection medicine, kidney medicine and sterility. We anticipate we will be able to introduce three to five new products to market each year.&#160;&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In addition to the work being done in our in-house research department, we are working with Chinese universities and research institutes in the PRC to develop effective, high margin products. Specifically:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE" FACE="SYMBOL, SERIF">
	&#183;
</FONT>
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In 2006, Aoxing Pharmaceutical entered into a technological cooperation agreement with Shaanxi University of Science and Technology (&#8220;Shaanxi University&#8221;) under which Shaanxi University agreed to provide interns to assist with our product development for payment from us of RMB 600 per month to the interns. Additionally, Shaanxi University agreed to provide advisory educational services to improve our pharmaceutical production techniques. We are authorized to use the education material in our production process but do not own the educational materials. Shaanxi University also agreed to assist us in developing improved production techniques for new drugs, the ownership of which shall be held by Aoxing Pharmaceutical. The fees to be paid to Shaanxi University for new drug development will be made under a separate agreement, although there is currently no funding requirement.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE" FACE="SYMBOL, SERIF">
	&#183;
</FONT>
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Also, in 2006, Aoxing Pharmaceuticals entered into a technological cooperation agreement with the College of Life Sciences of Northwest University (&#8220;Northwest University&#8221;), pursuant to which we agreed to make our facilities available for practical studies for interns from Northwest University. In return, Northwest University agreed to assign its personnel to teach our staff various agricultural sciences associated with growing plants and herbs used in traditional Chinese medicines (&#8220;TCM&#8221;). We are authorized to use the education material in our production process but do not own the educational materials. In addition, the parties agreed to cooperate on the development of new TCM, the ownership of which will be held by us. The fees to be paid Northwest University for new drug development were made under a separate agreement, although we have currently not entered into any such agreement.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE" FACE="SYMBOL, SERIF">
	&#183;
</FONT>
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On January 5, 2007, Aoxing Pharmaceutical entered into a cooperation agreement with Xianyang Material Medical Institute (&#8220;Xianyang Institute&#8221;) for the development of a new drug called Zenbaowan Capsule. Under the agreement, Xianyang Institute is responsible for the research and development of the new drug in compliance with the PRC Drug Administration Law and the Administration Regulations for Drug Registration, as well as the SFDA application process for, the new drug. In addition, the parties agreed to long term technical cooperation on products mutually identified in the future under the terms of separate agreements. Any product developed by Xianyang Institute under this agreement, and the intellectual property rights related thereto, will be owned by us. We agreed to pre-pay all application expenses and to pay Xianyang Institute the aggregate consideration of RMB 180,000 (approximately $24,290), of which 50% will be paid on the first day that Zenbaowan Capsule passes the first materials and production site examinations by the SFDA, and 50% upon accreditation and receipt of the drug approval number from the SFDA. The agreement can be terminated by either party without notice. No payments have been made to date.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE" FACE="SYMBOL, SERIF">
	&#183;
</FONT>
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On December 15, 2010, Aoxing Pharmaceutical entered into a product research and development agreement with Northwest University to jointly conduct the research, development and production of a medicine, Danshensu Borneol Ester (&#8220;DBZ&#8221;), for treatment of ischemic cerebrovascular disease. Pursuant to the agreement, Aoxing acquired a 60% equity interest in DBZ and&#160;is entitled to 60% of the after-tax profits after the product is put into production. Aoxing&#160;has the exclusive right to produce and sell the product in China and own the exclusive approval number. Northwest University shall not transfer the product to any third party in China.&#160;As of the date of this Annual Report, we have paid an aggregate of RMB&#160;72 million (approximately $11.5 million) to Northwest University in connection with the agreement.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In year 2014, the Company paid approximately $4 million (i.e. RMB 25 million) as further prepaid research fee for the testing process of the new drug which to be performed in year 2015 by the research institution.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Employees
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As of March 28, 2016, we had 430 full time employees who receive labor insurance. These employees are organized into a union under the labor laws of the PRC and can bargain collectively with us. We maintain good relations with&#160;our employees. We are required to contribute a portion of our employees' total salaries to the Chinese government's social insurance funds, including medical insurance, unemployment insurance and birth insurance and to purchase job injury insurance for employees, in accordance with relevant regulations. The government's social insurance funds account for 20% of employees' total salaries. The job injury insurance premium is about RMB 50 (approximately $7) per person. We expect the amount of our contributions to the government's social insurance funds and the cost related to job injury insurance to increase in the future as&#160;we expand our workforce and operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	18
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage19"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Seasonality of Sales
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Sales in the first quarter are usually lower due to people traveling and taking vacations during the traditional Chinese New Year and Chinese Spring Festival holidays. Sales in the second quarter are the highest among quarters. Sales in the second and third quarters of fiscal 2015 and 2014 were approximately 52% and 16%, and 31% and 29%, respectively.&#160;
</FONT>
</DIV>
</EFX_BUSINESS>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_RISK_FACTORS>
<A NAME="FIS_RISK_FACTORS"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_1A">
	ITEM
</A>
	1A.&#160;&#160;RISK FACTORS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	An investment in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider the risks described here. Our business, financial condition or results of operations could be materially adversely affected by any of these risks. The trading price of our securities could decline due to any of these risks, and you may lose all or part of your investment.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Risks Relating to Our Business
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: NORMAL">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	We Have Limited Sources of Working Capital and Will Need Substantial Additional Financing
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: NORMAL">
<BR>
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: NORMAL">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 36PT">
</FONT>
	Working capital required to implement our business plan will most likely be provided by funds obtained through offerings of our equity, debt, debt-linked securities, and/or equity-linked securities, and revenues generated by us. No assurance can be given that we will have revenues sufficient to support and sustain our operations or that we would be able to obtain equity/debt financing in the current economic environment. If we do not have sufficient working capital and are unable to generate sufficient revenues or raise additional funds, we may delay the completion of or significantly reduce the scope of our current business plan; delay some of our development and clinical or marketing efforts; postpone the hiring of new personnel; or, under certain dire financial circumstances, substantially curtail or cease our operations.
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: NORMAL">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 36PT">
</FONT>
	We may need substantial additional capital to fund our operations. To date, we have relied almost exclusively on organically generated revenues financing transactions to fund losses from our operations. Our inability to obtain sufficient additional financing would have a material adverse effect on our ability to implement our business plan and, as a result, could require us to significantly curtail or potentially cease our operations. At December 31, 2015, we had cash and cash equivalents of approximately $0.04 million, total current assets of approximately $16.2 million and total current liabilities of approximately $7.1 million. We will need to engage in capital-raising transactions in the near future. Such financing transactions may well cause substantial dilution to our shareholders and could involve the issuance of securities with rights senior to the outstanding shares. Our ability to complete additional financings is dependent on, among other things, the state of the capital markets at the time of any proposed offering, market reception of the Company and the likelihood of the success of its business model, of the offering terms, etc. There is no assurance that we will be able to obtain any such additional capital as we need to finance our efforts, through asset sales, equity or debt financing, or any combination thereof, on satisfactory terms or at all. Additionally, no assurance can be given that any such financing, if obtained, will be adequate to meet our capital needs and to support our operations. If adequate capital cannot be obtained on a timely basis and on satisfactory terms, our revenues and operations and the value of our common stock and common stock equivalents would be materially negatively impacted and we may cease our operations.
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Our operating history may not serve as an adequate basis to judge our future prospects and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Aoxing Pharmaceutical&#8217;s operating history may not provide a meaningful basis on which to evaluate its business. We cannot assure you that we will maintain our profitability or that we will not incur net losses in the future. We expect that our operating expenses will increase as we expand. Any significant failure to realize anticipated revenue growth could result in significant operating losses. We will continue to encounter risks and difficulties frequently experienced by companies at a similar stage of development, including our potential failure to:
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE" FACE="SYMBOL, SERIF">
	&#183;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	raise adequate capital for expansion and operations;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE" FACE="SYMBOL, SERIF">
	&#183;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	implement our business model and strategy and adapt and modify them as needed;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE" FACE="SYMBOL, SERIF">
	&#183;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	increase awareness of our brand name, protect our reputation and develop customer loyalty;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE" FACE="SYMBOL, SERIF">
	&#183;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	manage our expanding operations and service offerings, including the integration of any future acquisitions;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE" FACE="SYMBOL, SERIF">
	&#183;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	maintain adequate control of our expenses; or
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 54PT">
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 18PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE" FACE="SYMBOL, SERIF">
	&#183;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	anticipate and adapt to changing conditions in the medical over the counter, pharmaceutical and nutritional supplement markets in which we operate as well as the impact of any changes in government regulations, mergers and acquisitions involving our competitors, technological developments and other significant competitive and market dynamics.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	If we are not successful in addressing any or all of these risks, our business may be materially and adversely affected.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	19
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage20"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	The loss of Aoxing Pharmaceutical as our operating business would have a material adverse effect on our business and the price of our common stock.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We have no equity ownership interest in Aoxing Pharmaceutical. Our ability to control Aoxing Pharmaceutical and consolidate its financial results is through a series of contractual arrangements between it and our wholly owned subsidiary Shaanxi Biostar. Management of Aoxing Pharmaceutical is an affiliate of us and of Shaanxi Biostar and the stockholders of Aoxing Pharmaceutical are also our stockholders. Thus, the contractual arrangements were not entered into as a result of arms&#8217; length negotiations because the parties to such agreements are under common control. While we believe that the contractual arrangements are legal and enforceable under PRC law, our affiliates control the parties to the contractual arrangements, and it could be possible for them to cause Aoxing Pharmaceutical and its shareholders to breach the contractual arrangements, in which event our unaffiliated investors would have little or no recourse because of the inherent difficulties in enforcing their rights since all our assets are located in the PRC. In the event that management of Aoxing Pharmaceutical decides to cause a breach the contractual arrangements, the risk of loss for the affiliated shareholders of Aoxing Pharmaceutical could be lower than that for the unaffiliated investors, and the interests of the management and shareholders of Aoxing Pharmaceutical would be in conflict with the interest of our other stockholders.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Our failure to compete effectively may adversely affect our ability to generate revenue.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We compete with other companies, many of whom are developing or can be expected to develop products similar to ours. Many of our competitors are also more established than we are, and have significantly greater financial, technical, marketing and other resources than we presently possess. Some of our competitors have greater name recognition and a larger customer base. These competitors may be able to respond more quickly to new or changing opportunities and customer requirements and may be able to undertake more extensive promotional activities, offer more attractive terms to customers, and adopt more aggressive pricing policies. We cannot assure you that we will be able to compete effectively with current or future competitors or that the competitive pressures we face will not harm our business.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	&#160;
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	We may require additional financing in the future and a failure to obtain such required financing will inhibit our ability to grow.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The continued growth of our business may require additional funding from time to time, which we expect to raise in private placements of our equity or debt securities with accredited investors or by offering our securities for sale pursuant to an effective registration statement on a market where our common stock is traded. The proceeds of these funding will be forwarded to Aoxing Pharmaceutical and accounted for as a loan to Aoxing Pharmaceutical and eliminated during consolidation. The proceeds would be used for general corporate purposes of Aoxing Pharmaceutical, which could include acquisitions, investments, repayment of debt and capital expenditures among other things. We may also use the proceeds to repurchase our capital stock or for our corporate overhead expenses. If we borrow funds we expect to be the primary obligor on any debt. Obtaining additional funding would be subject to a number of factors including market conditions, operating performance and investor sentiment, many of which are outside of our control. These factors could make the timing, amount, terms and conditions of additional funding unattractive or unavailable to us.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	The terms of any future financing may adversely affect your interest as stockholders.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	If we require additional financing in the future, we may be required to incur indebtedness or issue equity securities, the terms of which may adversely affect your interests in us. For example, the issuance of additional indebtedness may be senior in right of payment to your shares upon our liquidation. In addition, indebtedness may be under terms that make the operation of Aoxing Pharmaceutical's business more difficult because the lender's consent could be required before we take certain actions. Similarly the terms of any equity securities we issue may be senior in right of payment of dividends to your common stock and may contain superior rights and other rights as compared to your common stock. Further, any such issuance of equity securities may dilute your interest in us.
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	We may engage in future acquisitions that could dilute the ownership interests of our stockholders, cause us to incur debt and assume contingent liabilities.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We may review acquisition and strategic investment prospects that we believe would complement our current product offerings, augment our market coverage or enhance our technical capabilities, or otherwise offer growth opportunities. From time to time we review investment opportunities in new businesses and we expect to make investments in, and to acquire, businesses, products, or technologies in the future. We expect that when we raise funds from investors for any of these purposes we will be either the issuer or the primary obligor while the proceeds will be forwarded to Aoxing Pharmaceutical and accounted for as a loan to Aoxing Pharmaceutical and eliminated during consolidation. In the event of any future acquisitions, we could:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;issue equity securities which would dilute current stockholders&#8217; percentage ownership;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;incur substantial debt;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;assume contingent liabilities; or
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;expend significant cash.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	20
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage21"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	These actions could have a material adverse effect on our operating results or the price of our common stock. Moreover, even if we do obtain benefits in the form of increased sales and earnings, there may be a lag between the time when the expenses associated with an acquisition are incurred and the time when we recognize such benefits. Acquisitions and investment activities also entail numerous risks, including:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;difficulties in the assimilation of acquired operations, technologies and/or products;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;unanticipated costs associated with the acquisition or investment transaction;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the diversion of management&#8217;s attention from other business concerns;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;adverse effects on existing business relationships with suppliers and customers;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;risks associated with entering markets in which Aoxing Pharmaceutical has no or limited prior experience;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the potential loss of key employees of acquired organizations; and
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 63PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -27PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;substantial charges for the amortization of certain purchased intangible assets, deferred stock compensation or similar items. purchased intangible assets, deferred stock compensation or similar items.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We cannot ensure that we will be able to successfully integrate any businesses, products, technology, or personnel that we might acquire in the future, and our failure to do so could have a material adverse effect on our business, operating results and financial condition.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	We may not have adequate internal accounting controls.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We are constantly striving to improve our internal accounting controls. We expect to continue to improve our internal accounting control for budgeting, forecasting, managing and allocating our funds and to better account for them as we grow. There is no guarantee that such improvements will be adequate or successful or that such improvements will be carried out on a timely basis. If we do not have adequate internal accounting controls, we may not be able to appropriately budget, forecast and manage our funds, we may also be unable to prepare accurate accounts on a timely basis to meet our continuing financial reporting obligations and we may not be able to satisfy our obligations under US securities laws.
</FONT>
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Rules adopted by the SEC pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 require every public company to include a management report on such company&#8217;s internal controls over financial reporting in its annual report, which contains management&#8217;s assessment of the effectiveness of our internal controls over financial reporting. The standards that must be met for management to assess the internal control over financial reporting as effective are new and complex, and require significant documentation, testing and possible remediation to meet the detailed standards. Some members of our management team have limited or no experience operating a public company, or subject to SEC rules and requirements, including SEC reporting practices and requirements that are applicable to a public company. While we are in the process of engaging a consulting firm to evaluate and assist us with implementing a viable internal control system, our lack of familiarity with Section 404 may nevertheless unduly divert management's time and resources in executing the business plan. Effective internal controls, particularly those related to revenue recognition, are necessary for us to produce reliable financial reports and are important to help prevent fraud. So far, our external auditors have not reported to our board of directors any significant weakness on our internal control and provided recommendations accordingly. Nevertheless, our failure to achieve and maintain effective internal controls over financial reporting could result in the loss of investor confidence in the reliability of our financial statements, which in turn could harm our business and negatively impact the trading price of our stock. Furthermore, we anticipate that we will incur considerable costs and use significant management time and other resources in an effort to comply with Section 404 and other requirements of the Sarbanes-Oxley Act.
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	We are dependent on certain key personnel and loss of these key personnel could have a material adverse effect on our business, financial condition and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our success is, to a certain extent, attributable to the management, sales and marketing, and pharmaceutical factory operational expertise of key personnel. We are dependent upon the services of Mr. Wang, our president, Chief Executive Officer and Chairman, for the continued growth and operation of our Company because of his experience in the industry and his personal and business contacts in the PRC. We do not have an employment agreement with Mr. Wang and do not anticipate entering into an employment agreement in the foreseeable future. Although we have no reason to believe that Mr. Wang will discontinue his services with us or Aoxing Pharmaceutical, the interruption or loss of his services would adversely affect our ability to effectively run our business and pursue our business strategy as well as our results of operations. Additionally, Qinghua Liu, our Interim Chief Financial Officer, Zhenghong Wang, our Chief Operating Officer, Shuang Gong, our Corporate Secretary, Yuan Jian, General Manager and Chief Engineer of Aoxing Pharmaceutical, perform key functions in the operation of our business. There can be no assurance that we will be able to retain these officers after the term of their employment contracts expire. The loss of these officers could have a material adverse effect upon our business, financial condition, and results of operations. We do not carry key man life insurance for any of our key personnel nor do we foresee purchasing such insurance to protect against a loss of key personnel.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	21
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage22"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	We may not be able to hire and retain qualified personnel to support our growth and if we are unable to retain or hire these personnel in the future, our ability to improve our products and implement our business objectives could be adversely affected.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We must attract, recruit and retain a sizeable workforce of technically competent employees. Competition for senior management and senior personnel in the PRC is intense, the pool of qualified candidates in the PRC is very limited, and we may not be able to retain the services of our senior executives or senior personnel, or attract and retain high-quality senior executives or senior personnel in the future. This failure could materially and adversely affect our future growth and financial condition.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	If we fail to increase our brand recognition, we may face difficulty in obtaining new customers and business partners.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We believe that establishing, maintaining and enhancing our brand in a cost-effective manner is critical to achieving widespread acceptance of our current and future products and services and is an important element in our effort to increase our customer base and obtain new business partners. We believe that the importance of brand recognition will increase as competition in our market develops. Some of our potential competitors already have well-established brands in the pharmaceutical promotion and distribution industry. Successful promotion of our brand will depend largely on our ability to maintain a sizeable and active customer base, our marketing efforts and ability to provide reliable and useful products and services at competitive prices. Brand promotion activities may not yield increased revenue, and even if they do, any increased revenue may not offset the expenses we will incur in building our brand. If we fail to successfully promote and maintain our brand, or if we incur substantial expenses in an unsuccessful attempt to promote and maintain our brand, we may fail to attract enough new customers or retain our existing customers to the extent necessary to realize a sufficient return on our brand-building efforts, in which case our business, operating results and financial condition, would be materially adversely affected.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Our operating results may fluctuate as a result of factors beyond our control.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our operating results may fluctuate significantly in the future as a result of a variety of factors, many of which are beyond our control. These factors include:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the costs of pharmaceutical products and development;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 63PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -27PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the relative speed and success with which we can obtain and maintain customers, merchants and vendors for our products;
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;capital expenditure for equipment;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;marketing and promotional activities and other costs;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;changes in our pricing policies, suppliers and competitors;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the ability of our suppliers to provide products in a timely manner to their customers;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;changes in operating expenses;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;increased competition in the pharmaceutical markets; and
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;other general economic and seasonal factors.
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Our future sales and operations may be adversely affected by recent PRC reports that gel capsules supplied by certain manufacturers contained impermissible levels of chromium.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In April 2012, the PRC news agencies reported that the SFDA suspended sales and distributions of 13 drugs from 9 pharmaceutical companies that used capsules supplied by certain gel capsule manufacturers in Zhejiang and Hebei Provinces, PRC. According to the SFDA investigation and testing of capsule samples, 23 out of 42 samples were found to contain excessive levels of chromium, a toxic heavy metal. As further reported in the PRC mass media, the regulatory inquiry into this matter is ongoing. In addition to drug sale suspensions, SFDA also revoked production licenses of two gel capsule manufacturers and was pursuing other regulatory and criminal prosecution measures. As of April 27, 2012, SFDA promulgated a set of regulations requiring pharmaceutical companies to self-inspect and self-screen to ensure no toxic products in their inventory, including, without limitation, employing toxic substance detection devices.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In May 2012, following an onsite inspection by the Xianyang State Food and Drug Administration (SFDA), samples from a batch of the Company&#8217;s Xin Aoxing capsules were found to contain chromium content higher than edible gelatin. Specifically, samples from a batch of 150 cases of the Xin Aoxing capsules (each of the 150 cases contains 8,000 capsules), representing Biostar sales of approximately RMB1,188,000 or approximately $188,000 were found to contain high levels of chromium, which capsules, in the Company&#8217;s estimation, were sold in the market in mid-2011.&#160;&#160;The Company did not check the batch in question for the chromium levels at that time since PRC pharmaceutical companies were not required to test their gel capsule inventories and purchases for chromium levels in 2011.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	22
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage23"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As required by SFDA in April 2012, the Company purchased gel capsule inspection equipment to measure the chromium levels in gel capsules it used. The Company also undertook a thorough inspection of all samples of drugs sold and its current product inventory to ensure that all of the gel capsules it had purchased and currently uses comply with the SFDA chromium content requirements.&#160;&#160;In addition, the Company conducted checks of every batch of raw materials it uses in every production category and, except as discussed above, found no violations of the chromium content requirements. Further, the Company recalled all such affected capsules as promptly and thoroughly as possible, and imposed heightened quality control and assurance measures going forward. On July 30, 2012, the SFDA approved the Company&#8217;s resumption of sales of its gel capsules following the thorough inspection. However, the suspension of sales of gel capsule products severely affected almost all China-based pharmaceutical companies that use gelatin capsules to manufacture their drugs.&#160;&#160;The Company was not immune to the industry-wide losses and the Company&#8217;s sales and overall results for the 2012 second quarter were similarly adversely affected. The Company has been taking a number of steps to restart sales of gel capsule drugs immediately following the SFDA approval, including, among others, engaging its employees to work overtime, adding a second shift, launching an aggressive advertising campaign to help improve consumer confidence, establishing incentives for the sales force in all of the distribution offices nationwide, and launching an innovating B2C call center to take order and provide hands-on sales support.&#160;&#160;There is no assurance that the Company will be successful in detecting such defective gel capsules in the future. In any such event, the Company may be required to find alternate gel capsule supplier and its operations and sales efforts in the short-term may therefore be adversely affected.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	We face marketing risks.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Newly developed drugs and technology may not be compatible with market needs. Because markets for drugs differentiate geographically inside the PRC, we must develop and manufacture our products to accurately target specific markets to ensure product sales. If we fail to invest in extensive market research to understand the health needs of consumers in different geographic areas, we may face limited market acceptance of our products, which could have material adverse effect on our sales and earnings.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	We face risks relating to difficulty in defending intellectual property rights from infringement.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our success depends on protection of our current and future technology and products and our ability to defend our intellectual property rights. We have filed for trademark protection for the various names and brands of our products sold in the PRC. We have also filed for patent protection on three of our products, one of which has been approved. However, it is possible for its competitors to develop similar competitive products even though it has taken steps to protect its intellectual property. If we fail to protect our intellectual property adequately, competitors may manufacture and market products similar to ours. We expect to file patent applications seeking to protect newly developed technology and products in various countries, including the PRC. Some patent applications in the PRC are maintained in secrecy until the patent is issued. Because the publication of discoveries tends to follow their actual discovery by many months, we may not be the first to invent, or file patent applications on any of our discoveries. Patents may not be issued with respect to any of our patent applications and existing or future patents issued to or licensed by us may not provide competitive advantages for our products. Patents that are issued may be challenged, invalidated or circumvented by our competitors. Furthermore, our patent rights may not prevent our competitors from developing, using or commercializing products that are similar or functionally equivalent to our products.
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We also rely on trade secrets, non-patented proprietary expertise and continuing technological innovation that we shall seek to protect, in part, by entering into confidentiality agreements with licensees, suppliers, employees and consultants. These agreements may be breached and there may not be adequate remedies in the event of a breach. Disputes may arise concerning the ownership of intellectual property or the applicability of confidentiality agreements. Moreover, our trade secrets and proprietary technology may otherwise become known or be independently developed by our competitors. If patents are not issued with respect to products arising from research, we may not be able to maintain the confidentiality of information relating to these products.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	We face risks relating to third parties that may claim that we infringe on their proprietary rights and may prevent us from manufacturing and selling certain of our products.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	There has been substantial litigation in the pharmaceutical industry with respect to the manufacturing, use and sale of new products. These lawsuits relate to the validity and infringement of patents or proprietary rights of third parties. We may be required to commence or defend against charges relating to the infringement of patent or proprietary rights. Any such litigation could:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;require us to incur substantial expense, even if covered by insurance or are successful in the litigation;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;require us to divert significant time and effort of our technical and management personnel;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;result in the loss of our rights to develop or make certain products; and
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 63PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -27PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;require us to pay substantial monetary damages or royalties in order to license proprietary rights from third parties.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	23
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage24"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Although patent and intellectual property disputes within the pharmaceutical industry have often been settled through licensing or similar arrangements, costs associated with these arrangements may be substantial and could include the long-term payment of royalties. These arrangements may be investigated by regulatory agencies and, if improper, may be invalidated. Furthermore, the required licenses may not be made available to us on acceptable terms. Accordingly, an adverse determination in a judicial or administrative proceeding or a failure to obtain necessary licenses could prevent us from manufacturing and selling some of our products or increase our costs to market these products. In addition, when seeking regulatory approval for some of our products, we may be required to certify to regulatory authorities, including the SFDA that such products do not infringe upon third party patent rights. Filing a certification against a patent gives the patent holder the right to bring a patent infringement lawsuit against us. Any lawsuit would delay the receipt of regulatory approvals. A claim of infringement and the resulting delay could result in substantial expenses and even prevent us from manufacturing and selling certain of our products. Our launch of a product prior to a final court decision or the expiration of a patent held by a third party may result in substantial damages to us. If we are found to infringe a patent held by a third party and become subject to such damages, these damages could have a material adverse effect on the results of our operations and financial condition.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	We face risks related to research and the ability to develop new drugs.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our growth and survival depends on our ability to consistently discover, develop and commercialize new products and find new and improve on existing technology and platforms. As such, if we fail to make sufficient investments in research, be attentive to consumer needs or does not focus on the most advanced technology, our current and future products could be surpassed by more effective or advanced products of other companies.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Risk Related To the Pharmaceutical Industry
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Our certificates, permits, and licenses related to our pharmaceutical operations are subject to governmental control and renewal and failure to obtain renewal will cause all or part of our operations to be terminated.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Aoxing Pharmaceutical is subject to various PRC laws and regulations pertaining to the pharmaceutical industry. Aoxing Pharmaceutical has attained certificates, permits, and licenses required for the operation of a pharmaceutical enterprise and the manufacturing of pharmaceutical products in the PRC. In 1998, the State Food and Drug Administration of the PRC (&#8220;SFDA&#8221;) introduced the Good Manufacturing Practice (GMP) Certificate in order to promote quality and safety of pharmaceutical production.&#160;&#160;The Good Manufacturing Practices were revised in July and October 2004.&#160;&#160;We and our competitors are required to meet GMP standards in order to continue manufacturing pharmaceutical products and health foods. For each new product, Aoxing Pharmaceutical prepares documentation of pharmacological, toxicity, pharmacokinetics and drug metabolism studies in addition to providing samples of the drug. The documentation and samples are then submitted to provincial food and drug administration. This process typically takes approximately three months. After the documentation and samples have been approved by the provincial food and drug administration, the provincial administration submits the approved documentation and samples to the SFDA. The SFDA examines the documentation and tests the samples and presents the findings to the New Drug Examination Committee for approval. If the application is approved by the SFDA, the SFDA will issue a clinical trial license to the applicant for clinical trials. This clinical trial license approval typically takes one year, followed by approximately two years of trials, depending on the category and class of the new drug. The SFDA then examines the documentation from the trial and, if approved, issues the new drug license to the applicant. This process usually takes eight months. The entire process takes anywhere from three to four years.
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Aoxing Pharmaceutical initially obtained pharmaceutical products and health food production permits by submitting its manufacturing processes and product tests to the SFDA who verified that its production processes and products met the standards by onsite inspections, review of test results and a determination that the market was not saturated by its products. The production permits are permanent once issued as long as they are renewed by the expiration date. The GMP certificate is valid for a term of five years, the pharmaceutical products production permits are subject to renewal every five years, and the health food production permits are valid for three year terms, and each must be renewed before its expiration, if applicable. Aoxing Pharmaceutical originally obtained its GMP certificate in January 2006, and it is valid until January 23, 2011. The GMP certificate applies to products described as medicinal tablets, granules, capsules, soft capsules, powder, and ointment. If the GMP certificate expires without renewal, Aoxing Pharmaceutical will not be able to continue production of pharmaceutical products, which will cause its operations to terminate. We filed the application to renew the GMP certificate before its expiration date, and SFDA has approved our application and issued its official GMP license on March 29, 2011. It is a common practice in China to have the grace period between the GMP expiry day and new GMP license day. We intend to apply for renewal of these health food production permits prior to expiration. During the renewal process, Aoxing Pharmaceutical will be re-evaluated by the appropriate governmental authorities and must comply with the then prevailing standards and regulations which may change from time to time. In the event that it is not able to renew the certificates, permits and licenses, all or part of its operations may be terminated. Furthermore, if escalating compliance costs associated with governmental standards and regulations restrict or prohibit any part of its operations, it may adversely affect its operation and our profitability.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	24
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage25"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	According to Drug Administration Law of the PRC and its implementing rules, the SFDA approvals, including Pharmaceutical Manufacturing Permit and Drug Approval Numbers, may be suspended or revoked prior to the expiration date under circumstances that include:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;producing counterfeit medicine;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;producing inferior quality products;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;failing to meet the drug GMP standards;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 63PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -27PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;purchasing medical ingredients used in the production of products sources that do not have Pharmaceutical Manufacturing Permit or Pharmaceutical Trade Permit;
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;fraudulent reporting of results or product samples in application process;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;failing to meet drug labeling and direction standards;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;bribing doctors or hospital personnel to entice them to use products,
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;producing pharmaceuticals for use or resale by companies that are not approved by the SFDA, or
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;the approved drug has a serious side effect.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	If our pharmaceutical products fail to receive regulatory approval or are severely limited in these products' scope of use, we may be unable to recoup considerable research and development expenditures.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our research and development of pharmaceutical products is subject to the regulatory approval of the SFDA. The regulatory approval procedure for pharmaceuticals can be quite lengthy, costly, and uncertain. Depending upon the discretion of the SFDA, the approval process may be significantly delayed by additional clinical testing and require the expenditure of resources not currently available; in such an event, it may be necessary for us to abandon our application. Even where approval of the product is granted, it may contain significant limitations in the form of narrow indications, warnings, precautions, or contra-indications with respect to conditions of use. If approval of our product is denied, abandoned, or severely limited in terms of the scope of products use, it may result in the inability to recoup considerable research and development expenditures. Currently, three of our products, Zushima, Gan Fu Kang and Azithromycin Dispersible Tablets, have pending applications with the SFDA. Phase II clinical testing is occurring for five other products (Shenrong Capsules, Zhixuening Pian, Xiao'aiping Dispersible Tablets, Zhenbao Wan Capsules, and KunLing Wan Capsules), which expects to be completed sometime in 2012 to 2015. After phase II clinical test, these products will need to go through a phase III clinical test before they can be submitted for SFDA approval. We expect phase III clinical test for all six products will be completed sometime in 2015 to 2017. If we do not receive timely approval for any of these drugs, then production will be delayed and sales of the products may be adversely affected.
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Price control regulations may decrease our profitability.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The laws of the PRC provide for the government to fix and adjust prices. The prices of certain medicines we distribute, including those listed in the Chinese government's catalogue of medications that are reimbursable under the PRC&#8217;s social insurance program, or the Insurance Catalogue, are subject to control by the relevant state or provincial price administration authorities. The PRC establishes price levels for products based on market conditions, average industry cost, supply and demand and social responsibility. In practice, price control with respect to these medicines sets a ceiling on their retail price. The actual price of such medicines set by manufacturers, wholesalers and retailers cannot historically exceed the price ceiling imposed by applicable government price control regulations. Although, as a general matter, government price control regulations have resulted in drug prices tending to decline over time, there has been no predictable pattern for such decreases.&#160;&#160;It is possible that additional products may be subject to price control, or that price controls may be increased in the future. To the extent that our products are subject to price control, our revenue, gross profit, gross margin and net income will be affected since the revenue we derive from our sales will be limited and we may face no limitation on our costs. Further, if price controls affect both our revenue and costs, our ability to be profitable and the extent of our profitability will be effectively subject to determination by the applicable regulatory authorities in the PRC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	If the medications we produce are replaced by other medicines or are removed from the PRC's insurance catalogue in the future, our revenue may suffer.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Under Chinese regulations, patients purchasing medicine listed by the central and/or provincial governments in the insurance catalogue may be reimbursed, in part or in whole, by a social medicine fund. Accordingly, pharmaceutical distributors prefer to engage in the distribution of medicine listed in the insurance catalogue. Currently, one of our main prescription products, Danshen Granule is listed in the insurance catalogue. The content of the insurance catalogue is subject to change by the PRC Ministry of Labor and Social Security, and new medicine may be added to the insurance catalogue by provincial level authorities as part of their limited ability to change certain medicines listed in the insurance catalogue. If the medicine we produce are replaced by other medicines or removed from the insurance catalogue in the future, our revenue may suffer.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	25
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage26"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Adverse publicity associated with our products, ingredients or network marketing program, or those of similar companies, could harm our financial condition and operating results.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The results of our operations may be significantly affected by the public's perception of our product and similar companies. This perception is dependent upon opinions concerning:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the safety and quality of our products and ingredients;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the safety and quality of similar products and ingredients distributed by other companies; and
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;our sales force.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Adverse publicity concerning any actual or purported failure to comply with applicable laws and regulations regarding product claims and advertising, good manufacturing practices, or other aspects of our business, whether or not resulting in enforcement actions or the imposition of penalties, could have an adverse effect on our goodwill and could negatively affect our sales and ability to generate revenue. In addition, our consumers' perception of the safety and quality of products and ingredients as well as similar products and ingredients distributed by other companies can be significantly influenced by media attention, publicized scientific research or findings, widespread product liability claims and other publicity concerning our products or ingredients or similar products and ingredients distributed by other companies. Adverse publicity, whether or not accurate or resulting from consumers' use or misuse of our products, that associates consumption of our products or ingredients or any similar products or ingredients with illness or other adverse effects, questions the benefits of our or similar products or claims that any such products are ineffective, inappropriately labeled or have inaccurate instructions as to their use, could negatively impact our reputation or the market demand for our products.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	If we fail to develop new products with high profit margins, and our high profit margin products are substituted by competitor's products, our gross and net profit margins will be adversely affected.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	There is no assurance that we will be able to sustain our profit margins in the future. The pharmaceutical industry in the PRC is very competitive, and there may be pressure to reduce sale prices of products without a corresponding decrease in the price of raw materials. In addition, new products are constantly being introduced to the market. In order to increase our sales and expand our market share, we may be forced to reduce prices in the future, leading to a decrease in gross profit margin. The research and development of new products and technology is costly and time consuming, and there are no assurances that our research and development of new products will either be successful or completed within the anticipated timeframe, if ever at all. There is no assurance that our competitors' new products, technology, and processes will not render our existing products obsolete or non-competitive. To the extent that we fail to develop new products with high profit margins and our high profit margin products are substituted by competitors' products, our gross profit margins will be adversely affected.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	The commercial success of our products depends upon the degree of market acceptance among the medical community and failure to attain market acceptance among the medical community may have an adverse impact on our operations and profitability.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The commercial success of our products depends upon the degree of market acceptance by the PRC medical community, such as hospitals and physicians. Even if our products are approved by the SFDA, there is no assurance that physicians will prescribe or recommend our products to patients. Furthermore, a product's prevalence and use at hospitals may be contingent upon its relationship with the medical community. Currently, Danshen Granule and Taohausan are only available by medical prescription. The acceptance of our products by the PRC medical community may depend upon several factors, including but not limited to, the product's acceptance by physicians and patients as a safe and effective treatment, cost effectiveness, potential advantages over alternative treatments, and the prevalence and severity of side effects. Failure to attain market acceptance among the medical community may have an adverse impact on our operations and profitability.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	26
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage27"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Risks Related to Doing Business in the PRC
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Changes in the policies of the PRC government could have a significant impact upon the business we may be able to conduct in the PRC and the profitability of such business.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our business operations may be adversely affected by the current and future political environment in the PRC. The PRC has operated as a socialist state since the mid-1900s and is controlled by the PRC&#8217;s Communist Party. The Chinese government exerts substantial influence and control over the manner in which we and it must conduct our business activities. The PRC has only permitted provincial and local economic autonomy and private economic activities since 1988. The government of the PRC has exercised and continues to exercise substantial control over virtually every sector of the Chinese economy, particularly the pharmaceutical industry, through regulation and state ownership. Our ability to operate in the PRC may be adversely affected by changes in Chinese laws and regulations, including those relating to taxation, import and export tariffs, raw materials, environmental regulations, land use rights, property and other matters. Under current leadership, the government of the PRC has been pursuing economic reform policies that encourage private economic activity and greater economic decentralization. There is no assurance, however, that the government of the PRC will continue to pursue these policies, or that it will not significantly alter these policies from time to time without notice. The PRC's economy is in a transition from a planned economy to a market oriented economy subject to five-year and annual plans adopted by the government that set national economic development goals. Policies of the PRC government can have significant effects on the economic conditions of the PRC. The PRC government has confirmed that economic development will follow the model of a market economy. Under this direction, we believe that the PRC will continue to strengthen its economic and trading relationships with foreign countries and business development in the PRC will follow market forces. While we believe that this trend will continue, there can be no assurance that this will be the case. A change in policies by the PRC government could adversely affect our interests by, among other factors: changes in laws, regulations or the interpretation thereof, confiscatory taxation, restrictions on currency conversion, imports or sources of supplies, or the expropriation or nationalization of private enterprises. Although the PRC government has been pursuing economic reform policies for more than two decades, there is no assurance that the government will continue to pursue such policies or that such policies may not be significantly altered, especially in the event of a change in leadership, social or political disruption, or other circumstances affecting the PRC's political, economic and social life.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	The PRC laws and regulations governing our current business operations are sometimes vague and uncertain. Any changes in such PRC laws and regulations may harm its business.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The PRC laws and regulations governing our current business operations are sometimes vague and uncertain. The PRC&#8217;s legal system is a civil law system based on written statutes, in which system decided legal cases have little value as precedents unlike the common law system prevalent in the United States. There are substantial uncertainties regarding the interpretation and application of PRC laws and regulations, including but not limited to the laws and regulations governing our business, or the enforcement and performance of our arrangements with customers in the event of the imposition of statutory liens, death, bankruptcy and criminal proceedings. The Chinese government has been developing a comprehensive system of commercial laws, and considerable progress has been made in introducing laws and regulations dealing with economic matters such as foreign investment, corporate organization and governance, commerce, taxation and trade. However, because these laws and regulations are relatively new, and because of the limited volume of published cases and judicial interpretation and their lack of force as precedents, interpretation and enforcement of these laws and regulations involve significant uncertainties. New laws and regulations that affect existing and proposed future businesses may also be applied retroactively. We are considered a foreign person or foreign funded enterprise under PRC laws, and as a result, we are required to comply with PRC laws and regulations. We cannot predict what effect the interpretation of existing or new PRC laws or regulations may have on its businesses. If the relevant authorities find that we are in violation of PRC laws or regulations, they would have broad discretion in dealing with such a violation, including, without limitation:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;levying fines;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;revoking Aoxing Pharmaceutical&#8217;s business and other licenses;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;requiring that we restructure our ownership or operations; and
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;requiring that we discontinue any portion or all of our business.
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Among the material laws of the PRC that we are subject to are (i) the Medicine Management Law, governing the management of pharmaceutical companies, medicine production procedure and packaging, prices, (ii) the Advertisement Law , the Rules of Medicine Advertisements Management implemented by the State Administration for Industry and Commerce, and the Regulations on Control of Advertisements from the State Council, governing rules on advertising, (iii) the Standardization of the Management on the Quality of Medicine Production issued by the SFDA, providing standards for staff, plants, equipment, materials, environment and production management, (iv) the Price Law, (v) the Measurement Law, (vi) the Tax Law, (vii) the Environmental Protection Law, (viii) the Contract Law, (ix) the Patent Law, (x) the Accounting Laws and (xi) the Labor Law.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	27
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage28"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	A slowdown, inflation or other adverse developments in the PRC economy may harm our customers and the demand for our services and products.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	All of our operations are conducted in the PRC and all of our revenue is generated from sales in the PRC. Although the PRC economy has grown significantly in recent years, we cannot assure you that this growth will continue. A slowdown in overall economic growth, an economic downturn, a recession or other adverse economic developments in the PRC could significantly reduce the demand for our products and harm our business. While the PRC economy has experienced rapid growth, such growth has been uneven among various sectors of the economy and in different geographical areas of the country. Rapid economic growth could lead to growth in the money supply and rising inflation. If prices for our products rise at a rate that is insufficient to compensate for the rise in the costs of supplies, it may harm our profitability. In order to control inflation in the past, the PRC government has imposed controls on bank credit, limits on loans for fixed assets and restrictions on state bank lending. Such an austere policy can lead to a slowing of economic growth. Repeated rises in interest rates by the central bank would likely slow economic activity in the PRC which could, in turn, materially increase its costs and also reduce demand for its products.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Governmental control of currency conversion may affect the value of your investment.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The PRC government imposes controls on the convertibility of the Chinese currency, the Renminbi (&#8220;RMB&#8221;), into foreign currencies and, in certain cases, the remittance of currency out of the PRC. We receive substantially all of our revenue in RMB, which is currently not a freely convertible currency. Shortages in the availability of foreign currency may restrict our ability to remit sufficient foreign currency to pay dividends, or otherwise satisfy foreign currency dominated obligations. Under existing PRC foreign exchange regulations, payments of current account items, including profit distributions, interest payments and expenditures from the transaction, can be made in foreign currencies without prior approval from the PRC State Administration of Foreign Exchange by complying with certain procedural requirements. However, approval from appropriate governmental authorities is required where Renminbi is to be converted into foreign currency and remitted out of the PRC to pay capital expenses such as the repayment of bank loans denominated in foreign currencies. The PRC government may also in the future restrict access to foreign currencies for current account transactions. If the foreign exchange control system prevents us from obtaining sufficient foreign currency to satisfy our currency demands, we may not be able to pay certain of our expenses as they come due.
</FONT>
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	The fluctuation of the Renminbi may harm your investment.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The value of the RMB against the U.S. dollar and other currencies may fluctuate and is affected by, among other things, changes in the PRC's political and economic conditions. According to the website www.oanda.com, as of March 12, 2016, US$1 was equal to RMB 6.4945. As we rely entirely on revenue earned in the PRC, any significant revaluation of the RMB may materially and adversely affect our cash flows, revenue and financial condition. For example, to the extent that we need to convert U.S. dollars we receive from an offering of our securities into RMB for Aoxing Pharmaceutical&#8217;s operations, appreciation of the RMB against the U.S. dollar would diminish the value of the proceeds of the offering and this could harm Aoxing Pharmaceutical&#8217;s business, financial condition and results of operations because it would reduce the proceeds available to us for capital investment in proportion to the appreciation of the RMB. Conversely, if we decide to convert our RMB into U.S. dollars for the purpose of making payments for dividends on our common shares or for other business purposes and the U.S. dollar appreciates against the RMB; the U.S. dollar equivalent of the RMB we convert would be reduced in proportion to the amount the U.S. dollar appreciates. While the international reaction to the RMB revaluation has generally been positive, there remains significant international pressure on the PRC government to adopt an even more flexible currency policy, which could result in a further and more significant appreciation of the RMB against the U.S. dollar.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Substantial uncertainties exist with respect to the enactment timetable and final content of draft PRC Foreign Investment Law and how it may impact the viability of our current corporate structure, corporate governance and business operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Ministry of Commerce published a discussion draft of the proposed Foreign Investment Law in January 2015 (the "Draft FIL") aiming to, upon its enactment, replace the trio of existing laws regulating foreign investment in China, namely, the Sino-foreign Equity Joint Venture Enterprise Law, the Sino-foreign Cooperative Joint Venture Enterprise Law and the Wholly Foreign-invested Enterprise Law, together with their implementation rules and ancillary regulations. The Draft FIL embodies an expected PRC regulatory trend to rationalize its foreign investment regulatory regime in line with prevailing international practice and the legislative efforts to unify the corporate legal requirements for both foreign and domestic investments. The Ministry of Commerce is currently soliciting comments on this draft and substantial uncertainties exist with respect to its enactment timetable, final content, interpretation and implementation.
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	28
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage29"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Among other things, the Draft FIL expands the definition of foreign investment and introduces the principle of "actual control" in determining whether a company is considered a foreign-invested enterprise, or an FIE. The Draft FIL specifically provides that entities established in China but "controlled" by foreign investors will be treated as FIEs, whereas an entity set up in a foreign jurisdiction would nonetheless be, upon market entry clearance, treated as a PRC domestic investor provided that the entity is "controlled" by PRC entities and/or citizens. Once an entity is determined to be an FIE, it will be subject to the foreign investment restrictions or prohibitions set forth in a "negative list," to be separately issued by the State Council later. Unless the underlying business of the FIE falls within the negative list, which calls for market entry clearance, prior approval from the government authorities as mandated by the existing foreign investment legal regime would no longer be required for establishment of the FIE. Under the Draft FIL, VIEs that are controlled via contractual arrangement would also be deemed as FIEs, if they are ultimately "controlled" by foreign investors. Therefore, for any companies with a VIE structure in an industry category that is on the "negative list" the VIE structure may be deemed legitimate only if the ultimate controlling person(s) is/are of PRC nationality (either PRC companies or PRC citizens). Conversely, if the actual controlling person(s) is/are of foreign nationalities, the VIEs will be treated as FIEs and any operation in the industry category on the "negative list" without market entry clearance may be considered as illegal.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The provision of services, which we conduct through our VIEs, is currently subject to foreign investment restrictions set forth in the Catalogue of Industries for Guiding Foreign Investment, or the Catalogue, issued by the National Development and Reform Commission and the Ministry of Commerce that was amended in 2011 and became effective in January 2012. The Draft FIL, if enacted as proposed, may materially impact the viability of our current corporate structure, corporate governance and business operations in many aspects.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	The State Administration of Foreign Exchange of the PRC ("SAFE") regulations regarding offshore financing activities by PRC residents which may increase the administrative burden we face. The failure by our shareholders who are PRC residents to make any required applications and filings pursuant to such regulations may prevent us from being able to distribute profits and could expose us and our PRC resident shareholders to liability under PRC law.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In October 2005, SAFE issued a public notice effective from November 1, 2005, the Notice on Relevant Issues in the Foreign Exchange Control over Financing and Return Investment Through Special Purpose Companies by Residents Inside China, or the SAFE notice or SAFE #75, which requires PRC residents, including both legal persons and natural persons, to register with the competent local SAFE branch before establishing or controlling any company outside of the PRC, referred to as an "offshore special purpose company," for the purpose of overseas equity financing involving onshore assets or equity interests held by them. In addition, any PRC resident that is the shareholder of an offshore special purpose company is required to amend its SAFE registration with the local SAFE branch with respect to that offshore special purpose company in connection with any increase or decrease of capital, transfer of shares, merger, division, equity investment or creation of any security interest over any assets located in the PRC. Moreover, if the offshore special purpose company was established and owned the onshore assets or equity interests before the implementation date of the SAFE notice, a retroactive SAFE registration is required to have been completed before March 31, 2006. If any PRC shareholder of any offshore special purpose company fails to make the required SAFE registration and amendment, the PRC subsidiaries of that offshore special purpose company may be prohibited from distributing their profits and the proceeds from any reduction in capital, share transfer or liquidation to the offshore special purpose company. Moreover, failure to comply with the SAFE registration and amendment requirements described above could result in liability under PRC laws for evasion of applicable foreign exchange restrictions.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Certain of our shareholders who may be subject to the foregoing registration requirement (including certain members of our management) have submitted their registration applications to the relevant SAFE authority as well as notified the local authority where we are domiciled of such applications. We have been advised by such SAFE authority, however, that it is unable to issue SAFE registration due to current internal policy, but may issue a confirmation acknowledging receipt of our applications in lieu thereof, and issue the SAFE registration at a later time when internal policy changes. There is no assurance, however, that we will receive such confirmation or that such confirmation, when issued, would be sufficient for compliance purpose with the SAFE notice. Additionally, we do not know when the internal policy of the relevant SAFE authority will change, if at all, and there is no assurance that when such policy changes, we will be issued SAFE registration. As such, we or our PRC resident shareholders may nevertheless be deemed in violation of SAFE #75 despite our attempt at compliance. In the event that we or our PRC resident shareholders are deemed to be in violation of SAFE #75 despite our attempt at compliance, Shaanxi Biostar could lose the ability to remit monies outside of the PRC and would therefore be unable to pay dividends or make other distributions. Our PRC resident shareholders could be subject to fines, other sanctions and even criminal liabilities under the PRC Foreign Exchange Administrative Regulations promulgated January 29, 1996, as amended.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	29
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage30"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	The PRC's legal and judicial system may not adequately protect our business and operations and the rights of foreign investors
</FONT>
	.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The PRC legal and judicial system may negatively impact foreign investors. In 1982, the National People's Congress amended the Constitution of the PRC to authorize foreign investment and guarantee the "lawful rights and interests" of foreign investors in the PRC. However, the PRC's system of laws is not yet comprehensive. The legal and judicial systems in the PRC are still rudimentary, and enforcement of existing laws is inconsistent. Many judges in the PRC lack the depth of legal training and experience that would be expected of a judge in a more developed country. Because the PRC judiciary is relatively inexperienced in enforcing the laws that do exist, anticipation of judicial decision-making is more uncertain than would be expected in a more developed country. It may be impossible to obtain swift and equitable enforcement of laws that do exist, or to obtain enforcement of the judgment of one court by a court of another jurisdiction. The PRC's legal system is based on the civil law regime, that is, it is based on written statutes; a decision by one judge does not set a legal precedent that is required to be followed by judges in other cases. In addition, the interpretation of Chinese laws may be varied to reflect domestic political changes. The promulgation of new laws, changes to existing laws and the pre-emption of local regulations by national laws may adversely affect foreign investors. However, the trend of legislation over the last 20 years has significantly enhanced the protection of foreign investment and allowed for more control by foreign parties of their investments in Chinese enterprises. There can be no assurance that a change in leadership, social or political disruption, or unforeseen circumstances affecting the PRC's political, economic or social life, will not affect the PRC government's ability to continue to support and pursue these reforms. Such a shift could have a material adverse effect on our business and prospects.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The practical effect of the PRC legal system on our business operations in the PRC can be viewed from two separate but intertwined considerations. First, as a matter of substantive law, the Foreign Invested Enterprise laws provide significant protection from government interference. In addition, these laws guarantee the full enjoyment of the benefits of corporate Articles and contracts to Foreign Invested Enterprise participants. These laws, however, do impose standards concerning corporate formation and governance, which are qualitatively different from the general corporation laws of the United States. Similarly, the PRC accounting laws mandate accounting practices, which are not consistent with U.S. generally accepted accounting principles. PRC's accounting laws require that an annual "statutory audit" be performed in accordance with PRC accounting standards and that the books of account of Foreign Invested Enterprises are maintained in accordance with Chinese accounting laws. Article 14 of the People's Republic of China Wholly Foreign-Owned Enterprise Law requires a wholly foreign-owned enterprise to submit certain periodic fiscal reports and statements to designated financial and tax authorities, at the risk of business license revocation. While the enforcement of substantive rights may appear less clear than United States procedures, the Foreign Invested Enterprises and Wholly Foreign-Owned Enterprises are Chinese registered companies, which enjoy the same status as other Chinese registered companies in business-to-business dispute resolution. Any award rendered by an arbitration tribunal is enforceable in accordance with the United Nations Convention on the Recognition and Enforcement of Foreign Arbitral Awards (1958). Therefore, as a practical matter, although no assurances can be given, the Chinese legal infrastructure, while different in operation from its United States counterpart, should not present any significant impediment to the operation of Foreign Invested Enterprises.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 36PT">
</FONT>
	As found in &#8220;Item 3 Legal Proceedings&#8221;, the Company Chairman and Chief Executive Officer, Mr. Ronghua Wang owed personal debts to certain creditors. Under the PRC legal system, since Mr. Ronghua Wang is a major shareholder of the Company, the Courts froze certain assets of the Company in order to prevent those assets from being transferred. While the Company was not a party to the lending arrangement with the creditor, it was involved in the legal disputes as result of its association with the Chairman and Chief Executive Officer. These are legal risks related to conducting business in the PRC that are not likely to exist for companies doing business in the United States.
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	There is no assurance that the Company&#8217;s assets will not be subject to future disputes as a result of its association to Mr. Ronghua Wang.
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	PRC regulations relating to the establishment of offshore special purpose companies by PRC residents may subject our PRC resident beneficial owners to personal liability and limit our ability to acquire PRC companies or to inject capital into our PRC entities, limit our PRC entities&#8217; ability to distribute profits to us or otherwise materially and adversely affect us.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The State Administration of Foreign Exchange (&#8220;SAFE&#8221;), issued the Notice on Relevant Issues Concerning Foreign Exchange Administration for PRC Residents to Engage in Financing and Round-trip Investment via Overseas Special Purpose Vehicles (&#8220;SAFE Circular No. 75&#8221;), and a series of implementation rules and guidance, requiring PRC residents, including both legal persons and natural persons, to register with the relevant local branch of SAFE before establishing or acquiring control over any company outside of China, referred to as an offshore special purpose company, for the purpose of raising funds from overseas to acquire assets of, or equity interest in, PRC companies. In addition, any PRC resident that is a beneficial owner of an offshore special purpose company is required to amend his or her registration with the local branch of SAFE, with respect to that offshore special purpose company in connection with any increase or decrease in its capital, transfer of shares, merger, division, equity investment or creation of any security interest over any assets located in China. Any failure to comply with the above registration requirements could result in our PRC entities being prohibited from distributing their profits and proceeds from any reduction in capital, share transfer or liquidation to their offshore parent companies, offshore parent companies being restricted in their ability to contribute additional capital into their PRC entities and may also subject the relevant PRC entities and PRC residents to penalties under PRC foreign exchange administration regulations. Any failure or inability by individuals to comply with SAFE regulations may subject us to fines or legal sanctions, such as restrictions on our cross-border investment activities or our direct PRC entities&#8217; ability to distribute dividends to, or obtain foreign-exchange-denominated loans from, our company or prevent us from making distributions or paying dividends. As a result, our business operations and our ability to make distributions to you could be materially and adversely affected.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	30
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage31"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	The approval of the China Securities Regulatory Commission may be required in connection with the global offering, and, if required, we cannot assure you that we will be able to obtain such approval.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On August 8, 2006, six PRC regulatory agencies, including the China Securities Regulatory Commission (&#8220;CSRC&#8221;), promulgated the Regulations on Mergers and Acquisitions of Domestic Companies by Foreign Investors (&#8220;M&amp;A Rules&#8221;), which became effective on September 8, 2006 and was amended on June 22, 2009. This regulation, among other things, requires offshore special purpose vehicles, or SPVs, formed for the purpose of an overseas listing and controlled by PRC companies or individuals, to obtain CSRC approval prior to listing their securities on an overseas stock exchange. The application of this regulation remains unclear. Our PRC counsel has advised us that, based on their understanding if the current PRC law, rules, and regulations:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="81%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	we established our PRC entities by means of direct investment other than by merger and acquisition of any equity interest or assets of a PRC domestic company owned by PRC companies and/or PRC individuals as defined under the M&amp;A Rules that are our beneficial owners after the effective date of the M&amp;A Rules;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="81%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="81%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	the CSRC currently has not issued any definitive rule or interpretation concerning whether offerings like ours under this Prospectus Supplement are subject to this regulation;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="81%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="MIDDLE" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#8226;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="81%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	given that no provision in this regulation clearly classified contractual arrangements as a type of transaction subject to its regulation, we are not required to submit an application to the CSRC for its approval.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Because there has been no official interpretation or clarification of M&amp;A Rules since its adoption, there is uncertainty as to how this regulation will be interpreted or implemented. If it is determined that the CSRC approval is required for the offering, we may face sanctions by the CSRC or other PRC regulatory agencies for failure to seek the CSRC approval for the offering. These sanctions may include fines and penalties on our operations in the PRC, delays or restrictions on the repatriation of the proceeds from the offering into the PRC, restrictions on or prohibition of the payments or remittance of dividends by our PRC entities, or other actions that could have a material adverse effect on our business, financial condition, results of operations, reputation and prospectus, as well as the trading price of the common stock.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Any recurrence of severe acute respiratory syndrome, or SARS, or another widespread public health problem, could harm our operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	A renewed outbreak of SARS or another widespread public health problem (such as bird flu) in the PRC, where all of our revenue is derived, could significantly harm our operations. Our operations may be impacted by a number of health-related factors, including quarantines or closures of some of our offices that would adversely disrupt our operations. Any of the foregoing events or other unforeseen consequences of public health problems could significantly harm our operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Because our principal assets are located outside of the United States and most of our directors and officers reside outside of the United States, it may be difficult for you to enforce your rights based on U.S. federal securities laws against us and our officers or to enforce U.S. court judgments against us or them in the PRC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Most of our directors and all of our officers reside in China. In addition, our operating company is located in the PRC and substantially all of our assets are located outside of the United States. It may therefore be difficult for investors in the United States to enforce their legal rights based on the civil liability provisions of the U.S. Federal securities laws against us in the courts of either the U.S. or the PRC and, even if civil judgments are obtained in U.S. courts, to enforce such judgments in PRC courts. Further, it is unclear if extradition treaties now in effect between the United States and the PRC would permit effective enforcement against us or our officers and directors of criminal penalties, under the U.S. Federal securities laws or otherwise.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	The relative lack of public company experience of our management team may put us at a competitive disadvantage.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our management team lacks public company experience, which could impair our ability to comply with legal and regulatory requirements such as those imposed by Sarbanes-Oxley Act of 2002. The individuals who now constitute our senior management have never had responsibility for managing a publicly traded company. Such responsibilities include complying with federal securities laws and making required disclosures on a timely basis. Our senior management may not be able to implement programs and policies in an effective and timely manner that adequately responds to such increased legal, regulatory compliance and reporting requirements. Our failure to comply with all applicable requirements could lead to the imposition of fines and penalties and distract our management from attending to the growth of our business.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	31
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage32"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Risks Relating to our Common Stock
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	We are not likely to pay cash dividends in the foreseeable future.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We intend to retain any future earnings for use in the operation and expansion of our business. We do not expect to pay any cash dividends in the foreseeable future but will review this policy as circumstances dictate. Should we decide in the future to do so, as a holding company, our ability to pay dividends and meet other obligations depends upon the receipt of dividends or other payments from our operating subsidiaries. In addition, our operating subsidiaries, from time to time, may be subject to restrictions on their ability to make distributions to us, including restrictions on the conversion of local currency into U.S. dollars or other hard currency and other regulatory restrictions.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	If we are unable to meet the Nasdaq Stock Market continued listing requirements, our securities may be subject to delisting.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Following the October 2013 transfer, our securities are listed and are trading on the Nasdaq Capital Market under the symbol &#8220;BSPM&#8221;. The Nasdaq Capital Market is a continuous trading market that operates in substantially the same manner as The Nasdaq Global Market. If we cannot demonstrate compliance with the continued listing requirements, our common stock may then be subject to delisting.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Our common shares have historically been thinly traded, and you may be unable to sell at or near ask prices or at all if you desire to liquidate your shares.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We cannot predict the extent to which an active public market for our common stock will develop or be sustained. Our common stock commenced trading on The Nasdaq Global Market on April 23, 2010 and is currently trading on the Nasdaq Capital Market. Our common stock was previously quoted on the OTC Bulletin Board, where they have historically been sporadically or &#8220;thinly traded&#8221;, meaning that the number of persons interested in purchasing our common shares at or near bid prices at any given time may be relatively small or non-existent. This situation is attributable to a number of factors, including the fact that we are a small company which is relatively unknown to stock analysts, stock brokers, institutional investors and others in the investment community that generate or influence sales volume, and that even if we came to the attention of such persons, they tend to be risk-averse and would be reluctant to follow an unproven company such as ours or purchase or recommend the purchase of our shares until such time as we became more seasoned and viable. As a consequence, there may be periods of several days or more when trading activity in our shares is minimal or non-existent, as compared to a seasoned issuer which has a large and steady volume of trading activity that will generally support continuous sales without an adverse effect on share price. We cannot give you any assurance that a broader or more active public trading market for our common stock will develop or be sustained, or that current trading levels will be sustained.&#160;The market price for our common stock is particularly volatile given our status as a relatively small company with a small and thinly traded &#8220;float&#8221; that could lead to wide fluctuations in our share price. The price at which you purchase our common stock may not be indicative of the price that will prevail in the trading market. You may be unable to sell your common stock at or above your purchase price if at all, which may result in substantial losses to you.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The market for our common shares is characterized by significant price volatility when compared to seasoned issuers, and we expect that our share price will continue to be more volatile than a seasoned issuer for the indefinite future. The volatility in our share price is attributable to a number of factors. First, as noted above, our common shares are sporadically and/or thinly traded. As a consequence of this lack of liquidity, the trading of relatively small quantities of shares by our stockholders may disproportionately influence the price of those shares in either direction. The price for our shares could, for example, decline precipitously in the event that a large number of our common shares are sold on the market without commensurate demand, as compared to a seasoned issuer which could better absorb those sales without adverse impact on its share price. Secondly, we are a speculative or &#8220;risky&#8221; investment due to our fluctuating level of revenues or profits to date and uncertainty of future market acceptance for our current and potential products. As a consequence of this enhanced risk, more risk-averse investors may, under the fear of losing all or most of their investment in the event of negative news or lack of progress, be more inclined to sell their shares on the market more quickly and at greater discounts than would be the case with the stock of a seasoned issuer. The following factors may add to the volatility in the price of our common shares: actual or anticipated variations in our quarterly or annual operating results; adverse outcomes; the termination of our contractual arrangements with Aoxing Pharmaceutical; and additions or departures of our key personnel, as well as other items discussed under this &#8220;Risk Factors&#8221; section, as well as elsewhere in this report. Many of these factors are beyond our control and may decrease the market price of our common shares, regardless of our operating performance. We cannot make any predictions or projections as to what the prevailing market price for our common shares will be at any time, including as to whether our common shares will sustain their current market prices, or as to what effect that the sale of shares or the availability of common shares for sale at any time will have on the prevailing market price.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	32
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage33"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Stockholders should be aware that the market for penny stocks has suffered in recent years from patterns of fraud and abuse. Such patterns include (1) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (2) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (3) boiler room practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (4) excessive and undisclosed bid-ask differential and markups by selling broker-dealers; and (5) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, along with the resulting inevitable collapse of those prices and with consequent investor losses. Our management is aware of the abuses that have occurred historically in the penny stock market. Although we do not expect to be in a position to dictate the behavior of the market or of broker-dealers who participate in the market, management will strive within the confines of practical limitations to prevent the described patterns from being established with respect to our securities. The occurrence of these patterns or practices could increase the volatility of our share price.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Techniques employed by manipulative short sellers in Chinese small cap stocks may drive down the market price of our common stock.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Short selling is the practice of selling securities that the seller does not own but rather has, supposedly, borrowed from a third party with the intention of buying identical securities back at a later date to return to the lender. The short seller hopes to profit from a decline in the value of the securities between the sale of the borrowed securities and the purchase of the replacement shares, as the short seller expects to pay less in that purchase than it received in the sale. As it is therefore in the short seller&#8217;s best interests for the price of the stock to decline, many short sellers (sometime known as &#8220;disclosed shorts&#8221;) publish, or arrange for the publication of, negative opinions regarding the relevant issuer and its business prospects in order to create negative market momentum and generate profits for themselves after selling a stock short. While traditionally these disclosed shorts were limited in their ability to access mainstream business media or to otherwise create negative market rumors, the rise of the Internet and technological advancements regarding document creation, videotaping and publication by weblog (&#8220;blogging&#8221;) have allowed many disclosed shorts to publicly attack a company&#8217;s credibility, strategy and veracity by means of so-called research reports that mimic the type of investment analysis performed by large Wall Street firms and independent research analysts. These short attacks have, in the past, led to selling of shares in the market, on occasion in large scale and broad base. Issuers with business operations based in the PRC and who have limited trading volumes and are susceptible to higher volatility levels than U.S. domestic large-cap stocks, can be particularly vulnerable to such short attacks. These short seller publications are not regulated by any governmental, self-regulatory organization or other official authority in the U.S., are not subject to the certification requirements imposed by the Securities and Exchange Commission in Regulation AC (Regulation Analyst Certification) and, accordingly, the opinions they express may be based on distortions of actual facts or, in some cases, fabrications of facts. In light of the limited risks involved in publishing such information, and the enormous profit that can be made from running just one successful short attack, unless the short sellers become subject to significant penalties, it is more likely than not that disclosed shorts will continue to issue such reports.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	While we intend to strongly defend our public filings against any such short seller attacks, often times we are constrained, either by principles of freedom of speech, applicable state law (often called &#8220;Anti-SLAPP statutes&#8221;), or issues of commercial confidentiality, in the manner in which we can proceed against the relevant short seller. You should be aware that in light of the relative freedom to operate that such persons enjoy &#8211; oftentimes blogging from outside the U.S. with little or no assets or identity requirements &#8211; should we be targeted for such an attack, our stock will likely suffer from a temporary, or possibly long term, decline in market price should the rumors created not be dismissed by market participants.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Volatility in our common share price may subject us to securities litigation.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The market for our common stock is characterized by significant price volatility when compared to seasoned issuers, and we expect that our share price will continue to be more volatile than a seasoned issuer for the indefinite future. In the past, plaintiffs have often initiated securities class action litigation against a company following periods of volatility in the market price of its securities. We may, in the future, be the target of similar litigation. Securities litigation could result in substantial costs and liabilities and could divert management&#8217;s attention and resources.
</FONT>
</DIV>
</EFX_RISK_FACTORS>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_UNRESOLVED_STAFF_COMMENTS>
<A NAME="FIS_UNRESOLVED_STAFF_COMMENTS"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_1B">
	IT
</A>
	EM 1B.&#160; UNRESOLVED STAFF COMMENTS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Not applicable.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	33
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage34"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_UNRESOLVED_STAFF_COMMENTS>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<EFX_PROPERTIES>
<A NAME="FIS_PROPERTIES"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_2">
	I
</A>
	TEM 2.&#160; DESCRIPTION OF PROPERTY
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The table below provides a general description of our major offices and facilities:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_8"></A>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Location
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="25%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Principal Activities
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Area (Sq meter)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	LUR and Lease Term
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	No. 588 Shiji Xi Road, Xianyang, Shaanxi Province, PRC 712000
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="25%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Headquarter, GMP Facility, R&amp;D
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	19,036
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	50-year land use right expiring in June 2056
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Wuquan Village Jiangcun Town Hu Country Xi'an City
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="25%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Herb cultivation
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	343,983
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	40-year land lease expiring on&#160;&#160;May 4, 2049
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Weihua Road, Weinan City, Shaanxi, PRC
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="25%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	GMP Facility, R&amp;D
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	63,851
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	50-year land use right expiring in August 2053
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	All land in the PRC is owned by the government and cannot be sold to any individual or entity. Instead, the government grants landholders a land use right in exchange for a purchase price for such right. The land use right allows its holder the right to use the land for a specified long-term period of time and enjoys all the incidents of ownership of the land.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The land use right for the site of our headquarters was acquired in 2006, including land confiscation fee, settlement compensation, ground structure compensation, city construction fitting fee, land reclamation fee, agriculture land fund, water construction fund, agricultural tax, land use fee, and land leasing fee. No additional payment will be needed to retain this right.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The land right for our cultivation site was acquired in 2009 for a total of RMB 8 million ($1.2 million).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The land use right of Weinan site was acquired in October 2011 when we made the acquisition of Shaanxi Weinan Huaren Pharmaceuticals, Ltd. at that time.
</FONT>
</DIV>
</EFX_PROPERTIES>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_LEGAL_PROCEEDINGS>
<A NAME="FIS_LEGAL_PROCEEDINGS"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_3">
	IT
</A>
	EM 3.&#160; LEGAL PROCEEDINGS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 36PT">
</FONT>
	The Company may, from time to time, be involved in various legal matters arising out of its operations in the normal cause of business, none of which are expected, individually or in the aggregate, to have a material effect on the Company.
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 36PT">
</FONT>
	To the best of the Company&#8217;s present understanding, in May 2015, one of the bank accounts of Shaanxi Aoxing Pharmaceutical Company Limited was frozen as a result of actions by certain lenders (not affiliated with the Company) in their attempt to collect the outstanding balance on the personal loan to Ronghua Wang in the amount of RMB 3 million (USD$0.48 million), which loan was in default. The foregoing debt was personal debt of Ronghua Wang and no assets of Shaanxi Aoxing Pharmaceutical Company Limited were pledged to secure Mr. Wang&#8217;s obligations in connection with such personal loan. As of April 8, 2016, Ronghua Wang had partially repaid the outstanding balance of the loan, thus avoiding the Company&#8217;s land use rights and buildings being seized and auctioned with proceeds used to settle this debt. It is the Company&#8217;s present understanding that Mr. Wang is in the process of resolving this matter and settling the outstanding balance on the loan.
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 36PT">
</FONT>
	To the best of the Company&#8217;s present understanding, on September 1, 2015, Shaanxi Aoxing Biostar Biotech Ltd. was informed by the People&#8217;s Court of Shaanxi Province that its properties, valued at $0.54 million (RMB 3.3 million) had been transferred to Mr. Lianhe Wang (not affiliated with the Company) to settle another outstanding personal loan to Ronghua Wang in the amount of approximately RMB 5.7 million (USD$0.9 million). The foregoing debt was personal debt of Ronghua Wang and no assets of Shaanxi Aoxing Biostar Biotech Ltd. were pledged to secure Mr. Wang&#8217;s obligations in connection with such personal loan. According to the Company&#8217;s PRC legal counsel (Shaanxi Wei Yang Law Firm), this settlement was approved by the parties to the loan agreement. It is the Company&#8217;s present understanding that Mr. Wang has undertaken to repay the Company in full for the foregoing property transfer by June 2016.
<FONT STYLE="DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	There is no assurance that Ronghua Wang will be able to repay his personal debts in full before his creditors take any other further legal action.
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</EFX_LEGAL_PROCEEDINGS>
<EFX_MINE_SAFETY_DISCLOSURE>
<A NAME="FIS_MINE_SAFETY_DISCLOSURE"></A>
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_4">
	IT
</A>
	EM 4.&#160; MINE SAFETY DISCLOSURE
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Not Applicable.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	34
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage35"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_MINE_SAFETY_DISCLOSURE>
</EFX_PART_I>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_PART_II>
<A NAME="FIS_PART_II"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	PART II
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_MARKET>
<A NAME="FIS_MARKET"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_5">
	IT
</A>
	EM 5. &#160;MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_9"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Market Information
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company&#8217;s securities are currently trading on NASDAQ under the trading symbol &#8220;BSPM&#8221; (subject to the listing exception), which listing was approved in April 2010. Prior to that, our securities were quoted on the OTC-BB.&#160;&#160;The market for our common stock is limited and volatile.&#160;&#160;Set forth below are the high and low closing sale prices for the common stock for each quarter in 2014 and 2015. The quotations reflect inter-dealer prices, without retail markup, markdown, or commissions, and may not represent actual transactions.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Quarter Ended
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	High
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Low
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	December 31, 2014
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8.47
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7.91
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	September 30, 2014
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	11.76
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	11.20
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	June 30, 2014
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	10.29
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9.52
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	March 31, 2014
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	14.49
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	13.37
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	December 31, 2015
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2.94
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2.80
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	September 30, 2015
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5.04
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4.90
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	June 30, 2015
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7.70
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7.07
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	March 31, 2015
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8.89
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8.19
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On March 28, 2016, the closing price of the Company&#8217;s common stock was $2.10.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Holders
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As of December 31, 2015, we had 25 record holders of our common stock based upon a shareholder list provided by our transfer agent. Our transfer agent is Interwest Transfer Co., Inc. located at 1981 Murray Holladay Road, Suite 100, Salt Lake City, UT&#160;&#160;84117, and their telephone number is (801) 272-9294.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Dividends
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We have not declared or paid any cash dividends on our common stock during either of our last two fiscal years. The payment of dividends, if any, is at the discretion of the Board of Directors and is contingent on the Company's revenue and earnings, capital requirements, financial conditions. We currently intend to retain all earnings, if any, for use in business operations. Accordingly, we do not anticipate declaring any dividends in the near future.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Securities Authorized for Issuance under Equity Compensation Plans
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Please see the discussion in Item 12 titled &#8220;Equity Compensation Plan Information&#8221; below.&#160;Except as previously reported in the Company&#8217;s public filings made with the SEC, the Company issued no unregistered shares of Common stock during the three months ended December 31, 2015. The Company did not repurchase any of its equity securities during the quarter ended December 31, 2015.
</FONT>
</DIV>
</EFX_MARKET>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_FINANCIAL_DATA>
<A NAME="FIS_FINANCIAL_DATA"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_6">
	I
</A>
	TEM 6.&#160; SELECTED FINANCIAL DATA
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Not applicable.
</FONT>
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	35
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage36"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_FINANCIAL_DATA>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<EFX_MANAGEMENTS_DISCUSSION>
<A NAME="FIS_MANAGEMENTS_DISCUSSION"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_7">
	I
</A>
	TEM 7.&#160; MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following discussion should be read in conjunction with our financial statements and the notes thereto which appear elsewhere in this report. The results shown herein are not necessarily indicative of the results to be expected in any future periods. This discussion contains forward-looking statements based on current expectations, which involve uncertainties. In some cases, you can identify forward-looking statements by terminology such as "anticipate," "estimate," "plan," "project," "predict," "potential," "continue," "ongoing," "expect," "believe," "intend," "may," "will," "should," "could," or the negative of these terms or other comparable terminology. All forward-looking statements included in this document are based on information available to the management on the date hereof.
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	&#160;
</FONT>
	Actual results and the timing of events could differ materially from the forward-looking statements as a result of a number of factors. Readers should also carefully review factors set forth in other reports or documents that we file from time to time with the Securities and Exchange Commission.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	You should read the following discussion and analysis in conjunction with our audited financial statements, and the &#8220;Risk Factors&#8221; section in our filings we make with the SEC.&#160;&#160;We undertake no obligation and do not intend to update, revise or otherwise publicly release any revisions to our forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of any unanticipated events.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Overview
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Biostar Pharmaceuticals, Inc. (&#8220;we&#8221;, the &#8220;Company&#8221; or &#8220;Biostar&#8221;) was incorporated on March 27, 2007 in the State of Maryland. Our business operation is conducted in China primarily through our variable interest entity (&#8220;VIE&#8221;), Shaanxi Aoxing Pharmaceutical Co., Ltd. (&#8220;Aoxing Pharmaceutical&#8221;), which we control through contractual arrangements between Aoxing Pharmaceutical and our wholly owned subsidiary, Shaanxi Biostar Biotech Ltd. (&#8220;Shaanxi Biostar&#8221;).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In October 2011, Aoxing Pharmaceutical entered into a Share Transfer Agreement to acquire Shaanxi Weinan Huaren Pharmaceuticals, Ltd. (&#8220;Shaanxi Weinan&#8221;) from the holders of 100% of equity interests in Shaanxi Weinan.&#160;The aggregate purchase price is RMB 61 million (approximately&#160;$9.55 million), in cash and payable in several tranches.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shaanxi Weinan owns drug approvals and permits for a portfolio of 86 drugs and one health product, all of which, were added to the Company&#8217;s drug portfolio following the completion of this acquisition. The Company completed this acquisition on October 25, 2011.&#160;&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In April 2013, Aoxing Pharmaceutical executed a supplemental agreement to the Weinan Share Transfer Agreement (the &#8220;Weinan Supplemental Agreement&#8221;) with all the former equity holders of Shaanxi Weinan to acquire 13 drug approval numbers which were excluded from the Weinan Share Transfer Agreement due to incomplete re-registration.&#160;&#160;The Company acquired ownership of the 13 drug approval numbers for which reregistration has been completed in April 2013. The aggregate purchase price was approximately $10.2 million, consisting of approximately $8.8 million in cash and 1,602,564 shares of the Company&#8217;s common stock, valued at approximately $1.4 million.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Since 2013, we improved our customer portfolio and provided subcontracting services to hospital which provides the prescription. For the years ended 31 December 2015 and 2014, the subcontracting services income from the hospital contributed $12.4million and $18.6 million, respectively, to our revenue.
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We currently manufacture and sell twelve over-the-counter&#160;(&#8220;OTC&#8221;) medications and seventeen prescription-based pharmaceuticals which are sold and distributed in over 25 provinces and provincial-level cities throughout China. We also have exclusive supply contract with a hospital to supply six pharmaceutical products, in which there are two additions of pharmaceutical products in 2014.&#160;&#160;Our best-selling product, Xin Ao Xing Oleanolic Acid Capsule (&#8220;Xin Aoxing Capsule&#8221;), is a state-approved OTC drug for treatment of Hepatitis B.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Agreement to co-develop new liver cancer drug
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In March 2014, the Company signed a letter of intent with the Research Institute of Pharmaceuticals at Shaanxi University of Chinese Medicine to develop a new liver cancer drug based on Oleanolic Acid injection.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	36
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage37"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	March 2014 Registered Offering
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On March 10, 2014, the Company and certain institutional investors entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) in connection with an offering (&#8220;Offering&#8221;) pursuant to which the Company agreed to sell, and the investors agreed to purchase 235,714 shares after one-for-seven reverse stock split (1,650,000 shares pre-split) of the Company&#8217;s common stock and warrants to purchase up to 94,286 shares after split (660,000 shares pre-split) of the Company&#8217;s common stock, for aggregate gross proceeds, before deducting fees to the placement agents and other estimated offering expenses payable by the Company, of approximately $4.1 million.&#160;&#160;The warrants are immediately exercisable upon issuance and remain exercisable for three years thereafter at an exercise price of $22.61 per share.&#160;&#160;The exercise price and number of shares underlying the warrants are subject to adjustment in the case of stock splits, stock dividends, combinations of shares, similar recapitalization transactions and certain events as down-round provision. The net proceeds from the offering will be used for working capital and other general corporate purposes. Moody Capital Solutions, Inc. and Axiom Capital Management, Inc. served as the placement agents for the offering. The Offering was effected as a takedown off the Company&#8217;s shelf registration statement on Form S-3 (File No. 333-192963), which became effective on January 3, 2014, pursuant to a prospectus supplement filed with the Securities and Exchange Commission.
</FONT>
</DIV>
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Gel Capsule Related Developments
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In April 2012, PRC State Food and Drug Administration (SFDA) launched an investigation of several capsule manufacturers based in Zhejiang, Hebei and Jiangxi provinces into their use of industrial gelatin, which contained impermissibly high chromium content. On May 25, 2012, following a nationwide inspection, SFDA authorities reported that 669 batches of gel capsules from 254 drug manufacturers in 28 provinces were found to have high chromium levels. The results of this inspection were publicly distributed in China, including publication on SFDA&#8217;s website http://www.sda.gov.cn/WS01/CL0001. As a result, SFDA effectively suspended sales of gel capsules nationwide until the investigation was completed. In May 2012, following an onsite inspection by the Xianyang State Food and Drug Administration (SFDA), samples from a batch of our Xin Aoxing capsules were found to contain chromium content higher than edible gelatin. Specifically, samples from a batch of 150 cases of the Xin Aoxing capsules (each of the 150 cases contains 8,000 capsules), representing Biostar sales of approximately RMB1,188,000 or approximately $188,000 were also found to contain high levels of chromium, which capsules, in the Company&#8217;s estimation, were sold in the market in mid-2011.&#160;As required by SFDA in April 2012, the Company purchased gel capsule inspection equipment to measure the chromium levels in gel capsules it used. The Company also undertook a thorough inspection of all samples of drugs sold and its current product inventory to ensure that all of the gel capsules it had purchased and currently uses comply with the SFDA chromium content requirements.&#160;In addition, the Company conducted checks of every batch of raw materials it uses in every production category and, except as discussed above, found no violations of the chromium content requirements. Further, the Company recalled all such affected capsules as promptly and thoroughly as possible, and imposed heightened quality control and assurance measures going forward.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On July 30, 2012, the SFDA approved the Company&#8217;s resumption of sales of its gel capsules following a thorough inspection of raw materials used in every production category, all samples of drugs sold and the current product inventory. However, the suspension of sales of gel capsule products severely affected all China-based pharmaceutical companies that use gelatin capsules to manufacture their drugs.&#160;&#160;Negative publicity associated with the foregoing events continues to affect consumer confidence in the PRC of capsule products.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	No additional penalty was paid for the year ended 31 December 2015 and 2014.
</FONT>
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	37
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage38"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<EFX_RESULTS_OF_OPERATIONS>
<A NAME="FIS_RESULTS_OF_OPERATIONS"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Results of Operations
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_10"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Net Sales
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following table illustrates our sales results for the years ended December 31, 2015 and 2014.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Year ended December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Increase (Decrease) due to changes in
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Product offering
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Sales volume
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Sales price
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Aoxing Pharmaceutical Products
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Xin Aoxing Capsule
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,076,174
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	21,193,331
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(12,117,157
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Other Aoxing Pharmaceutical products
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,101,887
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	13,785,726
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(10,683,839
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Sub-total
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	12,178,061
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	34,979,057
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(22,800,996
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shaanxi Weinan products
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,151,872
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7,806,259
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(3,654,387
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Hospital products
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	12,438,549
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	18,631,271
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(6,192,722
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Total gross sales
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	28,768,482
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	61,416,587
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="TEXT-ALIGN: RIGHT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	-
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(32,648,105
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Sales discount
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(1,638,873
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Total net sales
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	27,129,609
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	61,416,587
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For the year ended December 31, 2015, total net sales decreased by approximately $34.3 million or 55.8% compared to the year ended December 31, 2014.&#160;&#160;The decrease was mainly attributed to decrease in sales volume as the Company&#8217;s Aoxing factory has currently stopped production until the renewal of GMP certificates has been obtained.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company experienced a material decrease in sales volume of all Aoxing Pharmaceutical Products in the year ended December 31, 2015 when compared to the year ended December 31, 2014, as Aoxing Pharmaceutical has temporarily stopped production to conduct maintenance of its production lines in order to renew its GMP certificates by the second quarter of 2016, allowing the production to resume in second quarter of 2016. If the Company is unable to resume production, then the Company may become insolvent.
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Sales of Shaanxi Weinan&#8217;s product decreased during the year ended December 31, 2015 due to the temporarily stopped production to conduct maintenance of its production lines in order to renew its GMP certificates from first quarter to third quarter of 2015. After Shaanxi Weinan received the renewed GMP certificate in June 2015, the sales volume has been slowly climbing back to normal volume.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In order to improve the Company&#8217;s cash management, the Company intends to offer certain customers discounts on certain receivables balances to encourage faster settlement of such outstanding balances. The Company accounts for these discounts as a reduction of sales revenues. During the year 2015, the Company recognized $1,638,873 in sales discounts.
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Cost of sales
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following table summarizes our cost of goods sold for the years ended December 31, 2015 and 2014:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_11"></A>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="26%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Year ended December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="40%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Increase (Decrease) due to changes in
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Product offering
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Sales volume
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Product cost
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Aoxing Pharmaceutical Products
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Xin Aoxing Capsule
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,570,515
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,673,311
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2,102,796
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Other Aoxing Pharmaceutical products
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,327,039
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,770,526
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID; TEXT-ALIGN: RIGHT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	-
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(7,443,487
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Sub-total
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,897,554
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	13,443,837
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(9,546,283
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shaanxi Weinan products
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,283,613
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,591,955
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(1,308,342
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Hospital products
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,844,377
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	14,104,433
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(4,260,056
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Medical device
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Total cost of sales
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	16,025,544
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	31,140,225
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(15,114,681
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For the year ended December 31, 2015, cost of sales decreased by approximately $15.1 million or 48.5%, compared to the year ended December 31, 2014.&#160;&#160;This decrease in costs of sales is mainly due to a proportional decrease in sales volume.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	38
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage39"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The weighted average unit cost of our products during the year ended December 31, 2015 had increased by 0.5%, as compared to the year ended December 31, 2014.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Cost margin of our hospital products was 79.1% and 75.7% for the years ended December 31, 2015 and 2014, respectively.&#160;&#160;Management believes that the cost margin will be maintained in a stable level.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_12"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Gross Profit
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following table summarizes our gross profit for the years ended December 31, 2015 and 2014:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="14" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Year ended December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Gross Profit
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Product Gross Margin %
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Gross Profit
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Product Gross Margin%
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Aoxing Pharmaceutical Products
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="44%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Xin Aoxing Capsule
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7,505,659
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	82.7
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	17,520,020
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	82.7
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="44%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Other Aoxing Pharmaceutical products
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	774,848
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	25.0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,015,200
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	29.1
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="44%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;Sub-total
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8,280,507
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	68.0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	21,535,220
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	61.6
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="44%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="44%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shaanxi Weinan products
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,868,259
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	45
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,214,304
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	54.0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="44%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="44%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Hospital products
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,594,172
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	20.9
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,526,838
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	15.0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="44%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="44%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Medical device
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="44%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="44%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Sales discount
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(1,638,873
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="44%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="44%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;Total gross profit
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	11,104,065
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	40.9
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	30,276,362
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	49.3
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Gross profit decreased by approximately $19.2 million or 63.3% for the year ended December 31, 2015, as compared to the year of 2014. The decrease in gross profit was due primarily to the decrease in sales of all products.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The overall gross profit margin decreased to 40.9% for the year ended December 31, 2015 from 49.3% for the year ended December 31, 2014.&#160;&#160;&#160;The decline in gross profit margin during the year 2015, as compared to the year 2014 was the result of the decline in sales as detailed in &#8220;Net Sales&#8221;. The allocation of fixed production costs also contributed to lower gross profit margins.
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_13"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Operating Expenses
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="14" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Year Ended December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Operating expenses
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	% of net sales
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Operating expenses
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	% of net sales
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	% change
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Advertising expenses
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,803,780
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	14.0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8,594,303
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	14.0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(55.7
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Selling expenses
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,835,398
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	17.8
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,892,447
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	16.1
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(51.1
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	General and administrative expenses
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,648,902
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	17.1
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7,718,388
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	12.6
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(39.8
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Research and development expenses
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,020,909
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	14.8
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,766,162
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4.5
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	45.4
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Provision for doubtful debts
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,666,730
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	17.2
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	100
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Impairment loss on loan receivables
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8,845,999
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	32.6
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	100
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Impairment loss on prepaid lease payment
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,066,115
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3.9
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	100
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Impairment loss on intangible assets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,973,796
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	11.0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	990,603
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1.6
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(200.2
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Construction in progress written off
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,627,154
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2.6
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(100
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Total operating expenses
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	34,861,629
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	128.5
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	31,589,057
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	51.4
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	14.3
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Total operating expense increased by approximately $3.3 million or 10.4% for the year ended December 31, 2015, as compared to the year ended December 31, 2014.&#160;&#160;The increase is attributable to increase in research and development expenses and impairment loss on intangible assets, trade receivables, loan receivables, loan interest receivables, and prepaid lease payment.&#160;&#160;
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
	&#160;
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	39
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage40"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Advertising expenses accounted for 14.0% of our total net sales for the years ended December 31, 2015 and 2014.&#160;Although Advertising expenses decreased by 55.7%, the spending is proportional to the Company&#8217;s sales revenue, and the proportion has remained relatively stable from 2014 to 2015.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Selling expenses consist mostly of sales salaries, commission and other selling expenses.&#160;&#160;Overall decrease was approximately $5.0 million or 51.1%.&#160;Selling expenses is proportional
<FONT STYLE="DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	to the Company&#8217;s sales revenue, and the proportion has remained relatively stable from 2014 to 2015.
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	General and administrative expenses consist of salaries and wages, amortization and depreciation, stock based compensation and other general and administrative expenses. It also includes the loss on land disposal of approximately $0.6 million for land settled by the PRC Court for a legal dispute involving personal debts owed by the Company&#8217;s Chairman and Chief Executive Officer, Ronghua Wang.&#160;&#160;During the year ended December 31, 2015, general and administrative expenses were approximately $4.6 million. The decrease in general and administrative expenses was mainly due to the decrease in expenses in tax, legal fee, and supplies correlated to the decrease in sales revenue.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We make periodical assessments as to the progress of our research and development projects, and charge to expense as appropriate, as these projects reach different stages or project milestones.&#160;&#160;In 2015, the Company has fully amortized the Research &amp; Development expenses that were initially incurred in 2014. We incurred a total of approximately $4.0 million and $2.8 million in research and development expenses for the years ended December 31, 2015 and 2014, respectively.
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We have incurred impairment charges for trade receivables, loan receivables, and prepaid lease payments.
<FONT STYLE="DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	The Company has offered certain customers discounts on certain receivables balances to encourage faster settlement of such outstanding balances.&#160; The impairment loss of intangible asset of $3.0 million was related to drug permits that were previously purchased by the Company; however, the Company has determined that these permits will not provide any profit in the foreseeable future.&#160;The impairment loss on trade receivables pertains to specific write offs of accounts receivables owed by customers. Impairment loss on loan receivables relates to unsecured loan provided to a third party borrower whom the Company has determined as insolvent. The Company recognized impairment loss on prepaid lease payments because the Company has decided to discontinue the growing of plants used as raw materials in the Company&#8217;s drug products.
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Provision for Income Taxes
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For the year ended December 31, 2015, our deferred tax expense was approximately $1.3 million. For the year ended December 31, 2014, we had an income tax expense and deferred tax benefit of approximately $1.0 million and $4.4 million, respectively.&#160;&#160;The uniform corporate income tax rate is 25% in China. The calculation of effective tax rate includes the operating results of&#160;all our subsidiaries, including the U.S. corporate company. As of December 31, 2015, valuation allowance of approximately $7.1 million was provided in the consolidated financial statements.
</FONT>
</FONT>
</DIV>
</DIV>
</EFX_RESULTS_OF_OPERATIONS>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_LIQUIDITY_CAPITAL>
<A NAME="FIS_LIQUIDITY_CAPITAL"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Liquidity and Capital Resources
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As of December 31, 2015, we had cash and cash equivalents of approximately $0.04 million and net working capital of approximately $9.0 million.&#160;
<FONT STYLE="DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	Collection of receivables and lower production capacity from preparation for further GMP renewal certification at our Aoxing facility led to weak results in generating cash flows during the fiscal year. We have been working with the bank to extend the outstanding loans, trying to collect as much account receivables as possible, and restoring production volumes to regular levels; however, as of the time of this filing, we cannot provide any assurance that we will be able to successfully extend our loans and restore all production to regular volumes. The Company&#8217;s short-term bank loan is due on demand and the Company is in negotiations to extend this loan.
</FONT>
	As of December 31, 2015, cash and cash equivalents were mainly denominated in RMB and were placed with banks in the PRC.&#160;&#160;These cash and cash equivalents may not be freely convertible into foreign currencies and the remittance of these funds out of the PRC may be subjected to exchange control restrictions imposed by the PRC government.
</FONT>
</FONT>
</DIV>
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On an on-going basis, we take steps to identify and plan our needs for liquidity and capital resources, to fund our operations and day to day business operations. Our future capital expenditures will include, among others, expanding product lines, research and development capabilities, and making acquisitions as deemed appropriate.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Based on our current plans for the next 12 months, we anticipate that the sales of the Company&#8217;s pharmaceutical products will be the primary organic source of funds for future operating activities in 2016. However, to fund continued expansion of our operation and extend our reach to broader markets, and to acquire additional entities, as we may deem appropriate, we may rely on more bank borrowing, if available, as well as capital raises. There is no assurance that we will find such funding on acceptable terms, if at all.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	40
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage41"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Net cash provided by operating activities for the year ended December 31, 2015 was approximately $5.9 million. This was primarily due to our net loss of approximately $25.1 million, adjusted by non-cash related expenses including depreciation and amortization of approximately $2.3 million, recognition of research and development expenses of approximately $4.0 million, and a non-cash increase in deferred tax assets of approximately $1.3 million, and a net decrease in working capital items of approximately $6.8 million. The net decrease in working capital items was mainly due to increase in accounts receivable offset by increase in accounts and other payables, and prepaid expenses.
</FONT>
</FONT>
</DIV>
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Net cash used in investing activities for the year ended December 31, 2015 was approximately $7.4 million, primarily consisting of approximately $8.1 million paid on intended acquisition offset by $0.8 million received from loan receivables.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Net cash used in financing activities for the year ended December 31, 2015 was approximately $0.2 million, consisting repayment for short term bank loans.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Critical Accounting Policies
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We believe the following critical accounting policies, among others, affect management&#8217;s more significant judgments and estimates used in the preparation of the financial statements:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Allowance for Doubtful Accounts
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. The allowance for doubtful accounts is based on specific identification of customer accounts and management&#8217;s best estimate of the likelihood of potential loss, taking into account such factors as the financial condition and payment history of major customers. Management evaluates the collectability of the receivables at least quarterly. If the financial condition of a customer was to deteriorate further, resulting in an impairment of their ability to make payments, additional allowances may be required.&#160;&#160;Such differences could be material and could significantly impact cash flows from operating activities.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following are steps the Company takes in collecting accounts receivable:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Step 1: After the payment term has been exceeded, the Company stops taking orders from the delinquent customer and allows the responsible sales person three to six months to collect the accounts receivable. Most of the accounts receivable will be collected in this step because the sales person&#8217;s compensation is tied to sales receipts. The Company&#8217;s normal sales term is 90 to 120 days credit period (2014: 90 to 120 days).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Step 2: If the sales person&#8217;s collection efforts are not successful, the Company hires a collection agent and allows the agent another three to six months to collect the accounts receivable.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Step 3: If the collection agent&#8217;s efforts are not successful, the Company will commence legal action to collect the accounts receivable.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our policies for writing off the accounts receivable are as follows:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="81%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	If after taking legal action, it appears that an accounts receivable is not likely to become collectible, such accounts receivable will be written off if it is more than two years old.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="81%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	If during the collection period, the customer provides bankruptcy or other insolvency documentation, the corresponding accounts receivable will be written off.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="81%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	If we are no longer able to locate a particular customer in order for us to take any collection or legal actions, the accounts receivable for such customer will be written off if it is more than two years old.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Inventory
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We write down our inventory for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand, future pricing and market conditions. If actual future demands, future pricing or market conditions are less favorable than those projected by management, additional inventory write-downs may be required and the differences could be material. Such differences might significantly impact cash flows from operating activities.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	41
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage42"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Property and Equipment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Property and equipment are stated at historical cost less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. Judgment is required to determine the estimated useful lives of assets, especially for computer equipment, including determining how long existing equipment can function and when new technologies will be introduced at cost-effective price points to replace existing equipment. Changes in these estimates and assumptions could materially impact the financial position and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Stock-Based Compensation
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our stock-based compensation expense is estimated at the grant date based on the award&#8217;s fair value as calculated by the Black-Scholes-Merton (BSM) option-pricing model for share options and Binominal Model for warrants and is recognized as expense over the requisite service period. The BSM model and Binominal Model requires various highly judgmental assumptions including expected volatility and option life. Changes in these assumptions could materially impact the financial position and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Valuation of Intangibles
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	From time to time, we acquire intangible assets that are beneficial to our product development processes. Management periodically evaluates the carrying value of intangibles, including the related amortization periods. In evaluating acquired intangible assets, management determines whether there has been impairment by comparing the anticipated undiscounted cash flows from the operation and eventual disposition of the product line with its carrying value. If the undiscounted cash flows are less than the carrying value, the amount of the impairment, if any, will be determined by comparing the carrying value of each intangible asset with its fair value.&#160;&#160;Fair value is generally based on either a discounted cash flows analysis or market analysis. Future operating income is based on various assumptions, including regulatory approvals, patents being granted, and the type and nature of competing products. If regulatory approvals or patents are not obtained or are substantially delayed, or other competing technologies are developed and obtain general market acceptance or market conditions otherwise change, our intangibles may have a substantially reduced value, which could be material.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Research and Development
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The remuneration of the Company&#8217;s research and development staff, materials used in internal research and development activities, and payments made to third parties in connection with collaborative research and development arrangements, are all expensed as incurred.&#160;&#160;Where the Company makes a payment to a third party to acquire the right to use a product formula which has received regulatory approval, that payment is accounted for as the acquisition of a license or patent and is capitalized as an intangible asset and amortized over the shorter of the remaining license period or patent life (See above &#8220;Intangible Assets&#8221;).
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Income Taxes
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We use the asset and liability method of accounting for income taxes. Under this method, income tax expense is recognized for the amount of taxes payable or refundable for the current year. In addition, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating losses and tax credit carry-forwards. Management must make assumptions, judgments and estimates to determine the current provision for income taxes and the deferred tax assets and liabilities and any valuation allowance to be recorded against a deferred tax asset. Management&#8217;s judgments, assumptions and estimates relative to the current provision for income tax take into account current tax laws, management&#8217;s interpretation of current tax laws and possible outcomes of current and future audits conducted by foreign and domestic tax authorities. Changes in tax law or management&#8217;s interpretation of tax laws and the resolution of current and future tax audits could significantly impact the amounts provided for income taxes in the financial statements. Management&#8217;s assumptions, judgments and estimates relative to the value of a deferred tax asset take into account predictions of the amount and category of future taxable income, such as income from operations. Actual operating results and the underlying amount and category of income in future years could render management&#8217;s current assumptions, judgments and estimates of recoverable net deferred taxes inaccurate. Any of the assumptions, judgments and estimates mentioned above could cause our actual income tax obligations to differ from the estimates, thus materially impact the financial position and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	42
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage43"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Foreign Currency
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our functional currency is the U.S. dollar, and our subsidiary and our VIE in China use their respective local currencies as their functional currencies, i.e. the RMB. An entity&#8217;s functional currency is the currency of the primary economic environment in which the entity operates. Management must use judgment in determining an entity&#8217;s functional currency, assessing economic factors including cash flow, sales price, sales market, expense, financing and inter-company transactions and arrangements. The impact from exchange rate changes related to transactions denominated in currencies other than the functional currency is recorded as a gain and loss in the statements of operations, while the impact from exchange rate changes related to translating a foreign entity&#8217;s financial statements from the functional currency to its reporting currency, the U.S. dollar, is disclosed and accumulated in a separate component under the equity section of the balance sheets. Different judgments or assumptions resulting in a change of functional currency may materially impact our financial position and results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Business Combinations
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Business combinations are accounted for under the acquisition method of accounting in accordance with ASC 805, Business Combinations. Under the acquisition method the acquiring entity in a business combination recognizes 100 percent of the acquired assets and assumed liabilities, regardless of the percentage owned, at their estimated fair values as of the date of acquisition. Any excess of the purchase price over the fair value of net assets and other identifiable intangible assets acquired is recorded as goodwill. To the extent the fair value of net assets acquired, including other identifiable assets, exceed the purchase price, a bargain purchase gain is recognized. Assets acquired and liabilities assumed from contingencies must also be recognized at fair value, if the fair value can be determined during the measurement period. Results of operations of an acquired business are included in the statement of earnings from the date of acquisition. Acquisition-related costs, including conversion and restructuring charges, are expensed as incurred.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_14"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Contractual Obligations
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following table sets forth our contractual obligations as of December 31, 2015:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="18" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Payments due by period ($ million)
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Total
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Within 1 year
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	1-3 years
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	3-5 years
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&gt;5 years
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Research and development contracts
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0.8
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0.8
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Purchase of a health product manufacturer
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4.9
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4.9
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Acquire a project for mining rights, mining assets and a mining company
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0.2
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0.2
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="30%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Total contractual obligations
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5.9
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5.9
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Inflation
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Management believes that inflation has not had a material effect on our results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Off-Balance Sheet Arrangements
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We have no off-balance sheet arrangements, as defined in Regulation S-K Section 303(a)(4).
</FONT>
</DIV>
</EFX_LIQUIDITY_CAPITAL>
</EFX_MANAGEMENTS_DISCUSSION>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_MARKET_RISK>
<A NAME="FIS_MARKET_RISK"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_7A">
	I
</A>
	TEM 7A.&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We are a &#8220;smaller reporting company&#8221; as defined by Regulations S-K and as such, are not required to provide this information.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	43
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage44"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_MARKET_RISK>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_FINANCIAL_STATEMENTS>
<A NAME="FIS_FINANCIAL_STATEMENTS"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_8">
	IT
</A>
	EM 8.&#160;&#160;FINANCIAL STATEMENTS
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_AUDITORS_OPINION>
<A NAME="FIS_AUDITORS_OPINION"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_REPORT">
	R
</A>
	eport of Independent Registered Public Accounting Firm
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	To the Board of Directors and Stockholders of
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Biostar Pharmaceuticals, Inc.
</FONT>
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We have audited the accompanying consolidated balance sheet of Biostar Pharmaceuticals, Inc. and its subsidiaries (the &#8220;Company&#8221;) as of December 31, 2015 and 2014 and the related consolidated statements of operations and comprehensive income, stockholders&#8217; equity and cash flows for the year then ended.&#160;These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. Our audits also included examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2015, and the results of its operations and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As discussed in Note 3 to the consolidated financial statements, the Company signed letters of intent in November 2013 and December 2014 to acquire 100% interests in a health product manufacturer and a company in the PRC, which is principally engaged in supply of raw materials to produce health products respectively. Deposits for these intended acquisitions have been paid and included in the &#8220;Deposits&#8221; under Non-current assets and these intended acquisitions are still in progress as of December 31, 2015.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As more described in Note 2 &#8220;Liquidity and Going Concern&#8221;, the Company had net decrease in cash and cash equivalents during the year and had a low cash position at December 31, 2015 and had experienced a substantial decrease in sales volume which resulting a net loss for the year. Also, part of the Company&#8217;s buildings and land use rights are subject to litigation between two independent third parties and the Company&#8217;s Chief Executive Officer, and the title of these buildings and land use rights has been seized by the PRC Courts so that the Company cannot be sold without the Court&#8217;s permission. In addition, as discussed in Note&#160;5 &#8220;Short-term Bank Loans&#8221; to the consolidated financial statements, the Company already violated its financial covenants included in its short-term bank loans. These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.
</FONT>
</FONT>
</DIV>
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Mazars CPA Limited
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Certified Public Accountants
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Hong Kong
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	April 14, 2016
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage45"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_AUDITORS_OPINION>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_BALANCE_SHEET>
<A NAME="FIS_BALANCE_SHEET"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_BS">
	B
</A>
	IOSTAR PHARMACEUTICALS, INC.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	CONSOLIDATED BALANCE SHEETS
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	AS OF DECEMBER 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	ASSETS
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Current Assets
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Cash and cash equivalents
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	38,898
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,685,154
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Accounts receivable, net
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	15,814,880
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	26,962,078
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Inventories
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	234,660
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	673,989
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Deposits and other receivables
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,591
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,471,992
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Income tax recoverable
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	76,280
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	67,370
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Loan receivable, net
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,772,464
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 18PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Total Current Assets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	16,167,309
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	43,633,047
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Non-current Assets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Deposits
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	16,099,958
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8,795,218
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Deferred tax assets, net
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5,406,593
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7,065,523
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Property and equipment, net
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6,810,933
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8,483,113
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Intangible assets, net
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6,878,787
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	13,270,330
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 18PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Total Non-Current Assets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	35,196,271
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	37,614,184
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Total Assets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	51,363,580
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	81,247,231
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	LIABILITIES AND STOCKHOLDERS' EQUITY
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Current Liabilities
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Accounts and other payables
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,153,411
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5,001,086
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Short-term bank loans
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,773,199
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,094,614
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Valued-added tax payable
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	112,629
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	432,885
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Warrants liability
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	59,202
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	383,295
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 18PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Total Current Liabilities
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7,098,441
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8,911,880
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Commitment and contingencies
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Stockholders' Equity
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Common stock, $0.001 par value, 100,000,000 shares authorized,
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 18PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,210,913 shares issued and outstanding&#160;as of December 31, 2015 and 2014
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,210
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,210
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Additional paid-in capital
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	30,316,774
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	30,316,774
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Statutory reserve
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7,354,413
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7,354,413
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Retained earnings
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,157,394
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	28,269,956
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Accumulated other comprehensive income
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,434,348
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6,391,998
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 18PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Total Stockholders' Equity
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	44,265,139
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	72,335,351
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Total Liabilities and Stockholders' Equity
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	51,363,580
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	81,247,231
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_BALANCE_SHEET>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The accompanying notes are an integral part of these consolidated financial statements
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage46"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_INCOME_STATEMENT>
<A NAME="FIS_INCOME_STATEMENT"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_OS">
	B
</A>
	IOSTAR PHARMACEUTICALS, INC.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	CONSOLIDATED STATEMENTS OF OPERATIONS
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	AND COMPREHENSIVE INCOME
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="7" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	FOR THE YEARS ENDED DECEMBER 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Sales, net
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	27,129,609
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	61,416,587
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Cost of sales
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	16,025,544
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	31,140,225
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Gross profit
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	11,104,065
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	30,276,362
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Operating expenses:
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Advertising expenses
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,803,780
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8,594,303
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Selling expenses
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,835,398
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,892,447
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;General and administrative expenses
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,648,902
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7,718,388
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Research and development expenses
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,020,909
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,766,162
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Impairment loss on intangible assets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,973,796
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	990,603
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Provision for doubtful accounts receivable
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,666,730
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Impairment loss on loan receivables
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8,845,999
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Impairment loss on prepaid lease payment
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,066,115
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Construction in progress written off
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,627,154
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total operating expenses
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	34,861,629
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	31,589,057
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Loss from operations
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(23,757,564
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(1,312,695
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Other (expense) income
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Interest income
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8,895
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,330,329
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Interest expense
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(283,596
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(154,547
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Fair value adjustment on warrants
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	324,093
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	577,599
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Gain on disposal of intangible assets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD COLSPAN="2" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Additional compensation received for the disposed land use rights
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,093,878
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Other (expense) income, net
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(84,544
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	67
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total other (expense) income, net
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(35,152
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,847,326
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	(Loss) Income before income taxes
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(23,792,716
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,534,631
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Provision for income tax (Income tax benefit)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,319,846
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(3,313,581
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	(Loss) Net income
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(25,112,562
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,848,212
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Foreign currency translation adjustment
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2,957,650
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(208,456
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Comprehensive (loss) income
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(28,070,212
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,639,756
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(Loss) Earning per share
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;&#160;Basic
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(11.4
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2.3
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;&#160;Diluted
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(11.4
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2.3
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Weighted average number of common shares outstanding
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;&#160;Basic
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,210,913
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,071,343
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;&#160;Diluted
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,210,913
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,071,343
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_INCOME_STATEMENT>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The accompanying notes are an integral part of these consolidated financial statements
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-3
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage47"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_STOCKHOLDERS_EQUITY>
<A NAME="FIS_STOCKHOLDERS_EQUITY"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_ES">
	B
</A>
	IOSTAR PHARMACEUTICALS, INC.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	FOR THE YEARS ENDED DECEMBER 31, 2015 AND 2014
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Accumulated
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Additional
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Deferred
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Other
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Total
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="20%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Common Stock
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Paid-in
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Stock-Based
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Statutory
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Retained
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Comprehensive
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Stockholders'
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Shares
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Amount
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Capital
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Compensation
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Reserve
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Earnings
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Income
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Equity
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Balance, January 1, 2014
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	12,676,113
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	12,676
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	25,748,669
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(365,017
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7,126,432
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	23,649,725
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6,600,454
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	62,772,939
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7-to-1 Reverse Split
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(10,865,199
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(10,865
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	10,865
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Stock-based compensation
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	164,285
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	164
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,655,836
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	365,017
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,021,017
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shares issuance in public offering
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	235,714
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	235
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,901,404
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,901,639
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Transfer to statutory reserve
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	227,981
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(227,981
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Net income
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,848,212
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,848,212
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Foreign currency translation adjustment
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(208,456
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(208,456
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Balance, December 31, 2014
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,210,913
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,210
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	30,316,774
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7,354,413
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	28,269,956
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6,391,998
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	72,335,351
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Balance, December 31, 2014
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,210,913
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,210
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	30,316,774
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7,354,413
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	28,269,956
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6,391,998
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	72,335,351
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Net (loss)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(25,112,562
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(25,112,562
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Foreign currency translation adjustment
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2,957,650
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2,957,650
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Balance, December 31, 2015
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,210,913
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,210
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	30,316,774
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7,354,413
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,157,394
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,434,348
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	44,265,139
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_STOCKHOLDERS_EQUITY>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The accompanying notes are an integral part of these consolidated financial statements
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-4
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage48"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_CASH_FLOW>
<A NAME="FIS_CASH_FLOW"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_CF">
	BIO
</A>
	STAR PHARMACEUTICALS, INC.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	CONSOLIDATED STATEMENTS OF CASH FLOWS
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	FOR THE YEARS ENDED DECEMBER 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	CASH FLOWS FROM OPERATING ACTIVITIES
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Net (loss) income
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(25,112,562
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,848,212
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Adjustments to reconcile net (loss) income to net cash provided by operating activities:
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Deferred income tax expense (benefit)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,332,951
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(4,284,655
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Depreciation and amortization
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,320,195
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,086,188
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Provision for doubtful debts
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,666,730
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Recognition of deferred research and development expenses
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,020,909
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,766,162
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Impairment loss on intangible assets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,973,796
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	990,603
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Impairment loss on loan receivable
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8,845,999
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Impairment loss on prepaid lease payment
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,066,115
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Construction in progress written off
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,627,154
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Loss on disposal of property, plant and equipment
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	738,834
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,275
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Additional compensation received for the disposed land use rights
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(1,093,878
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Stock-based compensation
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,021,017
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Warrants liability
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(324,093
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(577,599
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Changes in operating assets and liabilities:
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Accounts receivable
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5,448,178
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(7,441,446
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Inventories
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	420,584
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	152,454
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Deposits and other receivables
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	392,425
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	244,270
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Accounts payable and accrued expenses
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(602,958
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	573,102
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Value-added tax payable
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(309,890
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	90,148
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;Income tax payable
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	305,611
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Net cash provided by operating activities
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5,877,213
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,310,618
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	CASH FLOWS FROM INVESTING ACTIVITIES
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Purchase of property, plant and equipment
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(59,475
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2,869,204
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Proceeds from disposal of property, plant and equipment
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,929
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Deposit paid for research and development&#160;- Note 3(a)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(4,067,885
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Deposit paid for intended acquisitions - Notes 3(c) and 3(d)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(8,122,236
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(4,881,462
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Proceeds from disposal of two drug approval numbers
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,390,661
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Receipt from loan receivable
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	804,182
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Compensation received for disposed land use rights
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,546,822
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Net cash used in investing activities
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(7,377,529
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(8,878,139
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	CASH FLOWS FROM FINANCING ACTIVITIES
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Proceeds from short-term bank loans
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,254,307
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Repayment of short-term bank loans
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(160,836
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(162,715
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Proceeds from stock issuance and warrants
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,862,533
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Net cash (used in) provided by financing activities
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(160,836
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6,954,125
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Effect of exchange rate changes on cash and cash equivalents
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	14,896
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	218,478
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Net (decrease) increase in cash and cash equivalents
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(1,646,256
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,605,082
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Cash and cash equivalents, beginning balance
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,685,154
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	80,072
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Cash and cash equivalents, ending balance
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	38,898
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,685,154
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	SUPPLEMENTAL DISCLOSURES:
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Interest received
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8,896
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,330,329
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Interest paid
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(133,618
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(154,547
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Income tax payments
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(665,621
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_CASH_FLOW>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	SUPPLEMENTAL DISCLOSURES OF NON-CASH ACTIVITIES:
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	a)
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;&#160;
</FONT>
	&#160;&#160;&#160;&#160;&#160;&#160;In
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	July 2014, the Company issued a total of 164,285
</FONT>
	shares of common stock valued at approximately $1,656,000 to its employees &#8211; Note 6(a)
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	The accompanying notes are an integral part of these financial statements.
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-5
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage49"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_NOTES">
	BI
</A>
	OSTAR PHARMACEUTICALS, INC.
</FONT>
</FONT>
</DIV>
<EFX_NOTES_TO_FINANCIAL_STATEMENT>
<A NAME="FIS_NOTES_TO_FINANCIAL_STATEMENT"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Note 1 -
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	ORGANIZATION AND NATURE OF OPERATIONS
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Biostar Pharmaceuticals, Inc. (&#8220;Biostar&#8221; or the &#8220;Company&#8221;) was incorporated in the State of Maryland on March 27, 2007. On June 15, 2007, Biostar formed Shaanxi Biostar Biotech Ltd. (&#8220;Shaanxi Biostar&#8221;). Shaanxi Biostar is a wholly owned subsidiary of Biostar and a limited liability company organized under the laws of the People&#8217;s Republic of China (the &#8220;PRC&#8221;).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On November 1, 2007, Shaanxi Biostar entered into a series of agreements including a Management Entrustment Agreement, a Shareholders&#8217; Voting Proxy Agreement, an Exclusive Option Agreement and a Share Pledge Agreement (collectively the &#8220;Agreements&#8221;) with Shaanxi Aoxing Pharmaceutical Co., Ltd. (&#8220;Aoxing Pharmaceutical&#8221;) and its registered owners (the &#8220;Transaction&#8221;). Aoxing Pharmaceutical is a corporation formed under the laws of the PRC. According to these Agreements, Shaanxi Biostar acquired management control of Aoxing Pharmaceutical whereby Shaanxi Biostar is entitled to all of the net profits of Aoxing Pharmaceutical as a management fee and is obligated to fund Aoxing Pharmaceutical&#8217;s operations and pay all of the debts. In exchange for entering into the Agreements, on November 1, 2007, the Company issued 2,833,187 shares of its common stock to Aoxing Pharmaceutical&#8217;s registered owners, representing approximately 90% of the Company&#8217;s common stock outstanding immediately after the Transaction.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Following the change in registered owners of Aoxing Pharmaceutical on July 9, 2010, a set of new Agreements had been entered into with all the then existing registered owners of Aoxing Pharmaceutical on the same day.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Agreements dated July 9, 2010 were merely replacement of the Agreements dated November 1, 2007 and therefore, there was no significant change in the contractual terms between the Agreements dated July 9, 2010 and November 1, 2007. The then existing registered owners of Aoxing Pharmaceutical, Shaanxi Biostar and Biostar had mutually agreed that no consideration would be paid / payable upon the execution of the Agreements on July 9, 2010. The interest of Biostar in Aoxing Pharmaceutical was not and would not be affected by the replacement for the Agreements.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Following the change in registered owners of Aoxing Pharmaceutical on May 24, 2013, a set of new Agreements had been entered into with all the existing registered owners of Aoxing Pharmaceutical on May 24, 2013.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Agreements dated May 24, 2013 are merely replacements of the Agreements dated July 9, 2010 and therefore, there is no significant change in the contractual terms between the Agreements dated May 24, 2013, July 9, 2010 and November 1, 2007. The existing registered owners of Aoxing Pharmaceutical, Shaanxi Biostar and Biostar had mutually agreed that no consideration would be paid / payable upon the execution of the Agreements on May 23, 2013. The interest of Biostar in Aoxing Pharmaceutical was not and would not be affected by the replacement for the Agreements.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Following the change in registered owners of Aoxing Pharmaceutical on October 29, 2014, a set of new Agreements had been entered into with all the existing registered owners of Aoxing Pharmaceutical on October 29, 2014.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Agreements dated October 29, 2014 are merely replacements of the Agreements dated May 24, 2013 and therefore, there is no significant change in the contractual terms between the Agreements dated October 29, 2014, May 24, 2013, July 9, 2010 and November 1, 2007. The existing registered owners of Aoxing Pharmaceutical, Shaanxi Biostar and Biostar had mutually agreed that no consideration would be paid / payable upon the execution of the Agreements on October 29, 2014. The interest of Biostar in Aoxing Pharmaceutical was not and would not be affected by the replacement for the Agreements.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Following the change in registered owners of Aoxing Pharmaceutical on May 11, 2015, a set of new Agreements had been entered into with all the existing registered owners of Aoxing Pharmaceutical on May 11, 2015.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Agreements dated May 11, 2015 are merely replacements of the Agreements dated October 29, 2014 and therefore, there is no significant change in the contractual terms between the Agreements dated May 11, 2015, October 29, 2014, May 24, 2013, July 9, 2010 and November 1, 2007. The existing registered owners of Aoxing Pharmaceutical, Shaanxi Biostar and Biostar had mutually agreed that no consideration would be paid / payable upon the execution of the Agreements on May 11, 2015. The interest of Biostar in Aoxing Pharmaceutical was not and would not be affected by the replacement for the Agreements.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Agreements provide Shaanxi Biostar&#160;with control over&#160;Aoxing Pharmaceutical as defined by Accounting Standards Codification (&#8220;ASC&#8221;) 810,&#160;
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Consolidation
</FONT>
	, which requires Shaanxi Biostar to consolidate the financial statements of Aoxing Pharmaceutical and ultimately consolidate with its parent company, Biostar (see Note 2 &#8220;Principles of Consolidation&#8221;).
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In October 2011, Aoxing Pharmaceutical entered into&#160;and completed&#160;a Share Transfer Agreement (the &#8220;Weinan Share Transfer Agreement&#8221;) to acquire Shaanxi Weinan Huaren Pharmaceuticals, Ltd. (&#8220;Shaanxi Weinan&#8221;) from the holders of 100% of equity interests in Shaanxi Weinan.&#160;&#160;Therefore, Shaanxi Weinan became a wholly owned subsidiary of Aoxing Pharmaceutical. Shaanxi Weinan is engaged in manufacturing of drugs and health products.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-6
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage50"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In April 2013, Aoxing Pharmaceutical executed a supplemental agreement to the Weinan Share Transfer Agreement (the &#8220;Weinan Supplemental Agreement&#8221;) with all the former equity holders of Shaanxi Weinan to acquire 13 drug approval numbers which were excluded from the Weinan Share Transfer Agreement due to incomplete re-registration.&#160;&#160;The Company acquired ownership of the 13 drug approval numbers for which re-registration has been completed in April 2013. The aggregate purchase price was approximately $10.2 million, consisting of approximately $8.8 million in cash and 228,938 shares (after the one-for-seven reverse split of the issued and outstanding common stock of the Company effective on February 4, 2016) of the Company&#8217;s common stock, valued at approximately $1.4 million.
</FONT>
</FONT>
</DIV>
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company, through its subsidiary and the Agreements with Aoxing Pharmaceutical, is engaged in the business of developing, manufacturing and marketing over-the-counter (&#8220;OTC&#8221;) and prescription pharmaceutical products in the PRC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Note 2 -
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Basis of Presentation
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;US GAAP&#8221;).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Liquidity and Going Concern
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As of December&#160;31, 2015, we had $38,898 of cash and working capital of $9,068,868. For the year ended December&#160;31, 2015, we incurred a net loss of $25,112,562 and net cash provided by operating activities of $5,877,213. We generated cash flow from operations even though we incurred a net loss as our net loss includes certain non-cash expenses that are added back to our cash flow from operations as shown on our consolidated statements of cash flows.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We had experienced a substantial decrease in sales volume of all Aoxing Pharmaceutical Products due to the temporarily suspension of production to conduct maintenance of its production lines to renew its GMP certificates by the second quarter in 2016. While our production levels of Shaanxi Weinan products helped to offset the substantial decrease in our sales volume in the most recent fiscal quarter, our sales volume continued to remain at the present decreased levels. There is no assurance that the production lines at Aoxing will resume and the renewal of GMP certificates will occur when anticipated, or even if they are renewed, we will be able to return to the production levels as anticipated. Our inability to regain our production levels as anticipated may have material adverse effects on our business, operations and financial performance, and the Company may become insolvent. In addition, the Company already violated its financial covenants included in its short-term bank loans as discussed in Note 5 &#8220;Short-term Bank Loans&#8221;.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	During 2015, as a result of outstanding personal debts of the Chief Executive Officer, Mr. Ronghua Wang, one of the Company&#8217;s bank accounts was frozen, the Company&#8217;s properties were transferred, and the Company&#8217;s land use rights and buildings were at the risk of being seized and auctioned.&#160;As of April 8, 2016, Mr. Ronghua Wang had partially repaid the outstanding balance of the loan, thus avoiding the Company&#8217;s land use rights and buildings being seized and auctioned with proceeds used to settle this debt. Mr. Ronghua Wang intends to repay the Company in full for the loss.
<FONT STYLE="DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	The Company has disclosed the above legal proceedings related to the Company to the best of its knowledge. There is no assurance that Mr. Ronghua Wang will be able to repay his personal debts in full before his creditors take any other further legal action. There is also no assurance that there will be no other cases that would put the Company&#8217;s properties at risk.
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The factors discussed above raise substantial doubt as to our ability to continue as a going concern. Based on our current plans for the next twelve months, we anticipate that the sales of the Company&#8217;s pharmaceutical products in Shaanxi Weinan after having recently gained renewal of its GMP certificates, will be the primary organic source of funds for future operating activities in 2016. The Company will also make substantial efforts to collect outstanding accounts and other receivables to meet its debt obligations; we may also try to procure bank borrowing, if available, as well as capital raises through public or private offerings. There is no assurance that we will find such funding on acceptable terms, if at all. The accompanying consolidated financial statements do not include any adjustments that might result from these uncertainties.
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Principles of Consolidation
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The consolidated financial statements include the accounts of the Company, its subsidiary and variable interest entity (&#8220;VIE&#8221;) for which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated in consolidation. The Company has adopted ASC 810,
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Consolidation
</FONT>
	which requires a VIE to be consolidated by a company if that company has both the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (1) the obligation to absorb losses of the VIE or (2) the right to receive benefits from the VIE&#8221;.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-7
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage51"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In determining Aoxing Pharmaceutical is a VIE of Shaanxi Biostar, the Company considered the following indicators, among others:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="4%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#9679;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="83%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shaanxi Biostar has the full right to control and administer the financial affairs and daily operation of Aoxing Pharmaceutical and has the right to manage and control all assets of Aoxing Pharmaceutical. The registered owners of Aoxing Pharmaceutical as a group have no right to make any decision about Aoxing Pharmaceutical&#8217;s activities without the consent of Shaanxi Biostar.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="4%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#9679;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="83%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shaanxi Biostar is assigned all voting rights of Aoxing Pharmaceutical and has the right to appoint all directors and senior management personnel of Aoxing Pharmaceutical. The registered owners of Aoxing Pharmaceutical possess no substantive voting rights.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="4%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#9679;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="83%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shaanxi Biostar is committed to provide financial support if Aoxing Pharmaceutical requires additional funds to maintain its operations and to repay its debts.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="RIGHT" VALIGN="TOP" WIDTH="4%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#9679;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="83%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shaanxi Biostar is entitled to a management fee equal to Aoxing Pharmaceutical&#8217;s net profits and is obligated to assume all operation risks and bear all losses of Aoxing Pharmaceutical.&#160;&#160;Therefore, Shaanxi Biostar is the primary beneficiary of Aoxing Pharmaceutical.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Additional capital provided to Aoxing Pharmaceutical by the Company was recorded as an interest-free loan to Aoxing Pharmaceutical. There was no written note to this loan, the loan was not interest bearing, and was eliminated during consolidation. Under the terms of the Agreements, the registered owners of Aoxing Pharmaceutical are required to transfer their ownership of Aoxing Pharmaceutical to the Company&#8217;s subsidiary in the PRC when permitted by the PRC laws and regulations or to designees of the Company at any time when the Company considers it is necessary to acquire Aoxing Pharmaceutical. In addition, the registered owners of Aoxing Pharmaceutical have pledged their shares in Aoxing Pharmaceutical as collateral to secure these Agreements.
</FONT>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Foreign Currency
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company&#8217;s reporting currency is the U.S. dollar (&#8220;$&#8221;). The Company&#8217;s operation in the PRC uses Chinese Yuan Renminbi (&#8220;RMB&#8221;) as its functional currency. The financial statements of the subsidiary and VIEs are translated into U.S. dollars in accordance with ASC 830,
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Foreign Currency Matters
</FONT>
	. According to the topic, all assets and liabilities were translated at the current exchange rate, stockholders&#8217; equity are translated at the historical rates and income statement items are translated at the average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with ASC 220,
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Comprehensive Income
</FONT>
	. Foreign exchange transaction gains and losses are reflected in the statement of operations.&#160;&#160;For the years ended December 31, 2015 and 2014, the foreign currency translation adjustment to the Company&#8217;s other comprehensive loss were $2,957,650 and $208,456, respectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Use of Estimates
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates are used for, but not limited to, the accounting for certain items such as allowance for doubtful accounts, depreciation and amortization, impairment, inventory allowance, taxes and contingencies.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Contingencies
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company&#8217;s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company&#8217;s management evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#8217;s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.
</FONT>
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-8
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage52"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Cash and Cash Equivalents
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Cash and cash equivalents include cash in hand and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less.&#160;&#160;As of December 31, 2015 and 2014, cash and cash equivalents were mainly denominated in RMB and were placed with banks in the PRC.&#160;&#160;These cash and cash equivalents may not be freely convertible into foreign currencies and the remittance of these funds out of the PRC may be subjected to exchange control restrictions imposed by the PRC government.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Accounts Receivable
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company maintains provisions for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these allowances. Terms of sales vary. Allowances are recorded primarily on a specific identification basis.
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As of December 31, 2015 and 2014, the doubtful debt provision was approximately $4.7 million and $2.4 million, respectively.
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Reverse Stock Split
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On February 4, 2016, the Company effectuated a one-for-seven reverse split of its common stock; the Company&#8217;s stockholder&#8217;s equity, information on a number of shares and (loss) earnings per share has been retroactively restated to the first period presented. See Note 6(a).
</FONT>
</FONT>
<BR>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Inventories
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Inventories are valued at the lower of&#160;weighted average cost or market. Management compares the cost of inventories with the market value, and allowance is made for writing down the inventories to market value, if lower. Inventories consisted of the following:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_15"></A>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Raw materials
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	164,352
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	380,529
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Work in process
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	51,041
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	143,475
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Finished goods
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	19,267
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	132,491
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Goods in transit
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	17,494
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	234,660
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	673,989
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_16"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Property and Equipment
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Property and equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the straight-line method for substantially all assets with estimated lives of:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="9%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="25%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Buildings
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="53%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	30 years
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="9%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="25%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Building improvements
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="53%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	30 years
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="9%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="25%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Machinery &amp; equipment
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="53%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5-10 years
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="9%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="25%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Furniture &amp; fixtures and vehicles
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="53%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5-10 years
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-9
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage53"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;Property and equipment consisted of the following:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_17"></A>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Buildings
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,548,537
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,651,647
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Building improvements
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5,517,178
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5,895,382
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Machinery &amp; equipment
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,187,421
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,224,229
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Furniture &amp; fixtures
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	53,192
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	68,853
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Vehicle
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	111,701
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	119,553
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Construction in progress
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	483,004
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	516,959
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,901,033
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	11,476,623
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Less: Accumulated depreciation
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(3,090,100
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2,993,510
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6,810,933
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8,483,113
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As set out in Note 5, buildings with carrying value of approximately $1.2 million as of December 31, 2015 were pledged to a local bank in PRC as part of security for a short term bank loan facilities granted to the Company.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Intangible Assets
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Intangible assets are amortized using the straight-line method over their estimated period of benefit, ranging from ten to fifty years. Management evaluates the recoverability of intangible assets periodically and takes into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists. The Company&#8217;s land use rights will expire between 2053 and 2056. The Company&#8217;s proprietary technologies, include drug approvals and permits. All of the Company&#8217;s intangible assets are subject to amortization with estimated useful lives of:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="24%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Land use rights
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="53%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	50 years
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="24%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Proprietary technologies
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="53%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	10 years
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The components of finite-lived intangible assets are as follows:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_18"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Land use rights
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,083,608
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,521,705
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Proprietary technologies
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	16,065,254
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	19,006,655
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	19,148,862
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	22,528,360
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Less: Accumulated amortization and impairment
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(12,270,075
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(9,258,030
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6,878,787
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	13,270,330
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The estimated future amortization expenses related to intangible assets as of December 31, 2015 are as follows:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="50%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="36%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Years Ending December 31,
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="36%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="36%">
<A NAME="FIS_UNIDENTIFIED_TABLE_19"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2016
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,135,712
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="36%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2017
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,135,712
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="36%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2018
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,135,712
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="36%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2019
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,071,108
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="36%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2020
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	114,958
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="36%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Thereafter
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,285,585
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As set out in Note 5, land use right with carrying value of approximately $2.5 million as of December 31, 2015 were pledged to a local bank in PRC as part of security for a short term bank loan facilities granted to the Company.
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	During the course of the Company&#8217;s strategic review of its drugs formula with approval numbers (i.e. &#8220;drug permits&#8221;) in 2014 after renewal of the Certificate of Good Manufacturing Practices for Pharmaceutical Products (&#8220;GMP Certificate&#8221;), the Company identified 57 out of 98 Drug Permits had no active production. In 2015, the Company had another review of its drug permits and identified 6 more permits that the Company did not have plans in the foreseeable operating periods to reconvene production. Accordingly, the Company has made full impairment loss on those drug permits. Impairment related to the 6 and 57 drug permits for the years ended December 31, 2015 and 2014 were approximately $3.0 million and $1.0 million, respectively.
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
	&#160;
</DIV>
<DIV>
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-10
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage54"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Long-Lived Assets
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company adopted ASC 360,
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Property, Plant, and Equipment
</FONT>
	, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company periodically evaluates the carrying value of long-lived assets to be held and used. Impairment loss is recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair market value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair market values are reduced for the cost of disposal. During the year ended December 31, 2015, the Company incurred loss on disposal of property and equipment of $738,834 and included in general and administrative expenses.
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Fair Value of Financial Instruments
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	ASC 825,
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Financial Instruments
</FONT>
	, requires that the Company discloses estimated fair values of financial instruments. The carrying amounts reported in the balance sheets for current assets and current liabilities qualifying as financial instruments are a reasonable estimate of fair value.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company applies the provisions of ASC 820-10,
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Fair Value Measurements and Disclosures.
</FONT>
	ASC 820-10 defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. For certain financial instruments, including cash and cash equivalents, loan receivable, and short-term bank loans, the carrying amounts approximate fair value due to their relatively short maturities. The three levels of valuation hierarchy are defined as follows:
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV>
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: SYMBOL, SERIF; DISPLAY: INLINE">
	&#183;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="77%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: SYMBOL, SERIF; DISPLAY: INLINE">
	&#183;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="77%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: SYMBOL, SERIF; DISPLAY: INLINE">
	&#183;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="77%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company analyzes all financial instruments with features of both liabilities and equity under ASC 480,
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Distinguishing Liabilities From Equity,
</FONT>
	and ASC 815,
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Derivatives and Hedging.
</FONT>
	Derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjustments to fair value of derivatives. The effects of interactions between embedded derivatives are calculated and accounted for in arriving at the overall fair value of the financial instruments. In addition, the fair values of freestanding derivative instruments such as warrant are valued using the Binominal Model.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company uses Level 3 inputs for its valuation methodology for the fair value of warrant.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The binomial lattice relies on the following Level 3 inputs: (1) expected volatility of the Company&#8217;s common stock; and (2) risk free rate which is based on daily treasury yield curve rates as published by U.S. Department of the Treasury. The expected volatility of the Company&#8217;s common stock is estimated from the historical volatility of daily returns in the Company&#8217;s common stock price.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-11
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage55"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following tables present the estimated fair value of the following financial assets and liabilities of the Company:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_20"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	At December 31, 2015:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="40%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Carrying amount
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Level 1
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Level 2
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Level 3
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="BOTTOM" WIDTH="13%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Estimated
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	fair value
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="19%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Financial assets
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="3" VALIGN="BOTTOM" WIDTH="13%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="19%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="3" VALIGN="BOTTOM" WIDTH="13%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="19%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Carried at (amortized) cost:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="3" VALIGN="BOTTOM" WIDTH="13%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="19%" STYLE="TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Cash and cash equivalents
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	38,898
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	38,898
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX; TEXT-ALIGN: LEFT; PADDING-LEFT: 0PT; MARGIN-LEFT: 9PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Loan receivable
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	38,898
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	38,898
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="40%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Carrying amount
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Level 1
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Level 2
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Level 3
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Estimated
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	fair value
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="19%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Financial liabilities
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="19%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="19%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Carried at (amortized) cost:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="19%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Short-term bank loans
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,773,199
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,773,199
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="19%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="19%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Carried at fair value:
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Warrants liability
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	59,202
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	59,202
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,832,401
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,832,401
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	At December 31, 2014:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="40%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Carrying amount
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Level 1
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Level 2
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Level 3
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Estimated
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	fair value
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="19%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Financial assets
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="19%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="19%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Carried at (amortized) cost:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="19%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Cash and cash equivalents
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,685,154
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,685,154
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Loan receivable
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,772,464
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,772,464
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,685,154
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,772,464
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	11,457,618
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="10" VALIGN="BOTTOM" WIDTH="40%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Carrying amount
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Level 1
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Level 2
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Level 3
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Estimated
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	fair value
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="19%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Financial liabilities
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="19%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="19%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Carried at (amortized) cost:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="19%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Short-term bank loans
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,094,614
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,094,614
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="19%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="19%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Carried at fair value:
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Warrants liability
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	383,295
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	383,295
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="19%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,477,909
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,477,909
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-12
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage56"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The table below provides a reconciliation of the beginning and ending balances for the liabilities measured at fair value using significant unobservable inputs (Level 3).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Fair value measurements using significant unobservable inputs (Level 3):
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_21"></A>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="61%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Liabilities:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" COLSPAN="3" VALIGN="BOTTOM" WIDTH="13%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="61%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Warrants
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	liability as of January 1, 2015
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	383,295
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="61%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Change in fair value of warrants
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(324,093
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="61%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 18PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Warrants liability as of December 31, 2015
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	59,202
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Value-added Tax Payable
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company is subject to a value-added tax rate of 17% on product sales in the PRC.&#160;&#160;Value-added tax payable is computed net of value-added tax paid on purchases for sales in the PRC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Revenue Recognition
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company&#8217;s revenue recognition policies are in compliance with ASC 605,
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Revenue Recognition
</FONT>
	. Sales revenue is recognized at the date of shipment to customers when a formal arrangement exists, the price is fixed or determinable, the delivery is completed, no other significant obligations of the Company exist and collectability is reasonably assured. Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as unearned revenue.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company does not allow its customers to return products.&#160;&#160;The Company&#8217;s customers can exchange products only if they are damaged in transportation.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Revenue reported is net of value-added tax and sales discounts.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Stock-Based Compensation
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company has elected to use the Black-Scholes-Merton (&#8220;BSM&#8221;) pricing model to determine the fair value of stock options on the dates of grant. Also, the Company recognizes stock-based compensation using the straight-line method over the requisite service period.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company values stock awards using the market price on or around the date the shares were awarded and includes the amount of compensation as a period compensation expense over the requisite service period.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For the years ended December 31, 2015 and 2014, the Company recognized stock-based compensation of approximately $0 and $2.0 million, respectively.
</FONT>
</FONT>
</DIV>
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Share Warrants
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In accordance with ASC815, share warrants with term of down-round provision are initially recognized at fair value at grant date as a derivative liability. At each reporting period date, the fair value of the share warrants will be re-measured and the fair value change will be reported as gain/loss in the Consolidated Statements of Operations and Comprehensive Income.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Advertising
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Advertising expense consists primarily of costs of promoting the Company&#8217;s corporate image and product marketing and costs of direct advertising. The Company expenses all advertising costs as incurred. For the years ended December&#160;31, 2015 and 2014, the Company incurred advertising expense of approximately $3.8 million and $8.6 million, respectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Research and Development
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The remuneration of the Company&#8217;s research and development staff, materials used in internal research and development activities, and payments made to third parties in connection with collaborative research and development arrangements, are all expensed as incurred.&#160;&#160;Where the Company makes a payment to a third party to acquire the right to use a product formula which has received regulatory approval, that payment is accounted for as the acquisition of a license or patent and is capitalized as an intangible asset and amortized over the shorter of the remaining license period or patent life (See above &#8220;Intangible Assets&#8221;).
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-13
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage57"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Income Taxes
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	We use the asset and liability method of accounting for income taxes. Under this method, income tax expense is recognized for the amount of taxes payable or refundable for the current year. In addition, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating losses and tax credit carry-forwards. Management must make assumptions, judgments and estimates to determine the current provision for income taxes and the deferred tax assets and liabilities and any valuation allowance to be recorded against a deferred tax asset. Management&#8217;s judgments, assumptions and estimates relative to the current provision for income tax take into account current tax laws, management&#8217;s interpretation of current tax laws and possible outcomes of current and future audits conducted by foreign and domestic tax authorities. Changes in tax law or management&#8217;s interpretation of tax laws and the resolution of current and future tax audits could significantly impact the amounts provided for income taxes in the financial statements. Management&#8217;s assumptions, judgments and estimates relative to the value of a deferred tax asset take into account predictions of the amount and category of future taxable income, such as income from operations. Actual operating results and the underlying amount and category of income in future years could render management&#8217;s current assumptions, judgments and estimates of recoverable net deferred taxes inaccurate. Any of the assumptions, judgments and estimates mentioned above could cause our actual income tax obligations to differ from the estimates, thus materially impact the financial position and results of operations.
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Earnings per Share
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Basic earnings per share is computed on the basis of the weighted average number of common stock outstanding during the period.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Diluted earnings per share is computed on the basis of the weighted average number of common stock and common stock equivalents outstanding. Dilutive securities having an anti-dilutive effect on diluted earnings per share are excluded from the calculation.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Dilution is computed by applying the treasury stock method for options and warrants. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. All of the Company&#8217;s outstanding stock options (Note 6(c)) and warrants (Note 6(b)) were not included in the diluted net earnings per share calculation because they were out of the money and considered antidilutive. See &#8220;Note 8 (Loss) Earnings Per Share&#8221;.
</FONT>
</FONT>
</DIV>
</DIV>
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Comprehensive income
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. For the Company, comprehensive income for the periods presented includes net income and foreign currency translation adjustments.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Statement of Cash Flows
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In accordance with ASC 230,
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Statement of Cash Flows,
</FONT>
	cash flows from the Company&#8217;s operations is based upon the local currencies. As a result, amounts related to assets and liabilities reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheet.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Concentration of Credit Risk
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Financial instruments that potentially subject the Company to concentrations of credit risk are cash, accounts receivable and other receivables arising from its normal business activities. The Company places its cash in what it believes to be credit-worthy financial institutions. The Company has a diversified customer base, most of which are in the PRC. The Company controls credit risk related to accounts receivable through credit approvals, credit limits and monitoring procedures. The Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk, establishes an allowance, if required, for uncollectible accounts and, as a consequence, believes that its accounts receivable credit risk exposure beyond such allowance is limited.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Segment Reporting
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	ASC 280,
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Segment Reporting,
</FONT>
	requires use of the management approach model for segment reporting. The management approach model is based on the way a company's management organizes segments within the company for making operating decisions and assessing performance. Reportable segments are based on products and services, geography, legal structure, management structure, or any other manner in which management disaggregates a company.
</FONT>
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
	&#160;
</DIV>
<DIV>
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-14
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage58"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Business Combinations
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Business combinations are accounted for under the acquisition method of accounting in accordance with ASC 805,
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Business Combinations.
</FONT>
	Under the acquisition method the acquiring entity in a business combination recognizes 100 percent of the acquired assets and assumed liabilities, regardless of the percentage owned, at their estimated fair values as of the date of acquisition. Any excess of the purchase price over the fair value of net assets and other identifiable intangible assets acquired is recorded as goodwill. To the extent the fair value of net assets acquired, including other identifiable assets, exceed the purchase price, a bargain purchase gain is recognized. Assets acquired and liabilities assumed from contingencies must also be recognized at fair value, if the fair value can be determined during the measurement period. Results of operations of an acquired business are included in the statement of earnings from the date of acquisition. Acquisition-related costs, including conversion and restructuring charges, are expensed as incurred.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Recent accounting pronouncements
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In May&#160;2014, the FASB issued Accounting Standards Update ASU No. 2014-09, &#8220;Revenue from Contracts with Customers&#8221;, a converged standard on revenue recognition.&#160;The new pronouncement requires revenue
<FONT STYLE="DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	&#160;
</FONT>
	recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&#160;The guidance also specifies the accounting for some costs to obtain or fulfil a contract with a customer, as well as enhanced disclosure requirements.&#160; ASU 2014-9 is effective for annual reporting periods beginning after December&#160;15, 2016.&#160;Early adoption is not permitted.&#160; As an update to ASU 2014-09, in August 2015, the FASB issued Accounting Standards Update ASU No. 2015-14 "
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Revenue from Contracts with Customers (Topic 606)
</FONT>
	:&#160;
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Deferral of the Effective Date" ("ASU 2015-14").
</FONT>
	The amendments in this Update defer the effective date of Update 2014-09 for all entities by one year. Public business entities, certain not-for-profit entities, and certain employee benefit plans should apply the guidance in Update 2014-09 to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. ASU 2015-14 is effective for public business entities for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. The Company will adopt the accounting standard in accordance to the prescribed timeline.&#160;&#160;The Company is assessing the impact to its accounting practices and financial reporting procedures as a result of this the issuance of this standard.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In August 2014, the FASB issued Accounting Standards Update ASU No. 2014-15, &#8220;Presentation of Financial Statements Going Concern (Subtopic 205-40) &#8211; Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern&#8221;. Currently, there is no guidance in U.S. GAAP about management&#8217;s responsibility to evaluate whether there is substantial doubt about an entity&#8217;s ability to continue as a going concern or to provide related footnote disclosures. The amendments in this Update provide that guidance. In doing so, the amendments are intended to reduce diversity in the timing and content of footnote disclosures. The amendments require management to assess an entity&#8217;s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management&#8217;s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management&#8217;s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). ASU 2014-15 is effective for annual reporting periods beginning after December 15, 2016. Early adoption is permitted. The Company will adopt the standard in annual reporting periods beginning after December 15, 2016.&#160;&#160;This standard is expected to increase the amount of disclosure for the Company in future periods.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In February 2015, the FASB issued Accounting Standards Update ASU No. 2015-02, &#8220;Consolidation&#8221; (Topic 810). ASU 2015-02 changes the guidance with respect to the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. All legal entities are subject to reevaluation under the revised consolidation mode. ASU 2015-02 affects the following areas: (1) Limited partnerships and similar legal entities. (2) Evaluating fees paid to a decision maker or a service provider as a variable interest. (3) The effect of fee arrangements on the primary beneficiary determination. (4) The effect of related parties on the primary beneficiary determination. (5) Certain investment funds. ASU 2015-02 is effective for public business entities for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. If an entity early adopts the guidance in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. A reporting entity may apply the amendments in this guidance using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. A reporting entity also may apply the amendments retrospectively. The Company will adopt has adopted this standard in 2016 and is expected to be included in the Company&#8217;s consideration when carrying out its consolidation process for financial reporting purposes.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-15
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage59"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In April 2015, the FASB issued Accounting Standards Update ASU No.&#160;2015-03, &#8220;Simplifying the Presentation of Debt Issuance Costs&#8221;. The accounting guidance requires that debt issuance costs related to a recognized debt liability be reported on the Consolidated Statements of Financial Condition as a direct deduction from the carrying amount of that debt liability. ASU 2015-03 is effective for the Company retrospectively beginning in the first quarter of fiscal 2017 and early adoption is permitted. The Company will adopt the standard and beginning applying where applicable in the first quarter of 2017.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In July 2015, the FASB issued Accounting Standards Update ASU No. 2015-11, &#8220;Inventory (Topic 330): Simplifying the Measurement of Inventory,&#8221; which applies to inventory that is measured using first-in, first-out (&#8220;FIFO&#8221;) or average cost. Under the updated guidance, an entity should measure inventory that is within scope at the lower of cost and net realizable value, which is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Subsequent measurement is unchanged for inventory that is measured using last-in, first-out (&#8220;LIFO&#8221;). ASU 2015-11 is effective for annual and interim periods beginning after December 15, 2016, and should be applied prospectively with early adoption permitted at the beginning of an interim or annual reporting period. The Company will adopt the standard in the interim and annual period after De3cember 31, 2016.&#160;&#160;The principle if expected have impact on the Company&#8217;s financial reporting process, but it currently uncertain if the consolidated financial statements will be effected.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In September 2015, the FASB issued Accounting Standards Update ASU No. 2015-16, the guidance eliminates the requirement to restate prior period financial statements for measurement period adjustments following a business combination. The new guidance requires that the cumulative impact of a measurement period adjustment (including the impact on prior periods) be recognized in the reporting period in which the adjustment is identified. The prior period impact of the adjustment should be either presented separately on the face of the income statement or disclosed in the notes.&#160;ASU 2015-16 is effective for annual and interim periods beginning after December 15, 2015, and should be applied prospectively to adjustments to provisional amounts that occur after the effective date with earlier application permitted for financial statements that have not been issued. The Company is currently reviewing the provisions of this ASU 2015-16 to determine if there will be any impact on the Company&#8217;s consolidated financial statements.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In November 2015, the FASB issued Accounting Standards Updates ASU No. 2015-17, &#8220;Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes&#8221; (&#8220;ASU 2015-17&#8221;). The FASB issued ASU 2015-17 as part of its ongoing Simplification Initiative, with the objective of reducing complexity in accounting standards. The amendments in ASU 2015-17 require entities that present a classified balance sheet to classify all deferred tax liabilities and assets as a noncurrent amount. This guidance does not change the offsetting requirements for deferred tax liabilities and assets, which results in the presentation of one amount on the balance sheet. Additionally, the amendments in this ASU align the deferred income tax presentation with the requirements in International Accounting Standards (IAS) 1, Presentation of Financial Statements.&#160; The amendments in ASU 2015-17 are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company is currently reviewing the provisions of this ASU 2015-17 to determine if there will be any impact on the Company&#8217;s consolidated financial statements.
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In February 2016, the FASB issued ASU No. 2016-02,&#160;&#8220;Leases (Topic 842)&#8221; (&#8220;ASU 2016-02&#8221;). ASU 2016-02 requires an entity to recognize assets and liabilities arising from a lease for both financing and operating leases. ASU 2016-02 will also require new qualitative and quantitative disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases.&#160;ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is currently reviewing the provisions of this ASU 2016-02 to determine if there will be any impact on the Company&#8217;s consolidated financial statements.
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As of December 31, 2015, except for the above, there are no recently issued accounting standards not yet adopted that would have a material effect on the Company&#8217;s financial statements.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-16
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage60"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_22"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Note 3&#160;-
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	DEPOSITS AND OTHER RECEIVABLES
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Deposits and other receivables consisted of the following:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Current portion
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	a) Deposits paid for research and development of new medicine
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,071,860
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	b) Prepaid sale commission
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	348,745
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	c) Other receivables and prepaid expenses
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,591
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	51,387
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;Prepaid expenses and other receivables
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,591
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,471,992
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Non-current portion
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	d) Deposit paid for intended acquisition a health product material supplier
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	12,402,360
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,886,232
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	e) Deposit paid for intended acquisition a health product manufacturer
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,697,598
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,908,986
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;&#160;&#160;&#160;Deposits
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	16,099,958
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8,795,218
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; DISPLAY: INLINE">
	a.&#160;&#160;
</FONT>
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; DISPLAY: INLINE">
	Deposits paid for research and development represents progress payment for the development of a new drug, less amounts recognized as research and development expense.&#160;&#160;In December 2010, the Company entered into an agreement with a research institution to jointly develop a new drug for treatment of cardiovascular disease.&#160;In year 2014, the Company paid approximately $4 million as further prepaid research fee for the testing process of the new drug which to be performed in year 2015 by the research institution. The amount of approximately $4.0 million&#160;bought forward from year 2014 had been fully recognized as research and development expense during the year ended December 31, 2015 when the relevant service is provided by the research institution.
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; DISPLAY: INLINE">
	b.&#160;&#160;
</FONT>
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; DISPLAY: INLINE">
	The amount represents prepayment of sale commission expense to a distributor which will be used for the deduction of future sale commission payment. The amount was fully utilized during the year ended December 31, 2015.
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; DISPLAY: INLINE">
	c.
</FONT>
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; DISPLAY: INLINE">
	In December 2014, the Company signed a letter of intent to acquire 100% interest in a company in the PRC, which is principally engaged in supply of raw materials to produce health product, for an aggregate consideration of approximately $12.6 million (RMB 82 million) in cash. The completion of the acquisition is subject to the completion of a valuation report and certain conditions set out in the letter of intent being met. The deposit is fully refundable if certain conditions set out in the letter of intent are not met. The remaining balance of $0.2 million (RMB 1.5 million) was expected to be settled by the second quarter of 2016.
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; DISPLAY: INLINE">
	d.&#160;&#160;
</FONT>
</FONT>
</DIV>
</TD>
<TD>
<DIV ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; DISPLAY: INLINE">
	In November 2013, the Company signed a letter of intent to acquire 100% interest in a health product manufacturer for an aggregate consideration of approximately $8.6 million (RMB 56 million), consisting of approximately $4.6 million (RMB 30 million) in cash and shares of the Company&#8217;s common stock valued at approximately $4.0 million (RMB 26 million), the acquisition is in final stage and the Company is reviewing the draft of shares transfer agreement. It is expected to be completed in the second quarter of 2016.
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Note 4&#160;-
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	LOAN RECEIVABLES
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In November 2012, the Company advanced approximately $9.2 million (RMB 60 million) to a third party as a commercial loan, interest bearing at 13% per annum. The principal and interest were originally to be repaid on December 31, 2013. In 2013, the term of loan was extended to June 30, 2014. In 2014, the term of loan was further extended to December 31, 2015.
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	During the year ended December 31, 2015, the Company received approximately $0.8 million (RMB 5 million) for loan principal and no interest has been received. Therefore, no interest income has been recognized for the year 2015 and the Company recognized full impairment loss on loan receivables as the Company has determined the borrower is insolvent.
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-17
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage61"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV>
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_23"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Note 5&#160;-
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	SHORT-TERM BANK LOANS
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Short-term bank loans consisted of the followings:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="59%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="26%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Balance as at December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Inception date
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="59%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Details
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="59%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	May 26, 2014
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="59%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	RMB 20 million, one year term loan, annual interest rate at 7.80%. During the year ended December 31, 2015, the Company repaid RMB 1 million and paid interest of RMB 0.8 million; as of December 31, 2015, the Company had cumulatively repaid RMB 2 million and recorded accrued interest expenses of RMB 0.9 million.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,773,199
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,094,614
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The loan is secured by (i) personal guarantee executed by a major shareholder of the Company; (ii) pledge of the Company&#8217;s buildings and land use right with carrying amount of approximately $3.7 million as of December 31, 2015 (Note 2); and the guarantee executed by Shaanxi BioStar.
<FONT STYLE="DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	As of December 31, 2015, the short-term bank loan is due on demand due to violation of loan covenants, and the Company is in negotiations with the bank to extend the loans.
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Note 6&#160;-
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	STOCKHOLDERS&#8217; EQUITY
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	(a) Common stock
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As of December 31, 2015 and 2014, the Company has 100,000,000 shares of common stock authorized, 2,210,913 shares issued and outstanding at par value of $0.001 per share respectively.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	On February 4, 2016, the Company effectuated a one-for-seven reverse split of its common stock; the Company&#8217;s stockholder&#8217;s equity, information on number of shares and (loss) earnings per share has been retroactively restated to the first period presented.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_24"></A>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For the year ended December 31, 2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Shares issued
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="BOTTOM" WIDTH="13%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Value
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -9PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	i. issued to selected investors through placement agent, at $17.43 per share less financing cost
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	235,714
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,862,533
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -9PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	ii. issued to employees based on 2013 Incentive Stock Plan, valued at $10.08 per share
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	164,285
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,656,000
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -9PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Total common stock issued during the year ended December 31, 2014
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	399,999
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5,518,533
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The amount of $3,862,533 relating to item (i) above is allocated to the following equity and liability:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_25"></A>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="61%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Common stock
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	235
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="61%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Warrants liability - Note 6(b)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	960,894
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="61%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Additional paid-in-capital
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,901,404
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="61%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -9PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,862,533
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The shares as issued in item (ii) above were fully vested and exercisable as of December 31, 2015 and 2014. The Company recognized $0 and $1,656,000 as stock-based compensation expense for the years ended December 31, 2015 and 2014, with respect of these shares issuance, which was included in general and administrative expenses.
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	(b) Warrants
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In connection with a public offering (Note 6(a)i), the Company issued&#160;
<FONT STYLE="DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	warrants to purchase an aggregate of 660,000 shares of common stock with a per share exercise price of $22.61. Additionally, the Company issued warrants to the placement agents to purchase 14,143 shares of common stock in the aggregate on the same terms as the warrants sold in the offering. The warrants are exercisable immediately as of the date of issuance and expiring three years from the date of issuance
</FONT>
	.
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-18
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage62"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In accordance with the Company&#8217;s stated accounting policy in Note 2, the warrants are initially recognized as a derivative liability at fair value at grant date. Accordingly, an amount $960,894, representing the full fair value of the warrants was recognized in year 2014. As of December 31, 2015, the carrying amount of the warrants was $59, 202, being its fair value. For the years ended December 31, 2015 and 2014, a fair value adjustment of $324,093 and $577,599 reduced the carrying value of warrants was made and recorded as a gain in the Consolidated Statements of Operations and Comprehensive Income.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As of December 31, 2015 and 2014, the Company has 108,428 warrants outstanding, with weighted average exercise price of $22.61.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following table summarizes the Company&#8217;s outstanding warrants as of December 31, 2015 and 2014.
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<EFX_UNIDENTIFIED_TABLE>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="33%" STYLE="PADDING-BOTTOM: 2PX">
<A NAME="FIS_UNIDENTIFIED_TABLE_26"></A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="26%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Outstanding as at December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="33%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Expiry date
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Exercise Price
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="33%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	June 30, 2014
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	57.54
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="33%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	March 12, 2017 *
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	22.61
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	108,428
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	108,428
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="33%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	108,428
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	108,428
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	* The Company&#8217;s recurring fair value measurements at December 31, 2015 were as follows:&#160;
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_27"></A>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Fair&#160;Value&#160;as&#160;of
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31, 2015
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="BOTTOM" WIDTH="13%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Significant
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Unobservable
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Inputs
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	(Level 3)
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Liabilities:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Warrants expiring March 2017
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	59,202
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	59,202
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company determined the fair value of the warrant liability using the Binomial Model. The model considered amounts and timing of future possible equity and warrant issuances and historical volatility of the Company&#8217;s stock price.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	(c) Stock Options
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following tables summarize activities for the Company&#8217;s options for the years ended December 31, 2015 and 2014.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_28"></A>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="33%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	For the Year Ended December 31, 2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="6" VALIGN="BOTTOM" WIDTH="26%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="33%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="26%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Weighted Average
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="33%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Number of options
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Exercise Price ($)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Remaining Life (years)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="33%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Outstanding at beginning of period
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,143
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	34.79
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1.54
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="33%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Granted, exercised or forfeited
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="33%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Expired
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2,381
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="33%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Outstanding at end of period
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6,762
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	26.39
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0.54
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="33%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	For the Year Ended December 31, 2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="6" VALIGN="BOTTOM" WIDTH="26%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="33%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="26%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Weighted Average
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="33%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Number of options
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Exercise Price ($)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Remaining Life (years)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="33%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Outstanding at beginning of period
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	55,174
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	54.67
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1.08
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="33%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Granted, exercised or forfeited
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="33%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Expired
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(46,031
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	58.59
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="33%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Outstanding at end of period
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,143
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	34.79
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1.54
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-19
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage63"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For the year ended December 31, 2015, 2,381 share options were lapsed due to expiry of unexercised share options.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The options were fully vested and exercisable as of December 31, 2015 and 2014. As of December 31, 2015, there was no unrecognized compensation cost related to outstanding stock options, and the intrinsic value was close to zero because the exercise price was out-of-the-money.
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_29"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Note 7 -
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	INCOME TAXES
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company was incorporated in the United States of America (&#8220;USA&#8221;) and has operations in one tax jurisdiction, i.e. the PRC. The Company generated substantially all of its net income from its operations in the PRC for the years ended December 31, 2015 and 2014, and has recorded income tax provision for the periods.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The provision for income taxes (income tax benefit) consists of the following:
</FONT>
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="26%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 5.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Year Ended December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0.8PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Current:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	USA
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	PRC
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	971,074
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	971,074
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Deferred:
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;USA
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;&#160;&#160;PRC
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,319,846
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(4,284,655
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Provision for income taxes (Income tax benefit)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,319,846
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(3,313,581
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The reconciliation of USA statutory income tax rate to the Company&#8217;s effective income tax rate is as follows:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_30"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="26%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 5.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Year Ended December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Income tax at USA statutory rate (34%)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(8,089,523
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	521,774
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Foreign rate differential
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,154,408
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(324,564
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Tax effect of permanent differences due to:
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Non deductible expenses
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	171,932
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	406,788
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Under provision in prior year
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	464,943
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Others
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	297,348
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(6,108
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)&#160;
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Change in valuation allowance
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6,785,681
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	656,423
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Utilization of previously unrecognized tax losses
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(672,068
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Recognition of previously unrecognized deferred tax
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(4,360,769
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(Income tax benefit) Provision for income taxes
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,319,846
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(3,313,581
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For the years ended December 31, 2015 and 2014, the change in valuation allowance is mainly arise from the tax benefit on net operating loss carry forward for PRC and USA operation and the temporary differences on the carrying amount of accounts receivable, loans receivable, and intangible assets.
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-20
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage64"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The deferred tax assets for the USA operation as of December 31, 2015 and 2014 consists mainly of net operating loss carry-forwards and for which a full valuation allowance has been provided, as the management believes it is more likely than not that these assets will not be realized in the future. Components of deferred tax assets in the USA were as follows:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_31"></A>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	USA Tax benefit on net operating loss carry forward
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,873,434
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,970,167
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Valuation allowance
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2,873,434
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2,970,167
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;Deferred tax asset - USA
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As of December 31, 2015 and 2014, the Company had federal and state net operating loss carry-forwards of $8.6 million and $8.7 million available to offset future taxable income in the USA respectively. The net operating loss carry-forwards will expire, if unused, in varying amounts through the year ending December&#160;31, 2035.
</FONT>
</FONT>
</DIV>
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company&#8217;s subsidiaries and VIE were incorporated in the PRC and are governed by the Income Tax Law of the PRC and various local income tax laws. Effective January 1, 2008, China adopted a uniform tax rate of 25% for all enterprises (including foreign-invested enterprises).&#160;&#160;Components of deferred tax assets in the PRC were as follows:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_32"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	PRC Tax benefit on net operating loss carry forward
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,497,612
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$&#160;
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,992,715
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Tax effect of temporary differences due to
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Depreciation, amortization and impairment&#160;of assets
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5,426,964
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,169,318
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Provision of bad debts
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1,737,314
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	655,168
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Provision of commission expense
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	455,930
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	655,351
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Others
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	396,126
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	592,971
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Valuation allowance
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(7,107,353
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Deferred tax asset - PRC
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5,406,593
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7,065,523
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As of December 31, 2015, the Company had net operating loss carry-forward of approximately $17.5 million (RMB 113.5 million) available to offset future taxable income in the PRC.&#160;The net operating loss carry-forward of $10.9 million, $0.5 million, $6.1 million will expire, if unused, in the years ending December 31, 2017, 2018, 2020, respectively.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	A valuation allowance against deferred tax assets of $5.4 million as of December 31, 2015 is not considered necessary because it is more likely than not the deferred tax asset will be fully realized.&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	Uncertain Tax Positions
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Interest associated with unrecognized tax benefits are classified as income tax, and penalties are classified in selling, general and administrative expenses in the statements of operations.&#160;For the years ended December 31, 2015 and 2014, the Company had no unrecognized tax benefits and related interest and penalties expenses.&#160;&#160;Currently, the Company is not subject to examination by major tax jurisdictions.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-21
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage65"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_33"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Note 8 &#8211;&#160;
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	(LOSS)
</FONT>
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	EARNINGS PER SHARE
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following table sets forth the computation of basic and diluted earnings per share of common stock:
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="26%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Years Ended
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Basic (loss) earnings per share:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 18PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Numerator:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -9PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Net (loss) income used in computing basic earnings per share
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(25,112,562
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,848,212
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 18PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Denominator:
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 27PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Weighted average common shares outstanding
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,210,913
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,071,343
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Basic (loss) earnings per share
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(11.4
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2.3
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Diluted (loss) earnings per share:
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 18PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Numerator:
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 18PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -18PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Net (loss) income used in computing diluted earnings per share
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(25,112,562
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4,848,212
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 18PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Denominator:
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 27PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Weighted average common shares outstanding
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,210,913
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,071,343
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Diluted (loss) earnings per share
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(11.4
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2.3
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Dilutive securities having an anti-dilutive effect on diluted (loss) earnings per share are excluded from the calculation.
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	In accordance to ASC-260-10-50-I(c), for the years end December 31, 2015 and 2014, the Company, using the treasury stock method, determined that both the outstanding options and warrants would have been anti-dilutive if included in the denominator of the Company's dilutive loss and earnings per share calculation because they were both out of the money. Holders of either securities would not have exercised the rights under these securities; accordingly, the options and warrants have been excluded from the loss and earnings per share calculation. Details of the attributes, such a strike price and time to maturity of the options and warrants are detailed in "Note 6 Stockholder&#8217;s Equity".
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Note 9 -
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	STATUTORY RESERVES
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company&#8217;s subsidiaries and VIE in the PRC are required to make appropriations to certain non-distributable reserve funds. In accordance with the laws and regulations applicable to China&#8217;s foreign investment enterprises and with China&#8217;s Company Laws, an enterprise&#8217;s income, after the payment of the PRC income taxes, must be allocated to the statutory surplus reserves. The proportion of allocation for reserves is 10 percent of the profit after tax to the surplus reserve fund, and the cumulative amount shall not to exceed 50 percent of registered capital.
</FONT>
</FONT>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-22
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage66"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Use of the statutory reserve fund is restricted to set off against losses, expansion of production and operation or increase in the registered capital of a company. This reserve fund is not transferable to the Company in the form of cash dividends, loans or advances, and therefore not available for distribution except in liquidation. As of December 31, 2015 and 2014, the Company&#8217;s VIE had allocated approximately $7.4 million to these non-distributable reserve funds.
</FONT>
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_34"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Note&#160;10 -
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	OTHER COMPREHENSIVE INCOME
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Balance of related after-tax components comprising accumulated other comprehensive income included in stockholders&#8217; equity as&#160;of December 31, 2015 and 2014 were as follows:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Year Ended December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 1.8PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Accumulated other comprehensive income, beginning of period
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6,391,998
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6,600,454
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Change in cumulative translation adjustment
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2,957,650
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(208,456
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	)
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="72%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Accumulated other comprehensive income, end of period
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,434,348
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6,391,998
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_35"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Note 11 -
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	COMMITMENTS
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following table illustrates the Company&#8217;s capital payment&#160;commitments as at December 31, 2015 and 2014:&#160;&#160;
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	(in million)
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Total capital&#160;payment commitment
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31, 2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31, 2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="58%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -9PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	a) Three agreements with certain research institutes to conduct clinical trials for two new and one existing drugs.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2.1
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0.8
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0.8
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="58%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -9PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	b) In December 2014, the Company signed a letter of intent to acquire 100% interest in a company in the PRC, which is principally engaged in supply of raw materials to produce health product, for an aggregate consideration of approximately $12.6 million (RMB 82 million) in cash.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	12.6
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0.2
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8.5
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="58%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 9PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: -9PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	c) In November 2013, the Company signed a letter of intent to acquire 100% interest in a health product manufacturer for an aggregate consideration of approximately $8.6 million (RMB 56 million), consisting of approximately $4.6 million (RMB 30 million) in cash and shares of the Company&#8217;s common stock valued at approximately $4.0 million (RMB 26 million), subject to the completion of a due diligence report and certain conditions set out in the letter of intent being met.
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8.6
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4.9
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5.3
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="58%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Total capital payment commitment
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5.9
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	14.6
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Note 12 -
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	SEGMENT INFORMATION
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	For the years ended December 31, 2015 and 2014, all revenues of the Company represented the net sales of pharmaceutical products. No financial information by business segment is presented. Furthermore, as all revenues are derived from the PRC, no geographic information by geographical segment is presented. All tangible and intangible assets are located in the PRC.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-23
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage67"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_36"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Note 13&#160;-
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	RISKS CONCENTRATION
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following tables illustrate the Company&#8217;s risks concentration:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" COLSPAN="17" VALIGN="BOTTOM" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Sales and accounts receivable risks concentration
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="14%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX; TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="28%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="14%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX; TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Percentage of total sales during the
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="28%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Percentage of total accounts receivable as at
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="14%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Customer
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX; TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="28%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	year ended December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31, 2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31, 2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="14%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX; TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="14%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="14%" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	A
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	19
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	19
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	28
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	12
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="14%" STYLE="PADDING-BOTTOM: 2PX; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	B
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX; TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	46
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	30
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	66
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	53
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="14%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Total risks concentration
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX; TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	65
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	49
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	94
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	65
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" COLSPAN="17" VALIGN="BOTTOM" WIDTH="74%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Purchase and accounts payable risks concentration
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="14%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX; TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="28%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="14%" STYLE="PADDING-BOTTOM: 2PX">
<A NAME="FIS_UNIDENTIFIED_TABLE_37"></A>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX; TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="28%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Percentage of total purchase during the
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="28%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Percentage of total accounts payable as at
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="BOTTOM" WIDTH="14%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Vendor
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX; TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="6" VALIGN="BOTTOM" WIDTH="28%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	year ended December 31,
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31, 2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	December 31, 2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="14%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX; TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="14%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="13%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="14%" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	C
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	27
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	22
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="14%" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	D
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	26
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	29
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="14%" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	E
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	8
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="14%" STYLE="PADDING-BOTTOM: 2PX; TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX; TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	7
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	10
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="14%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Total risks concentration
</FONT>
</DIV>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX; TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	68
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	68
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 4PX DOUBLE">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	0
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 4PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_SUBSEQUENT_EVENTS>
<A NAME="FIS_SUBSEQUENT_EVENTS"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Note 14&#160;-
<FONT STYLE="TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
	SUBSEQUENT EVENTS
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Except for one-for-seven reverse stock split effective on February 4, 2016, no other significant event occurred from December 31, 2015 to April 14, 2016, the date these consolidated financial statements are filed with the Securities Exchange Commission that would have a material impact on the Company&#8217;s consolidated financial statements.
</FONT>
</FONT>
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
	&#160;
</DIV>
<DIV>
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	F-24
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage68"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_SUBSEQUENT_EVENTS>
</EFX_NOTES_TO_FINANCIAL_STATEMENT>
</EFX_FINANCIAL_STATEMENTS>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_ACCOUNTING_CHANGES>
<A NAME="FIS_ACCOUNTING_CHANGES"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_9">
	I
</A>
	TEM 9.&#160;&#160;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
</FONT>
</DIV>
</EFX_ACCOUNTING_CHANGES>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_CONTROL_AND_PROCEDURES>
<A NAME="FIS_CONTROL_AND_PROCEDURES"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_9A">
	IT
</A>
	EM 9A.&#160;&#160;CONTROLS AND PROCEDURES
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Evaluation of Disclosure Controls and Procedures
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As of the end of the period covered by this Annual Report, under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer (the &#8220;Certifying Officers&#8221;), the Company conducted an evaluation of its disclosure controls and procedures. As defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act, the term &#8220;disclosure controls and procedures&#8221; means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer&#8217;s management, including the Certifying Officers, to allow timely decisions regarding required disclosure. Based on this evaluation, the Certifying Officers have concluded that the Company&#8217;s disclosure controls and procedures were effective as of December 31, 2015.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Management&#8217;s Report on Internal Control over Financial Reporting
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company&#8217;s management is responsible for establishing and maintaining adequate internal control over financial reporting. The Company&#8217;s internal control system was designed to provide reasonable assurance to our management and Board of Directors regarding the preparation and fair presentation of published financial statements.&#160;The Company&#8217;s management assessed the effectiveness of our internal control over financial reporting as of December 31, 2015. In making this assessment, it used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Internal Control&#8212;Integrated Framework.
</FONT>
	Based on its assessment the Company&#8217;s management believes that, as of December 31, 2015, the Company&#8217;s internal control over financial reporting is effective based on those criteria.&#160;This annual report does not include an attestation report of the Company&#8217;s registered accounting firm regarding internal control over financial reporting. The management&#8217;s report was not subject to attestation by the Company&#8217;s registered public accounting firm pursuant to the rules of the Securities and Exchange Commission.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Changes in Internal Control over Financial Reporting
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	No changes in the Company's internal control over financial reporting have come to management's attention during the fourth quarter of 2015 that have materially affected, or are likely to materially affect, the Company's internal control over financial reporting.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Limitations on Controls
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all error and fraud. Any control system, no matter how well designed and operated, is based upon certain assumptions and can provide only reasonable, not absolute, assurance that its objectives will be met. Further, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected.
</FONT>
</DIV>
</EFX_CONTROL_AND_PROCEDURES>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_OTHER_INFORMATION>
<A NAME="FIS_OTHER_INFORMATION"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_9B">
	I
</A>
	TEM 9B.&#160;&#160;OTHER INFORMATION
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	None.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	44
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage69"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_OTHER_INFORMATION>
</EFX_PART_II>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_PART_III>
<A NAME="FIS_PART_III"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	PART III
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_DIRECTORS_AND_OFFICERS>
<A NAME="FIS_DIRECTORS_AND_OFFICERS"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_10">
	IT
</A>
	EM 10.&#160; DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following table sets forth the names and ages of our directors and executive officers as of March 25, 2015.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_NAME_AND_TITLE>
<A NAME="FIS_NAME_AND_TITLE"></A>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="26%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Name
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="37%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Position
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="9%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Age
</FONT>
</DIV>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX; TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="25%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Date of Appointment
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="26%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Ronghua Wang
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="37%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Chairman, Chief Executive Officer
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	60
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="25%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	November 1, 2007
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="26%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Qinghua Liu
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="37%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Interim Chief Financial Officer and Director
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	48
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="25%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	November 1, 2008
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="26%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Leung King-fai
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="37%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Independent Director (1)(4)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	42
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="25%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	April 7, 2011
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="26%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Haipeng Wu
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="37%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Independent Director (1)(2)(3)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	58
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="25%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	July 1, 2007
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="26%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Zhongyang Shang
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="37%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Independent Director (1)(2)(3)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	64
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="25%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	December 30, 2009
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="26%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shuang Gong
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="37%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Secretary of Board
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	48
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="25%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	April 1, 2008
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="26%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Zhenghong Wang
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="37%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Chief Operating Officer
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="8%" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	35
</FONT>
</TD>
<TD NOWRAP VALIGN="BOTTOM" WIDTH="1%" STYLE="TEXT-ALIGN: LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="25%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	March 26, 2012
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	_____________________
</FONT>
</DIV>
</EFX_NAME_AND_TITLE>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Member of the Audit Committee.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Member of the Compensation Committee.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Member of the Nominating and Governance Committee.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Audit Committee Financial Expert.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Biographical Information of Directors and Executive Officers
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Biographical information with respect to the Company&#8217;s current executive officers and directors is provided below.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Ronghua Wang
</FONT>
	has been our Chairman and Chief Executive Officer since our inception and Chairman of Aoxing Pharmaceutical since September of 2006 and a director since 1997. He has served as Aoxing Pharmaceutical&#8217;s Chief Executive Officer since 1997 and its President since 2007. From 1997, he was Aoxing Pharmaceutical&#8217;s Manager in charge of sales, management and manufacturing. Prior to 2006, Mr. Wang was employed at Geological Research Institute and Drugs Research Institute (both in the PRC), and a General Contractor from 1985 to 1994. He graduated from Northwest University, with a Bachelor&#8217;s degree in Geology.&#160;&#160;His day to day leadership as our Chairman and Chief Executive Officer provides him with intimate knowledge of our operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Qinghua Liu
</FONT>
	has been our director since 2007. Ms. Liu also serves as Chief Financial Officer of Aoxing Pharmaceutical, a position she has held since 2006. She began working at Aoxing Pharmaceutical in 1996 as the Finance Department manager. Prior to that, Ms. Liu served as an accountant at Xing Ping Paper Mill and at a traditional Chinese medicine research academy. Ms. Liu graduated from Northwest Light Industry College in Shaanxi, PRC in 1990 with an Associate&#8217;s Degree in financial management.&#160;&#160;She brings her experience in the areas of accounting and finance to the Board and the Company.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Leung King-fai
</FONT>
	has been our director since April 2011.&#160;&#160;From February 2015 to present, Mr. Leung is an Executive Director of Creative Energy Solutions Holdings Limited, a company that offers energy saving solutions listed on the Hong Kong Stock exchange.&#160;&#160;He is also an Independent Non-executive Director of Daisho Microline Holdings Limited, a company listed on the Hong Kong Stock exchange. From September 2010 to March 2015, Mr. Leung served as an Executive Director of Hao Wen Holdings Limited, a company listed on the Hong Kong Stock exchange. He holds a Bachelor&#8217;s degree in Commerce from Deakin University, Victoria, Australia (1996).&#160;&#160;He is a member of the Hong Kong Institute of Certified Public Accountants and CPA Australia.&#160;&#160;He brings his experience and expertise in the areas of accounting, corporate finance and taxation to the Board and the Company.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Haipeng Wu
</FONT>
	has been our director since July 2007. From 2001, Mr. Wu has worked at Automobile Repairing Department as Manager and Chief Executive Officer. He graduated from Northwest University in Xi&#8217;an, PRC in 1982. He brings his experience and expertise in the areas of management and operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Zhongyang Shang
</FONT>
	has been our director since December 30, 2009, and is also the chairman of the board of directors&#8217; compensation committee. Mr. Shang is currently the director of Shaanxi Province Administration of Industry and Commerce&#8217;s Bureau of Fair Trading, a position he has held since 2006. From 1996 to 2006, Mr. Shang was the director of the Administration of Industry and Commerce for the municipalities of Tongchuan and Xianyang in Shaanxi Province.&#160;&#160;Mr. Shang is a graduate of the Central Party College of Economics and Management.&#160;&#160;He brings his experience in the areas of public finance, administration and marketing to the Board and the Company.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Shuang Gong
</FONT>
	has been corporate secretary of Aoxing Pharmaceutical since 2006. She is also Administration Manager of Aoxing Pharmaceutical. From 1998 to 2000, Ms. Gong served as Assets Operation Manager of West Securities and Assistant Economist at West Securities; she currently serves as Assistant Office Director of Aoxing Pharmaceutical. Ms. Gong graduated from Xi&#8217;an Institute of Technology in Xi&#8217;an, PRC, with a Bachelor&#8217;s degree in Machine and Electricity Integration and earned a second Bachelor&#8217;s degree in Business Management from Provincial Party College in Xi&#8217;an, China in 2001.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	45
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage70"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	Zhenghong Wang&#160;
</FONT>
<FONT STYLE="DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	has been Chief Operating Officer of Aoxing Pharmaceutical since March 2012. From 2001 until now he has served in various capacities at Aoxing Pharmaceutical including accountant, recruiting manager, sales manager, marketing director in charge of Guizhou Province. Mr. Wang graduated from Shaanxi Professional Financial Technology College in 2001.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Family Relationships
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	There are no family relationships between any of the Company&#8217;s executive officers or directors and there are no arrangements or understandings between a director and any other person pursuant to which such person was elected as director. There were no material changes to the procedures by which shareholders may recommend nominees to the Board since the Company&#8217;s last disclosure of such policies.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Involvement in Certain Legal Proceedings
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Company may, from time to time, be involved in various legal matters arising out of its operations in the normal cause of business, none of which are expected, individually or in the aggregate, to have a material effect on the Company.
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT ID="TAB1" STYLE="MARGIN-LEFT: 36PT">
</FONT>
	To the best of the Company&#8217;s present understanding, in May 2015, one of the bank accounts of Shaanxi Aoxing Pharmaceutical Company Limited was frozen as a result of actions by certain lenders (not affiliated with the Company) in their attempt to collect the outstanding balance on the personal loan to Ronghua Wang in the amount of RMB 3 million (USD$0.48 million), which loan was in default. The foregoing debt was personal debt of Ronghua Wang and no assets of Shaanxi Aoxing Pharmaceutical Company Limited were pledged to secure Mr. Wang&#8217;s obligations in connection with such personal loan. As of April 8, 2016, Ronghua Wang had partially repaid the outstanding balance of the loan, thus avoiding the Company&#8217;s land use rights being seized and auctioned with proceeds used to settle this debt. It is the Company&#8217;s present understanding that Mr. Wang is in the process of resolving this matter and settling the outstanding balance on the loan.
</FONT>
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	To the best of the Company&#8217;s present understanding, on September 1, 2015, Shaanxi Aoxing Biostar Biotech Ltd. was informed by the People&#8217;s Court of Shaanxi Province that its properties, valued at $0.54 million (RMB 3.3 million) had been transferred to Mr. Lianhe Wang (not affiliated with the Company) to settle another outstanding personal loan to Ronghua Wang in the amount of approximately RMB 5.7 million (USD$0.9 million). The foregoing debt was personal debt of Ronghua Wang and no assets of Shaanxi Aoxing Biostar Biotech Ltd. were pledged to secure Mr. Wang&#8217;s obligations in connection with such personal loan. According to the Company&#8217;s PRC legal counsel (Shaanxi Wei Yang Law Firm), this settlement was approved by the parties to the loan agreement. It is the Company&#8217;s present understanding that Mr. Wang has undertaken to repay the Company in full for the foregoing property transfer by June 2016.
<FONT STYLE="DISPLAY: INLINE; BACKGROUND-COLOR: #FFFFFF">
	There is no assurance that Ronghua Wang will be able to repay his personal debts in full before his creditors take any other further legal action.
</FONT>
</FONT>
<BR>
</FONT>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Except as described above, there are no other material proceedings that the Management is aware of to which any director, executive officer or affiliate of the Company, any owner of record or beneficial owner of more than five percent of any class of voting securities of the Company, or any associate of any such director, executive officer, affiliate or security holder is a party adverse to the Company or has a material interest adverse to the Company.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	To the best of our knowledge, none of the following events have occurred during the past ten years that are material to an evaluation of the ability or integrity of any director, director nominee or executive officer of the Company:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	any bankruptcy petition filed by or against, or any appointment of a receiver, fiscal agent or similar Officer for, the business or property of such person, or any partnership in which such person was a general partner or any corporation of which such person was an executive officer either, in each case, at the time of the filing for bankruptcy or within two years prior to that time;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining such person from, or otherwise limiting, the following activities:
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(i)&#160;&#160;acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company, or
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(ii)&#160;&#160;engaging in or continuing any conduct or practice in connection with such activity;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(iii)&#160;&#160;engaging in any type of business practice; or engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of federal or state securities laws or federal commodities laws.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any federal or state authority barring, suspending or otherwise limiting for more than 60 days the right of such person to act as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, Director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	being found by a court of competent jurisdiction in a civil action, the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or federal commodities law, and the judgment in such civil action or finding by the SEC or the Commodity Futures Trading Commission has not been subsequently reversed, suspended, or vacated;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	46
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage71"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	being the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial instructions or insurance companies, including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	being the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a) (26) of the Exchange Act), any registered entity (as defined in Section 1(a) (29) of the Commodity Exchange Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or person associated with a member.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Compliance with Section&#160;16(a) of the Exchange Act
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Section 16(a) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), requires officers, directors and persons who own more than ten percent of a registered class of equity securities to, within specified time periods, file certain reports of ownership and changes in ownership with the SEC.&#160;Based solely upon a review of Forms 3 and Forms 4 furnished to the Company pursuant to Rule 16a-3 under this Act during the Company&#8217;s most recent fiscal year, and Forms 5 with respect to the most recent fiscal year, it is the Company&#8217;s understanding that all such forms required to be filed pursuant to Section 16(a) were timely filed as necessary by the executive officers, directors and security holders.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Code of Ethics
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We have adopted a code of ethics that applies to our officers, directors and employees, including our chief executive officer, senior executive officers, principal accounting officer, and other senior financial officers. Our code of ethics is available on our website at
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	http://www.biostarpharmaceuticals.com
</FONT>
	. Information on our corporate website is not a part of this Annual Report. A copy of our code of ethics will also be provided to any person without charge, upon written request sent to us at our offices located at No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People&#8217;s Republic of China 712046.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Audit Committee
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Leung King-fai currently serves as Chairman of the Audit Committee. The Board has determined that he is also qualified an &#8220;Audit Committee financial expert&#8221; as defined by Item 407(d)(5) of Regulation S-K under the Securities Act.&#160;&#160;Other members of the Audit Committee are Haipeng Wu and Zhongyang Shang. The Board has determined that each member of the Audit Committee is &#8220;independent&#8221; as set forth by the Nasdaq Marketplace Rules and under the federal securities laws. The purpose of the Audit Committee is to assist the Board in its general oversight of Biostar&#8217;s financial reporting, internal controls and audit functions.&#160;&#160;The Audit Committee&#8217;s primary responsibilities include, among others:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Review whether or not management has maintained the reliability and integrity of the accounting policies and financial reporting and disclosure practices of the Company;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Review whether or not management has established and maintained processes to ensure that an adequate system of internal controls is functioning within the Company;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Review whether or not management has established and maintained processes to ensure compliance by the Company with legal and regulatory requirements that may impact its financial reporting and disclosure obligations;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Oversee the selection and retention of the Company&#8217;s independent registered public accounting firm, and their qualifications and independence;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Prepare a report of the Audit Committee for inclusion in the proxy statement for the Company&#8217;s annual meeting of shareholders;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Review the scope and cost of the audit, the performance of the independent registered public accounting firm, and their report on the annual financial statements of the Company; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Perform all other duties as the Board may from time to time designate.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Board has adopted a written charter for the Audit Committee. A copy of the Audit Committee charter is posted on our corporate website at
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	http://www.biostarpharmaceuticals.com
</FONT>
	.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	There have been no material changes to the procedures by which security holders may recommend nominees to the Board.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	47
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage72"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Compensation Committee
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We established our Compensation Committee in December 2009. The Committee consists of Haipeng Wu and Zhongyang Shang, each of whom is an independent director. Zhongyang Shang is the chairman of the Committee. The duties of the Committee include, among others, to:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Establish director compensation plan or any executive compensation plan or other employee benefit plan which requires shareholder approval;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Establish significant long-term director or executive compensation and director or executive benefits plans which do not require stockholder approval;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Determine if any other matter, such as severance agreements, change in control agreements, or special or supplemental executive benefits, within the Committee's authority;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Design overall compensation policy and executive salary plan; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" ID="HANGINGINDENT" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD STYLE="WIDTH: 36PT">
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Setting the annual base salary, annual bonus, and annual and long-term equity-based or other incentives of each corporate officer, including the CEO.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Board has adopted a written charter for the Compensation Committee. A copy of the Compensation Committee charter is posted on our corporate website at
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	http://www.biostarpharmaceuticals.com
</FONT>
	.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Nominating Committee
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We established our Nominating Committee in December 2009. The nominating committee consists of Haipeng Wu and Zhongyang Shang, each of whom is an independent director. Haipeng Wu is the chairman of the nominating committee. The nominating committee assists in the selection of director nominees, approves director nominations to be presented for stockholder approval at our annual general meeting and fills any vacancies on our board of directors, considers any nominations of director candidates validly made by stockholders, and reviews and considers developments in corporate governance practices. The board of directors has adopted a written charter for the nominating committee. A copy of the Nominating Committee charter is posted on our corporate website at
<FONT STYLE="FONT-STYLE: ITALIC; DISPLAY: INLINE">
	http://www.biostarpharmaceuticals.com
</FONT>
	.
</FONT>
</DIV>
</EFX_DIRECTORS_AND_OFFICERS>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_COMPENSATION>
<A NAME="FIS_COMPENSATION"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_11">
	IT
</A>
	EM 11.&#160; EXECUTIVE COMPENSATION
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Summary Compensation Table
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	This discussion focuses on the compensation paid to &#8220;named executive officers,&#8221; which is a defined term generally encompassing all persons that served as principal executive officer at any time during the fiscal year as well as certain other highly paid executive officers serving in such positions at the end of the fiscal year. During 2015 and 2014, the named executive officers consisted of Ronghua Wang (Chief Executive Officer (Principal Executive Officer)), Qinghua Liu (Interim Chief Financial Officer (Principal Financial Officer effective from December 18, 2012), and Zhenghong Wang (Chief Operating Officer).&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_38"></A>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="22%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Name/Office
</FONT>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Year
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Salaries ($)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Bonus ($)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Option Awards ($)(4)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Non-Equity
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Incentive Plan
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Compensation
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Earnings ($)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Non-Qualified Deferred Compensation Earnings ($)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	All Other
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Compensation ($)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="8%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Total ($)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="22%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Ronghua Wang
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	17,370
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	17,370
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="22%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Chairman, CEO (1)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	17,573
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	17,573
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="22%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="22%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Qinghua Liu
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	12,931
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	12,931
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="22%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Interim CFO (2)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	11,292
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	11,292
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="22%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="22%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Zhenghong Wang
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="22%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	COO (3)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	48
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage73"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mr. Ronghua Wang was appointed our President and Chief Executive Officer on November 1, 2007. Mr. Wang received the compensation set forth above from Aoxing Pharmaceutical in 2015 and 2014. Mr. Wang&#8217;s cash compensation was paid in RMB which, for reporting purposes, has been converted to U.S. dollars at the conversion rate of RMB 6.2175 to one U.S. dollars for 2015, and RMB 6.1457 to one U.S. dollars for 2014.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ms. Liu was appointed as Interim CFO on December 18, 2012. Prior to this appointment, Ms. Liu served as, and currently still remained as a member of our Board of Directors. Ms. Liu&#8217;s compensation for the years ended December 31, 2015 and 2014 is reflected in director compensation table.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mr. Wang was appointed as the Company&#8217;s COO on March 26, 2012. Mr. Wang&#8217;s compensation for the years ended December 31, 2015 and 2014 is reflected in director compensation table.
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_39"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Outstanding Equity Awards - 2015
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="34%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Name
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Grant Date
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Number of Securities Underlying Unexercised Options Exercisable*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Number of Securities Underlying Unexercised Options Unexercisable
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Option Exercise Price ($)*
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="MIDDLE" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Option Expiration Date
</FONT>
</DIV>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="34%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Zack Zibing Pan (2)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4/7/2011
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="MIDDLE" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,333
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(1)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="MIDDLE" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	41.37
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4/6/2016
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="34%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4/20/2012
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="MIDDLE" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,428
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="MIDDLE" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	11.76
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="MIDDLE" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4/19/2017
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The options vested on April 7, 2012.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The options are to be vested on April 20, 2013.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;The number of shares underlying the options and the exercise price have been adjusted retroactively to reflect the one-for-three reverse stock split.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Employment Agreements
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Except as set forth below, we have no any compensatory plans or arrangements resulting from the resignation, retirement or any other termination of any of our executive officers, from a change-in-control, or from a change in any executive officer&#8217;s responsibilities following a change-in-control.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The employment agreement between Aoxing and Mr. Ronghua Wang covering the 5-year term ending June 30, 2015 has expired; Shuang Gong, who serves as corporate secretary of both Aoxing Pharmaceutical and Biostar, and Amei Zhang, who was chief operating officer for both Aoxing Pharmaceutical and Biostar. The employment agreements of Ms. Gong and Ms. Zhang have the same material terms. Their employment agreements provide for a term of 5 years, year-end bonuses based on profitability of Aoxing Pharmaceutical, a salary increases based on performance, and health and insurance benefits. Aoxing Pharmaceutical may terminate the employment agreements for cause by reason of serious neglect, criminal charges, or violation of the Aoxing Pharmaceutical&#8217;s rules by the employee. The employee may terminate the employment agreement on 30-day notice and may terminate without notice in the event Aoxing Pharmaceutical violates health and safety regulations, fails to provide labor protection or fails to pay the employee.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	49
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage74"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_40"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Director Compensation
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The following table provides compensation information for our directors, except for Chairman Mr. Wang whose compensation was shown in ITEM 11, during the fiscal year ended December 31, 2015:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	No-Equity
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Non-Qualified
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Deferred
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Stock
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Incentive Plan
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Compensation
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	All other
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Fees
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Awards
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Compensation
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Earnings
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Compensation
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Total
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	($)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	($)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	($)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	($)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	($)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	($)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Qinghua Liu
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	12,931
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	12,931
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="16%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Haipeng Wu
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,650
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,650
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="16%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="16%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	King-fai Leung
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,650
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	9,650
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Agreements with Directors
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Under our agreement with Mr. Leung, he was appointed for one year or until the next annual shareholders&#8217; meeting, and will be entitled to receive annual compensation of Renminbi (&#8220;RMB&#8221;) 60,000 for his services rendered as a member of the board of directors and as chairman of the audit committee, payable on a monthly basis and subject to his continuous service on the board of directors. Mr. Leung is additionally granted options under our 2009 Incentive Stock Plan (the &#8220;Plan&#8221;) to purchase up to 6,667 shares of Common Stock, and in connection therewith, Mr. Leung had entered into a nonstatutory stock option agreement with us. Additionally, Mr. Leung will be reimbursed for his expenses incurred in connection with the performance of his duties, including travel expenses. We have also agreed to obtain directors&#8217; and officers&#8217; liability insurance, and to maintain such insurance during Mr. Pan&#8217;s appointment on the board of directors. Mr. Pan&#8217;s appointment terminates immediately if he: (a) resigns for any reason; (b) is removed or not re-elected at the next annual meeting of shareholders; (c); is declared bankrupt; (d) is disqualified from acting as a director; (e) dies; or (f) is ordered to resign by a court of competent jurisdiction.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Under our agreement with Mr. Shang, he was appointed for one year or until the next annual shareholders&#8217; meeting, and will be entitled to receive annual compensation of RMB 20,000 for his services rendered as a member of the board of directors and as chairman of the compensation committee and member of the audit and nominating committees, payable in quarterly installments and subject to his continuous service on the board of directors. Mr. Shang is additionally granted options under the Plan to purchase up to 16,667 shares of Common Stock, and in connection therewith, Mr. Shang will enter into a nonstatutory stock option agreement with us. Additionally, Mr. Shang will be reimbursed for his expenses incurred in connection with the performance of his duties, including travel expenses. We have also agreed to obtain directors&#8217; and officers&#8217; liability insurance, and to maintain such insurance during Mr. Shang&#8217;s appointment on the board of directors. Mr. Shang&#8217;s appointment terminates immediately if he: (a) resigns for any reason; (b) is removed or not re-elected at the next annual meeting of shareholders; (c); is declared bankrupt; (d) is disqualified from acting as a director; (e) dies; or (f) is ordered to resign by a court of competent jurisdiction.
</FONT>
</DIV>
</EFX_COMPENSATION>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;
</FONT>
</DIV>
<EFX_SECURITY_OWNERS>
<A NAME="FIS_SECURITY_OWNERS"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_12">
	I
</A>
	TEM 12.&#160; SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Equity Compensation Plan Information
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	At the annual general shareholder meeting held on October 28, 2011, the Company&#8217;s shareholders approved &#8220;Biostar Pharmaceuticals, Inc. 2011 Stock Option Compensation Plan&#8221; (hereinafter the &#8220;2011 Plan&#8221;). The maximum number of shares that may be issued under the 2011 Plan is 850,000 shares of our common stock. Under this Plan, the Company may issue common stock and/or options to purchase common stock to certain officers, directors and employees and consultants of the Company and its subsidiaries. The 2011 Plan is administered either by the compensation committee or a committee appointed by the Board, which is comprised of a combination of two or more officers and/or members of the Board. The committee has full and complete authority, in its discretion, but subject to the express provisions of the Plan to approve the eligible persons nominated by the management of the Company to be granted awards of common stock (&#8220;Awards&#8221;) or stock options, to determine the number of Awards or stock options to be granted to an eligible person; to determine the time or times at which or stock options shall be granted; to establish the terms and conditions upon which Awards or Stock Options may be exercised; to remove or adjust any restrictions and conditions upon Awards or Stock Options; to specify, at the time of grant, provisions relating to exercisability of Stock Options and to accelerate or otherwise modify the exercisability of any Stock Options; and to adopt such rules and regulations and to make all other determinations deemed necessary or desirable for the administration of the Plan.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	50
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage75"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	At the annual general shareholder meeting held on October 26, 2012, the Company&#8217;s shareholders approved &#8220;Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan&#8221; (hereinafter the &#8220;2012 Plan&#8221;). The maximum number of shares that may be issued under the 2012 Plan is 750,000 shares of our common stock. All of our employees, officers, and directors, and consultants are eligible to be granted options or restricted stock awards under the 2012 Plan. The 2012 Plan is administered by the Board, which has all the power to administer the 2012 Plan according to its terms, including the power to grant awards, determine who may be granted awards and the types and amounts of awards to be granted, prescribe award agreements, and establish programs for granting awards.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	At the annual general shareholder meeting held on November 22, 2013, the Company&#8217;s shareholders approved the 2013 Equity Incentive Plan. The maximum number of shares that may be issued under the 2013 Plan is 1,150,000 shares of our common stock. All of our employees, officers, and directors, and consultants are eligible to be granted options or restricted stock awards under the 2013 Plan. The 2013 Plan is administered by the Board, which has all the power to administer the 2013 Plan according to its terms, including the power to grant awards, determine who may be granted awards and the types and amounts of awards to be granted, prescribe award agreements, and establish programs for granting awards. As of December 31, 2015, 1,150,000 shares of common stock have been issued under the 2013 plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	At the annual general shareholder meeting held on December 3, 2014, the Company&#8217;s shareholders approved &#8220;Biostar Pharmaceuticals, Inc. 2014 Equity Incentive Plan&#8221; (hereinafter the &#8220;2014 Plan&#8221;). The maximum number of shares that may be issued under the 2011 Plan is 850,000 shares of our common stock. Under this Plan, the Company may issue common stock and/or options to purchase common stock to certain officers, directors and employees and consultants of the Company and its subsidiaries. The 2014 Plan is administered by the Compensation Committee of the Board (the &#8220;Committee&#8221;), which is comprised of directors who satisfy the &#8220;non-employee director&#8221; definition under Rule 16b-3 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and the &#8220;outside director&#8221; definition under Section 162(m) of the Code. The Committee may delegate to an officer of the Company its authority to grant awards to employees who are not subject to Section 16 of the Exchange Act or who are not &#8220;covered employees&#8221; under Section 162(m) of the Code (collectively, the "Specified Employees"). The committee has full and complete authority, in its discretion, but subject to the express provisions of the Plan to approve the eligible persons nominated by the management of the Company to be granted awards of common stock (&#8220;Awards&#8221;) or stock options, to determine the number of Awards or stock options to be granted to an eligible person; to determine the time or times at which or stock options shall be granted; to establish the terms and conditions upon which Awards or Stock Options may be exercised; to remove or adjust any restrictions and conditions upon Awards or Stock Options; to specify, at the time of grant, provisions relating to exercisability of Stock Options and to accelerate or otherwise modify the exercisability of any Stock Options; and to adopt such rules and regulations and to make all other determinations deemed necessary or desirable for the administration of the Plan. As of April 15, 2016, there were no shares of our common stock and / or options to purchase common stock available for future issuance under the 2014 plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_41"></A>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="16%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Number of Securities to Be Issued
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Upon Exercise of Outstanding
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Options, Warrants, and Rights (a)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="16%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Weighted Average
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Exercise
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Price of
</FONT>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Outstanding
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Options, Warrants, and Rights (b)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="16%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Number of Securities Remaining
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Available for Future Issuance (c)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Equity compensation plans approved by security holders
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="16%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="16%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM" WIDTH="16%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2009 Plan*
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	51,746
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	57.54
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2011 Plan
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,428
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	11.76
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	38,000
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2012 Plan
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2013 Plan
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2014 Plan
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	214,286
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2015 Plan
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	214,286
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Equity compensation plans not approved by security holders
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="46%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	TOTAL
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	55,174
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	54.67
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="15%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	252,286
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV ALIGN="CENTER">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	* The number of shares underlying the options and the exercise price have been adjusted retroactively to reflect the one-for-seven reverse stock split.&#160;
</FONT>
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	51
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage76"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_BENEFICIAL_OWNERS>
<A NAME="FIS_BENEFICIAL_OWNERS"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Security Ownership of Certain Beneficial Owners and Management
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Set forth below is information regarding the beneficial ownership of our common stock, as of March 25 2016, by:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	each person known to us that beneficially owns more than 5% of our outstanding shares of common stock;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	each of our directors;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	each of our named executive officers; and
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="12%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#183;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="75%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	all of our current directors and executive officers as a group.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_BENEFICIAL_OWNERS>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We believe that, except as otherwise noted below, each named beneficial owner has sole voting and investment power with respect to the shares listed. Unless otherwise indicated herein, beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission, and includes voting or investment power with respect to shares beneficially owned. Shares of common stock underlying options or warrants currently exercisable or exercisable on or within 60 days of the date of this report are deemed outstanding for computing the percentage ownership of the person holding the options or warrants, but are not deemed outstanding for computing the percentage ownership of any other person.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
	&#160;
</DIV>
<EFX_BENEFICIAL_OWNERS>
<A NAME="FIS_BENEFICIAL_OWNERS_2"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Name of Beneficial Owner (1)&#160;&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Amount of Beneficial Ownership
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Percent of Class
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Ronghua Wang (2)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	437,475
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	19.7
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Liu Qinghua (3)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3,953
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	*
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Haipeng Wu (3)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	952
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	*
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Zhenghong Wang (3)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	952
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	*
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shuang Gong (3)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	6,334
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	*
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Leung King-fai (3)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	952
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	*
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Zhongyang Shang (3)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2,381
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	*
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	All directors and executive officers&#160;of the Company (seven persons)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	452,999
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	20.3
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	%
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;____________________&#160;
</FONT>
</DIV>
</EFX_BENEFICIAL_OWNERS>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	*Less than 1%.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(1)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="84%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Unless otherwise indicated, the address for each of beneficial owner is: No. 588 Shiji Xi Avenue, Xianyang City, Shaanxi province, PRC, 712046.
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="84%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Includes
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	10,476
</FONT>
	&#160;shares of common stock issuable upon exercise of stock options that were granted on October 22, 2009.
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(3)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="84%" STYLE="TEXT-ALIGN: JUSTIFY">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Consists of shares of common stock issuable upon exercise of stock options there were granted on October 22, 2009.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_SECURITY_OWNERS>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_OFFICER_TRANSACTIONS>
<A NAME="FIS_OFFICER_TRANSACTIONS"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_13">
	IT
</A>
	EM 13.&#160; CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Certain Relationships and Related Transactions
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our executive officers and directors, and principal stockholders, including their immediate family members and affiliates, are not permitted to enter into a related party transaction with us without the prior consent of our Audit Committee, or other independent committee of our board of directors in the case it is inappropriate for our Audit Committee to review such transaction due to a conflict of interest. Any request for us to enter into a transaction with an executive officer, director, principal stockholder, or any of such persons&#8217; immediate family members or affiliates must first be presented to our Audit Committee for review, consideration and approval. All of our directors, executive officers and employees are required to report to our Audit Committee any such related party transaction. In approving or rejecting the proposed agreement, our Audit Committee shall consider the relevant facts and circumstances available and deemed relevant to the Audit Committee. Our Audit Committee shall approve only those agreements that, in light of known circumstances, are in, or are not inconsistent with, our best interests, as our Audit Committee determines in the good faith exercise of its discretion.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Except as set forth in notes to the financial statements included in this Annual Report, during the 2014 and 2015 fiscal years,&#160;the Company has not been a participant in any transaction that is reportable under Item 404(d) of Regulation S-K. The Company knows of no proposed transaction in which it will be a participant that would be reportable under Item 404(d) of Regulation S-K.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	52
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage77"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Director and Board Nominee Independence
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our Board is subject to the independence requirements of the Nasdaq Stock Market (&#8220;Nasdaq&#8221;). The Board undertakes periodic reviews of director independence. During this review, the Board considers transactions and relationships between each director or any member of his immediate family and Biostar and its affiliates, including those transactions that are contemplated under Item 404(a) of Regulation S-K to determine whether any such relationships or transactions exist that are inconsistent with a determination that the director is independent. Our Board has determined that all current members of the Audit Committee, the Compensation Committee and the Nominating and Governance Committee are &#8216;&#8216;independent&#8221; in accordance with the Nasdaq independence requirements and that the members of the Audit Committee are also &#8220;independent&#8221; for purposes of Section 10A-3 of the Exchange Act. Ronghua Wang, in addition to serving on the Board, also serves as our Chief Executive Officer, and does not serve on any of the Board committees. The majority of the Board is comprised of independent directors. The Board based these determinations primarily on a review of the responses of the directors and executive officers to questions regarding employment and transaction history, affiliations and family and other relationships and on discussions with the directors and the fact that no director previously reported a change in circumstances that could affect his independence. None of our directors engages in any transaction, relationship, or arrangement contemplated under Item 404(a) of Regulation S-K.
</FONT>
</DIV>
</EFX_OFFICER_TRANSACTIONS>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_ACCOUNTANT_FEES>
<A NAME="FIS_ACCOUNTANT_FEES"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_14">
	IT
</A>
	EM 14.&#160; PRINCIPAL ACCOUNTING FEES AND SERVICES
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The foregoing determination by the Company was made upon approval and recommendation of the Audit Committee of the Board. On October 19, 2014, the engagement of Mazars CPA Limited (&#8220;Mazars&#8221;), located at 42nd Floor, Central Plaza, 18 Harbour Road, Wanchai, Hong Kong, as the Company&#8217;s new independent registered public accounting firm to audit the Company&#8217;s financial statements for the year ending December 31, 2014 was reviewed, recommended and approved by the Audit Committee effective as of November 15, 2014.&#160;The following table presents fees for professional services rendered by the Company&#8217;s prior and current independent registered public accounting firms for the fiscal years 2014 and 2015:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_42"></A>
<DIV ALIGN="CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="75%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="47%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Services Performed
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2015
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	2014
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Audit Fees (1)
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	200,000
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	155,000
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Audit-Related Fees
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Tax Fees
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%" STYLE="PADDING-BOTTOM: 2PX">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	All Other Fees
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	-
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%" STYLE="PADDING-BOTTOM: 2PX">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="#CCEEFF">
<TD VALIGN="BOTTOM" WIDTH="47%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD COLSPAN="2" VALIGN="BOTTOM" WIDTH="12%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR BGCOLOR="WHITE">
<TD VALIGN="BOTTOM" WIDTH="47%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Total Fees
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	200,000
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	$
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="11%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	155,000
</FONT>
</DIV>
</DIV>
</TD>
<TD VALIGN="BOTTOM" WIDTH="1%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<BR>
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" ID="LIST" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR VALIGN="TOP">
<TD ALIGN="RIGHT" STYLE="WIDTH: 18PT">
<DIV>
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(1)&#160;&#160;
</FONT>
</DIV>
</TD>
<TD>
<DIV STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Audit fees &#8211; the fees related to the audit of our annual financial statements and the revision of our quarterly financial statements.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Audit Committee&#8217;s Pre-Approval Policies and Procedures
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Our Audit Committee has the sole authority to pre-approve all audit and non-audit services provided by our independent accountants.&#160;&#160;The Audit Committee has adopted policies and procedures for the pre-approval of services provided by the independent accountants.&#160;&#160;The Audit Committee on an annual basis reviews audit and non-audit services performed by the independent accountants.&#160;&#160;All audit and non-audit services are pre-approved by the Audit Committee, which considers, among other things, the possible effect of the performance of such services on the accountants&#8217; independence.&#160;&#160;As permitted under the Sarbanes-Oxley Act of 2002, the Audit Committee may delegate pre-approval authority to one or more of its members.&#160;&#160;Any service pre-approved by a delegate must be reported to the Audit Committee at the next scheduled quarterly meeting.&#160;&#160;The Audit Committee considered whether the provision of the auditors&#8217; services, other than for the annual audit and quarterly reviews, is compatible with its independence and concluded that it is compatible.&#160;&#160;In 2013, all such services were pre-approved by the Audit Committee.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	53
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage78"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_ACCOUNTANT_FEES>
</EFX_PART_III>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_PART_IV>
<A NAME="FIS_PART_IV"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	PART IV
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_EXHIBITS>
<A NAME="FIS_EXHIBITS"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_15">
	ITE
</A>
	M 15.&#160; EXHIBITS
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2.1
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Assets Acquisition Agreement with Xi&#8217;an Meipude Biotechnology Co., Ltd. (5)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3.1
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Articles of Incorporation filed with the corporate secretary of State of the State of Maryland on March 27, 2007 (1)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3.2
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Articles of Amendment filed with the corporate secretary of State of the State of Maryland on August 1, 2007 (1)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3.3
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Articles of Amendment filed with the corporate secretary of State of the State of Maryland on September 14, 2007 (1)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3.4
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Certificate of Designation for the Series B Convertible Preferred Stock as filed with the corporate secretary of State of Maryland on November 2, 2009 (2)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3.5
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Articles of Amendment to the Articles of Incorporation filed with the corporate secretary of State of the State of Maryland on April 3, 2012. (12)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3.6
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Bylaws (1)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4.1
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2009 Incentive Stock Plan ** (3)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4.2
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2011 Stock Option Compensation Plan (11)**
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4.3
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2012 Stock Option Compensation Plan (13) **
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	10.1
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Labor Contract between Shaanxi Aoxing Pharmaceutical Co., Ltd. and Ronghua Wang dated June 30, 2010 (6)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	10.2
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Form of Director Offer Letter (4)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	10.3
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Employment Agreement with Zack Pan dated as of April 7, 2011 (7) **
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	10.4
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Amendment No. 1 to the Employment Agreement with Zack Pan dated as of April 20, 2012 (9)**
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	10.5
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Share Transfer Agreement (8)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	10.6
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Supplemental Agreement to Share Transfer Agreement (10)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	10.7
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Product Research and Development Agreement, dated December 16, 2010, by and between Shanxi Aoxing Pharmaceutical Co., Ltd. and Northwest University, Colleague of Life Science*
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	10.8
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Supplemental Agreement to Share Transfer Contract, dated March 11, 2013, by and between Shaanxi Aoxing Pharmaceutical Co., Ltd. and all the former equity holders of Shaanxi Weinan Huaren Pharmaceuticals. Ltd.
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	14.1
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Code of Ethics (4)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	21
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#EX21_HTM">
	List of subsidiaries *
</A>
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	23.1
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#EX23-1_HTM">
	Consent of Independent Registered Public Accounting Firm *
</A>
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	23.2
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#EX23-2_HTM">
	Consent of Independent Registered Public Accounting Firm *
</A>
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	23.3
</FONT>
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#EX23-3_HTM">
	Consent of Independent Registered Public Accounting Firm *
</A>
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	31.1
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#EX31-1_HTM">
	Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *
</A>
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	31.2
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#EX31-2_HTM">
	Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *
</A>
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	32.1
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#EX32-1_HTM">
	Certification of the Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 *
</A>
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	32.2
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE">
<A HREF="#EX32-2_HTM">
	Certification of the Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 *
</A>
</FONT>
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	101.INS
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	XBRL Instance Document
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	101.SCH
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	XBRL Taxonomy Extension Schema
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	101.CAL
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	XBRL Taxonomy Calculation Linkbase
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	101.LAB
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	XBRL Taxonomy Extension Label Linkbase
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	101.PRE
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	XBRL Taxonomy Extension Presentation Linkbase
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	101.DEF
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	XBRL Taxonomy Extension Definition Document
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	* Filed herewith.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	** Management agreement or compensatory plan or agreement.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Previously filed and incorporated by reference from as an exhibit to the Company&#8217;s Registration Statement on Form SB-2 (File No. 333-147363) filed with the SEC on November 13, 2007.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Previously filed and incorporated by reference from as an exhibit to the Company&#8217;s Current Report on Form 8-K filed with the SEC on November 3, 2009.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Incorporated by reference from the Company&#8217;s Schedule 14A filed with the SEC on October 1, 2010.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Incorporated by reference from the Company&#8217;s Current Report on Form 8-K filed with the SEC on January 5, 2010.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(5)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Incorporated by reference from the Company&#8217;s Quarterly Report on Form 10-Q filed with the SEC on May 14, 2010.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(6)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Incorporated by reference from the Company&#8217;s Quarterly Report on Form 10-Q filed with the SEC on August 13, 2010.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(7)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Incorporated by reference from the Company&#8217;s Quarterly Report on Form 10-Q filed with the SEC on May 16, 2011.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(8)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Incorporated by reference from the Company&#8217;s Current Report on Form 8-K filed with the SEC on October 11, 2011.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(9)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Incorporated by reference from the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 24, 2012.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(10)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Incorporated by reference from the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 15, 2013.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(11)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Incorporated by reference from the Company&#8217;s Registration Statement on Form S-8 filed with the SEC on August 17, 2012.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(12)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Incorporated by reference from the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 4, 2012.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(13)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Incorporated by reference from the Company&#8217;s Proxy Statement on Schedule 14A filed with the SEC on September 21, 2012.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(14)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Incorporated by reference from the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 27, 2012.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	54
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage79"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<A HREF="#BIOSTARPHARMA10K123115_HTM_TOC">
	Table of Contents
</A>
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_EXHIBITS>
</EFX_PART_IV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_SIGNATURES>
<A NAME="FIS_SIGNATURES"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
<A NAME="BIOSTARPHARMA10K123115_HTM_SIG">
	S
</A>
	IGNATURE PAGE
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In accordance with the requirements of the Exchange Act, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;&#160;
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="36%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="3" VALIGN="TOP" WIDTH="64%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	BIOSTAR PHARMACEUTICALS, INC.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(Registrant)
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="36%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP" WIDTH="59%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="36%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Date: April 14, 2016
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	By:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="49%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	/s/ Ronghua Wang
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP" WIDTH="41%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="49%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Ronghua Wang
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Chief Executive Officer and President
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(Principal Executive Officer)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="36%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Date: April 14, 2016
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	By:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="49%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	/s/ Qinghua Liu
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP" WIDTH="41%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="49%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Qinghua Liu
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Interim Chief Financial Officer
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(Principal Financial and Accounting Officer)
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In accordance with the Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ALIGN="LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="36%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Date: April 14, 2016
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	By:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="49%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	/s/ Qinghua Liu
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="36%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="49%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Qinghua Liu, Interim Chief Financial Officer and Director
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="36%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="49%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="36%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Date: April 14, 2016
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	By:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="49%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	/s/ Haipeng Wu
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="36%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="49%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Haipeng Wu, Director
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="36%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="49%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="36%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Date: April 14, 2016
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	By:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="49%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	/s/ King-fai Leung
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="36%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="49%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	King-fai Leung, Director
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="36%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="49%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="36%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Date: April 14, 2016
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	By:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="49%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	/s/ Zhongyang Shang
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="36%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="5%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="49%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Zhongyang Shang, Director
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="10%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	55
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage80"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_SIGNATURES>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
</EFX_FORM>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage81"></A>
<A NAME="EX21_HTM"></A>
<EFX_EXHIBIT_21>
<A NAME="FIS_EXHIBIT_21"></A>
<EFX_SUBSIDIARIES>
<A NAME="FIS_SUBSIDIARIES"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Exhibit 21
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Biostar Pharmaceuticals, Inc.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	List of subsidiaries
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	As of December 31, 2015
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE">
	Name
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="48%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; TEXT-DECORATION: UNDERLINE; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE">
	Place of incorporation
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shaanxi Biostar Biotech Ltd
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="48%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	People&#8217;s Republic of China
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shaanxi Aoxing Pharmaceutical Co. Ltd.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="48%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	People&#8217;s Republic of China
</FONT>
</DIV>
</TD>
</TR>
</EFX_SUBSIDIARIES>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Shaanxi Weinan Haren Pharmaceuticals, Ltd.
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="48%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	People&#8217;s Republic of China
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage82"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_EXHIBIT_21>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage83"></A>
<A NAME="EX23-1_HTM"></A>
<EFX_EXHIBIT_23>
<A NAME="FIS_EXHIBIT_23"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Exhibit 23.1
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/04/14/0001185185-16-004237_LOGO.JPG" ALT="GRAPHIC">
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_EXPERTS_CONSENT>
<A NAME="FIS_EXPERTS_CONSENT"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Consent of Independent Registered Public Accounting Firm
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	To the Board of Directors of
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Biostar Pharmaceuticals, Inc.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We hereby consent to the incorporation by reference of our report dated April 14, 2016 with respect of the consolidated financial statements of Biostar Pharmaceuticals, Inc. as of and for the years ended December 31, 2015 and 2014 into the Annual Report on Form 10-K of Biostar Pharmaceuticals, Inc. for the year ended December 31, 2015, which report will be filed with the U.S. Securities and Exchange Commission on April 14, 2016.
</FONT>
</FONT>
</DIV>
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="48%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="DISPLAY: INLINE">
	/s/Mazars CPA Limited&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</FONT>
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="48%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Mazars CPA Limited
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Certified Public Accountants
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP" WIDTH="87%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Hong Kong
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP" WIDTH="87%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	April 14, 2016
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage84"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_EXPERTS_CONSENT>
</EFX_EXHIBIT_23>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage85"></A>
<A NAME="EX23-2_HTM"></A>
<EFX_EXHIBIT_23>
<A NAME="FIS_EXHIBIT_23_2"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Exhibit 23.2
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/04/14/0001185185-16-004237_LOGO.JPG" ALT="GRAPHIC">
</DIV>
<EFX_EXPERTS_CONSENT>
<A NAME="FIS_EXPERTS_CONSENT_2"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Consent of Independent Registered Public Accounting Firm
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	To the Board of Directors of
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Biostar Pharmaceuticals, Inc.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (and the Prospectus included therewith) had been included in the Annual Report on the Form 10-K of Biostar Pharmaceuticals, Inc. for the years ended December 31, 2015 and 2014 as filed with the U.S. Securities and Exchange Commission on April 14, 2016
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="48%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	/s/Mazars CPA Limited&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="48%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Mazars CPA Limited
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Certified Public Accountants
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP" WIDTH="87%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Hong Kong
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP" WIDTH="87%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	April 14, 2016
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
</DIV>
</EFX_EXPERTS_CONSENT>
</EFX_EXHIBIT_23>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage86"></A>
<A NAME="EX23-3_HTM"></A>
<EFX_EXHIBIT_23>
<A NAME="FIS_EXHIBIT_23_3"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Exhibit 23.3
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/04/14/0001185185-16-004237_LOGO.JPG" ALT="GRAPHIC">
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<EFX_EXPERTS_CONSENT>
<A NAME="FIS_EXPERTS_CONSENT_3"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Consent of Independent Registered Public Accounting Firm
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	To the Board of Directors of
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Biostar Pharmaceuticals, Inc.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated July 17, 2014 of Biostar Pharmaceuticals, Inc. of our report dated April 14, 2016 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K of Biostar Pharmaceuticals, Inc. for the years ended December 31, 2015 and 2014.
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="48%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	/s/Mazars CPA Limited&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="TOP" WIDTH="48%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Mazars CPA Limited
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	Certified Public Accountants
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP" WIDTH="87%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Hong Kong
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP" WIDTH="87%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	April 14, 2016
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
</DIV>
</EFX_EXPERTS_CONSENT>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
</EFX_EXHIBIT_23>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage87"></A>
<A NAME="EX31-1_HTM"></A>
<EFX_EXHIBIT_31>
<A NAME="FIS_EXHIBIT_31"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Exhibit 31.1
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_CERTIFICATION>
<A NAME="FIS_CERTIFICATION"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	CERTIFICATION
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	I, Ronghua Wang, certify that:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="84%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	I have reviewed this Annual
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	&#160;
</FONT>
	Report on Form
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	&#160;
</FONT>
	10-K of Biostar Pharmaceuticals, Inc.;
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV>
	&#160;
</DIV>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="84%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="84%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="84%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	a.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	b.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	c.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	d.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="84%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	a.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	b.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Dated: April 14, 2016
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	By:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="40%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	/s/ Ronghua Wang
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="40%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Ronghua Wang
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="40%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Chief Executive Officer
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="7%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="40%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(Principal Executive Officer)
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
	&#160;
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage88"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_CERTIFICATION>
</EFX_EXHIBIT_31>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage89"></A>
<A NAME="EX31-2_HTM"></A>
<EFX_EXHIBIT_31>
<A NAME="FIS_EXHIBIT_31_2"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Exhibit 31.2
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<EFX_CERTIFICATION>
<A NAME="FIS_CERTIFICATION_2"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	CERTIFICATION
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	I, Qinghua Liu, certify that:
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	1.&#160;&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="84%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	I have reviewed this Annual
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	&#160;
</FONT>
	Report on Form
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-STYLE: ITALIC; DISPLAY: INLINE">
	&#160;
</FONT>
	10-K of Biostar Pharmaceuticals, Inc.;
</FONT>
</FONT>
</DIV>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
	&#160;
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	2.&#160;&#160;
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="84%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	3.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="84%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	4.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="84%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	a.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	b.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	c.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	d.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	5.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="84%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	a.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	b.
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="82%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls over financial reporting.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Dated: April 14 2016
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	By:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="41%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	/s/ Qinghua Liu
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="41%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Qinghua Liu
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="41%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Interim Chief Financial Officer
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="41%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(Principal Financial and Accounting Officer)
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage90"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_CERTIFICATION>
</EFX_EXHIBIT_31>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage91"></A>
<A NAME="EX32-1_HTM"></A>
<EFX_EXHIBIT_32>
<A NAME="FIS_EXHIBIT_32"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Exhibit 32.1
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_CERTIFICATION>
<A NAME="FIS_CERTIFICATION_3"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	CERTIFICATION
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In connection with the Annual Report of Biostar Pharmaceuticals, Inc. (the &#8220;Company&#8221;) on Form 10-K for the fiscal year ended December 31, 2015, as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;), I, Ronghua Wang, Chief Executive Officer (Principal Executive Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(1)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Dated: April 14, 2016
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	By:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="41%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	/s/ Ronghua Wang
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="41%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Ronghua Wang
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="41%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Chief Executive Officer
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="41%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="MARGIN-LEFT: 0PT; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT">
<DIV ID="FTR">
<DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
<DIV ID="PN" STYLE="PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%">
<HR STYLE="COLOR: BLACK" NOSHADE SIZE="2">
</DIV>
</DIV>
<A NAME="eolPage92"></A>
<DIV ID="HDR">
<DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="RIGHT">
<FONT STYLE="FONT-SIZE: 8PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_CERTIFICATION>
</EFX_EXHIBIT_32>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage93"></A>
<A NAME="EX32-2_HTM"></A>
<EFX_EXHIBIT_32>
<A NAME="FIS_EXHIBIT_32_2"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	Exhibit 32.2
</FONT>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<EFX_CERTIFICATION>
<A NAME="FIS_CERTIFICATION_4"></A>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="CENTER">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD; DISPLAY: INLINE">
	CERTIFICATION
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 36PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	In connection with the Annual Report of Biostar Pharmaceuticals, Inc. (the &#8220;Company&#8221;) on Form 10-K for the fiscal year ended December 31, 2015, as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;), I, Qinghua Liu, Interim Chief Financial Officer (Principal Financial and Accounting Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(1)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="3%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD VALIGN="TOP" WIDTH="3%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	(2)
</FONT>
</DIV>
</TD>
<TD VALIGN="TOP" WIDTH="80%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="JUSTIFY">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN">
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Dated: April 14, 2016
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	By:
</FONT>
</DIV>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="41%" STYLE="BORDER-BOTTOM: BLACK 2PX SOLID">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	/s/ Qinghua Liu
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="41%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Qinghua Liu
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="41%">
<DIV STYLE="MARGIN-LEFT: 0PT; DISPLAY: BLOCK; MARGIN-RIGHT: 0PT; TEXT-INDENT: 0PT" ALIGN="LEFT">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	Interim Chief Financial Officer
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="39%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="6%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="41%">
<FONT STYLE="FONT-SIZE: 10PT; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE">
	&#160;
</FONT>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_CERTIFICATION>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
<DIV STYLE="DISPLAY: BLOCK; TEXT-INDENT: 0PT">
<BR>
</DIV>
</EFX_EXHIBIT_32>

<!-- FOOTER LOGO -->
</BODY>
</HTML>
